Michelle A.T. Hildebrandt, Ph.D.

Peer-Reviewed Articles

1. Tonn T, Thawani M, Mazer M, Aune G, Eshelman-Kent D, Albritton K, Koutroumpakis E, Roth ME, Hildebrandt MAT. Disparities in cardiovascular disease burden among Black and Hispanic survivors of adolescent and young adult (AYA) cancer. Cardiooncology, 2026. e-Pub 2026. PMID: 41508149.
2. Conry M, Ostrovnaya I, Kemel Y, Sinha S, Baughn LB, Avery B, Maclachlan K, Groner V, Banaszak L, Norman A, Boddicker NJ, Clay-Gilmour A, Kumar S, Kim E, Dandiker S, Waghmare M, Slager S, Sborov DW, Garber J, Brown EE, Hildebrandt M, Hari P, Camp N, Vachon C, Usmani S, Offit K, Joseph V. Multiple myeloma risk linked to DNA damage response genes. J Hematol Oncol, 2026. e-Pub 2026. PMID: 41495781.
3. Cerhan, JR, Sokolova, T, Cahn, EJ, Tsang, M, Strouse, CS, Hildebrandt, MA, Rosenthal, AC, Feldman, AL, Jaye, DL, Martin, P, Cohen, JB, Kahl, BS, Lossos, IS, Friedberg, JW, Nastoupil, L, Link, BK, Habermann, TM, Maurer, MJ, Casulo, C, Thompson, CA, Williams, A, Flowers, CR. Adaptation and Performance of the Self-Report-Generated Charlson Comorbidity Index in the Lymphoma Epidemiology of Outcomes (LEO) Cohort. Hematological Oncology 43(6), 2025. e-Pub 2025. PMID: 41057230.
4. Strati P, Brandt A, Lionel AC, Henderson J, Westin JR, Adkins S, Shpall EJ, Kebriaei P, Ramdial J, Saini N, Ahmed S, Flowers C, Neelapu SS, Hildebrandt MAT. Germline determinants of toxicity and efficacy in patients with large B-cell lymphoma treated with CAR T-cell therapy. J Immunother Cancer 13(10), 2025. e-Pub 2025. PMID: 41067879.
5. Colin-Leitzinger C, Lawson-Michod KA, Johnson CE, Vlasac IM, Yoder S, Mesa T, Roeber D, Huff C, Hildebrandt MAT, Haller K, Alberg AJ, Bandera EV, Bondy M, Cote ML, Hastert T, Peters ES, Terry PD, Lawson AB, Berchuck A, Fridley BL, Chern JY, Doherty JA, Marks JR, Schildkraut JM, Christensen BC, Salas LA, Peres LC. Retrotransposon methylation profiles and survival in Black women with high-grade serous ovarian carcinoma. Clin Epigenetics 17(1):134, 2025. e-Pub 2025. PMID: 40734190.
6. Choi E, Berkman AM, Andersen CR, Salsman JM, Betts AC, Milam J, Miller KA, Peterson SK, Lu Q, Cheung CK, Ghazal LV, Livingston JA, Hildebrandt MAT, Parsons SK, Freyer DR, Roth ME. Cancer Screening Uptake and Usual Source of Care Among Hispanic Survivors of Adolescent and Young Adult Cancer. J Adolesc Young Adult Oncol, 2025. e-Pub 2025. PMID: 40712648.
7. Berkman AM, Andersen CR, Puthenpura V, Short NJ, Merriman K, Swaminathan M, Cuglievan B, McCall D, DiNardo C, Nunez C, Jain N, Kadia T, Issa G, Gibson A, Garcia MB, Livingston JA, Parsons S, Hildebrandt MAT, Roth ME. Risk of early death after acute leukemia diagnosis among adolescents and young adults. JNCI Cancer Spectr 9(4), 2025. e-Pub 2025. PMID: 40579211.
8. Corrigan KL, Berkman AM, Gunther J, Andersen CR, Wu S, Gibson A, Cuglievan B, Garcia MB, Manzar G, Fang P, De B, Ahmed S, Nunez C, Hildebrandt MAT, McCall DC, Parsons SK, Roth ME. Trends in Radiation Use from 2004-2020 Among Adolescents and Young Adults with Hodgkin Lymphoma. Cancer Epidemiol Biomarkers Prev, 2025. e-Pub 2025. PMID: 40488452.
9. Berkman AM, Andersen CR, Dixon SB, Ramirez A, Gilmore K, Thoman W, Razouki ZA, Santos D, Thosani S, Livingston JA, Hildebrandt MAT, Roth ME. Weight-Related Outcomes Among Survivors of Adolescent and Young Adult Cancer after Anti-Obesity Medication Initiation. J Adolesc Young Adult Oncol, 2025. e-Pub 2025. PMID: 40452567.
10. Cruz CA, Rodriguez ER, Thawani M, Mazer M, Hayhurst M, Swanson M, Romero A, Livingston JA, Aune G, Eshelman-Kent D, Cuglievan B, Roth ME, Ahmed S, Albritton K, Hildebrandt MAT. Differences in time to treatment and impact on overall survival in adolescents and young adults with Hodgkin lymphoma. Leuk Lymphoma:1-7, 2025. e-Pub 2025. PMID: 40337837.
11. Ugalde-Morales E, Wilf R, Pluta J, Ploner A, Fan M, Damra M, Aben KK, Anson-Cartwright L, Chen C, Cortessis VK, Daneshmand S, Ferlin A, Gamulin M, Gietema JA, Gonzalez-Niera A, Grotmol T, Hamilton RJ, Harland M, Haugen TB, Hauser R, Hildebrandt MAT, Karlsson R, Kiemeney LA, Kim J, Lessel D, Lothe RA, Loveday C, Chanock SJ, McGlynn KA, Meijer C, Nead KT, Nsengimana J, Popovic M, Rafnar T, Richiardi L, Rocca MS, Schwartz SM, Skotheim RI, Stefansson K, Stewart DR, Turnbull C, Vaughn DJ, Winge SB, Zheng T, Monteiro AN, Almstrup K, Kanetsky PA, Nathanson KL, Wiklund F. Identification of genes associated with testicular germ cell tumor susceptibility through a transcriptome-wide association study. Am J Hum Genet 112(3):630-643, 2025. e-Pub 2025. PMID: 39999848.
12. Flowers CR, Anantha RW, Leautaud V, Desai P, Donald CE, Hildebrandt MAT, Koff JL, Tamimi RM, Cozen W, Nze C, Melnick AM. Addressing Health Disparities in Hematologic Malignancies: from Genes to Outreach. Blood Cancer Discov:OF1-OF15, 2025. e-Pub 2025. PMID: 39898759.
13. George IA, Souder B, Berkman A, Noyd DH, Jay Campbell M, Barker PCA, Roth M, Hildebrandt MAT, Oeffinger KC, McCrary AW, Landstrom AP. Obesity Predisposes Anthracycline-Treated Survivors of Childhood and Adolescent Cancers to Subclinical Cardiac Dysfunction. Pediatr Cardiol, 2025. e-Pub 2025. PMID: 38456890.
14. Berkman AM, Choi E, Cheung CK, Salsman JM, Peterson SK, Andersen CR, Lu Q, Livingston JA, Battle A, Hildebrandt MAT, Parsons SK, Roth ME. Excess risk of chronic health conditions in Black adolescent and young adult cancer survivors. J Cancer Surviv 18(6):1931-1940, 2024. e-Pub 2024. PMID: 37578615.
15. Giaccherini M, Clay-Gilmour AI, Liotti R, Macauda A, Gentiluomo M, Brown EE, Machiela MJ, Chanock SJ, Hildebrandt MAT, Norman AD, Manasanch E, Rajkumar SV, Hofmann JN, Berndt SI, Bhatti P, Giles GG, Ziv E, Kumar SK, Camp NJ, Cozen W, Slager SL, Canzian F, Gemignani F, Vachon CM, Campa D. Genetically determined telomere length in monoclonal gammopathy of undetermined significance, multiple myeloma risk and outcome. Blood Cancer J 14(1):200, 2024. e-Pub 2024. PMID: 39528488.
16. Roth M, Andersen CR, Berkman A, Siegel S, Cuglievan B, Livingston JA, Hildebrandt M, Estrada J, Bleyer A. Improved survival and decreased cancer deaths in young adults with cancer after passage of the Affordable Care Act Dependent Coverage Expansion. Cancer, 2024. e-Pub 2024. PMID: 39370757.
17. Choi E, Berkman AM, Andersen CR, Salsman JM, Betts AC, Milam J, Miller KA, Peterson SK, Lu Q, Cheung CK, Ghazal LV, Livingston JA, Hildebrandt MAT, Parsons SK, Freyer DR, Roth ME. Psychological distress and mental health care utilization among lesbian, gay, and bisexual survivors of adolescent and young adult cancer. Support Care Cancer 32(9):585, 2024. e-Pub 2024. PMID: 39134915.
18. Rodriguez ER, Tonn T, Jafry M, Ahmed S, Cuglievan B, Livingston JA, Flowers CR, Aune GJ, Albritton KH, Roth ME, Xiao Q, Hildebrandt MAT. Neighborhood-level Social Determinants of Health Burden among AYA Cancer Patients and Impact on Overall Survival. JNCI Cancer Spectr, 2024. e-Pub 2024. PMID: 39051679.
19. Kalariya N, Hildebrandt MAT, Hansen DK, Sidana S, Khouri J, Ferreri CJ, Doyle WN Jr, Castaneda Puglianini OA, Freeman CL, Hovanky V, Hosoya H, Shune L, Patel KK. Clinical Outcomes After Idecabtagene Vicleucel in Older Multiple Myeloma Patients: A Multicenter Real-world Experience. Blood Adv, 2024. e-Pub 2024. PMID: 39042903.
20. George GC, Andersen C, Tang X, Swartz MC, Ahmed S, Barcenas CH, Livingston JA, Roth M, Hildebrandt MAT. Patient-Reported Health-Related Quality of Life at Diagnosis in Survivors of Adolescent and Young Adult Cancers. J Natl Compr Canc Netw 12:1-8, 2024. e-Pub 2024. PMID: 38996438.
21. Dareng EO, Coetzee SG, Tyrer JP, Peng PC, Rosenow W, Chen S, Davis BD, Dezem FS, Seo JH, Nameki R, Reyes AL, Aben KKH, Anton-Culver H, Antonenkova NN, Aravantinos G, Bandera EV, Beane Freeman LE, Beckmann MW, Beeghly-Fadiel A, Benitez J, Bernardini MQ, Bjorge L, Black A, Bogdanova NV, Bolton KL, Brenton JD, Budzilowska A, Butzow R, Cai H, Campbell I, Cannioto R, Chang-Claude J, Chanock SJ, Chen K, Chenevix-Trench G, Chiew YE, Cook LS, DeFazio A, Dennis J, Doherty JA, Dork T, du Bois A, Durst M, Eccles DM, Ene G, Fasching PA, Flanagan JM, Fortner RT, Fostira F, Gentry-Maharaj A, Giles GG, Goodman MT, Gronwald J, Haiman CA, Hakansson N, Heitz F, Hildebrandt MAT, Hogdall E, Hogdall CK, Huang RY, Jensen A, Jones ME, Kang D, Karlan BY, Karnezis AN, Kelemen LE, Kennedy CJ, Khusnutdinova EK, Kiemeney LA, Kjaer SK, Kupryjanczyk J, Labrie M, Lambrechts D, Larson MC, Le ND, Lester J, Li L, Lubinski J, Lush M, Marks JR, Matsuo K, May T, McLaughlin JR, McNeish IA, Menon U, Missmer S, Modugno F, Moffitt M, Monteiro AN, Moysich KB, Narod SA, Nguyen-Dumont T, Odunsi K, Olsson H, Onland-Moret NC, Park SK, Pejovic T, Permuth JB, Piskorz A, Prokofyeva D, Riggan MJ, Risch HA, Rodriguez-Antona C, Rossing MA, Sandler DP, Setiawan VW, Shan K, Song H, Southey MC, Steed H, Sutphen R, Swerdlow AJ, Teo SH, Terry KL, Thompson PJ, Vestrheim Thomsen LC, Titus L, Trabert B, Travis R, Tworoger SS, Valen E, Van Nieuwenhuysen E, Edwards DV, Vierkant RA, Webb PM, Weinberg CR, Weise RM, Wentzensen N, White E, Winham SJ, Wolk A, Woo YL, Wu AH, Yan L, Yannoukakos D, Zeinomar N, Zheng W, Ziogas A, Berchuck A, Goode EL, Huntsman DG, Pearce CL, Ramus SJ, Sellers TA, Freedman ML, Lawrenson K, Schildkraut JM, Hazelett D, Plummer JT, Kar S, Jones MR, Pharoah PDP, Gayther SA. Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions. Am J Hum Genet 111(6):1061-1083, 2024. e-Pub 2024. PMID: 38723632.
22. Berkman AM, Choi E, Salsman JM, Peterson SK, Cheung CK, Andersen CR, Lu Q, Livingston JA, Hildebrandt MAT, Parsons SK, Roth ME. Excess Risk of Chronic Health Conditions in Hispanic Survivors of Adolescent and Young Adult Cancers. J Cancer Surviv 18(3):907-916, 2024. e-Pub 2024. PMID: 36750493.
23. Stafford LK, Tang X, Brandt A, Ma J, Banchs J, Livingston JA, Roth ME, Morrison AC, Hildebrandt MAT. Risk of Anthracycline-induced Cardiac Dysfunction in Adolescent and Young Adult (AYA) Cancer Survivors: Role of Genetic Susceptibility Loci. Pharmacogenomics J 24(4):21, 2024. e-Pub 2024. PMID: 38951505.
24. Berkman AM, Andersen CR, Landstrom AP, Hildebrandt MAT, Gilchrist SC, Roth ME. Cardiovascular Disease in Childhood, Adolescent, and Young Adult Cancer Survivors: The Impact of Family History of Premature Heart Disease. J Adolesc Young Adult Oncol 13(3):548-556, 2024. e-Pub 2024. PMID: 38261412.
25. Choi E, Berkman AM, Battle A, Betts AC, Salsman JM, Milam J, Andersen CR, Miller KA, Peterson SK, Lu Q, Cheung CK, Livingston JA, Hildebrandt MAT, Parsons SK, Freyer DR, Roth ME. Psychological distress and mental health care utilization among Black survivors of adolescent and young adult cancer. Cancer, 2024. e-Pub 2024. PMID: 38676935.
26. Berkman AM, Choi E, Cheung CK, Salsman JM, Peterson SK, Andersen CR, Lu Q, Livingston JA, Hildebrandt MAT, Parsons SK, Roth ME. Socioeconomic Status and Chronic Health Conditions in Asian Survivors of Adolescent and Young Adult Cancers. J Adolesc Young Adult Oncol 13(2):262-270, 2024. e-Pub 2024. PMID: 37594775.
27. Berkman AM, Choi E, Cheung CK, Salsman JM, Peterson SK, Andersen CR, Lu Q, Livingston JA, Hildebrandt MAT, Parsons SK, Roth ME. Risk of chronic health conditions in lesbian, gay, and bisexual survivors of adolescent and young adult cancers. Cancer 130(4):553-562, 2024. e-Pub 2024. PMID: 38044705.
28. Wooten SV, Amini B, Roth M, Leung CH, Wang J, Hildebrandt MAT, Kleinerman E. Adolescent and young adult Hodgkin lymphoma patients at risk for subcutaneous fat gain during early cancer treatment: a brief report. Leuk Lymphoma 65(1):62-68, 2024. e-Pub 2024. PMID: 37878765.
29. Choi E, Berkman AM, Cheung CK, Betts AC, Salsman JM, Andersen CR, Ochoa-Dominguez CY, Miller K, Milam J, Shah A, Peterson SK, Lu Q, Livingston JA, Hildebrandt MAT, Parsons SK, Freyer D, Roth ME. Psychological distress and mental health care utilization among Hispanic/Latino survivors of adolescent and young adult cancer. Psychooncology 32(12):1918-1929, 2023. e-Pub 2023. PMID: 37955581.
30. Wooten SV, Amini B, Livingston JA, Hildebrandt MAT, Chandra J, Gilchrist SC, Roth M, Kleinerman E. Poor Sit-to-Stand Performance in Adolescent and Young Adult Patients with Sarcoma. J Adolesc Young Adult Oncol 12(6):821-827, 2023. e-Pub 2023. PMID: 37155195.
31. Jeyabal P, Bhagat A, Wang F, Roth M, Livingston JA, Gilchrist SC, Banchs J, Hildebrandt MAT, Chandra J, Deswal A, Koutroumpakis E, Wang J, Daw NC, Honey TA, Kleinerman ES. Circulating microRNAs and cytokines as prognostic biomarkers for doxorubicin-induced cardiac injury and for evaluating the effectiveness of an exercise intervention. Clin Cancer Res 29(21):4430-4440, 2023. e-Pub 2023. PMID: 37651264.
32. Macauda A, Briem K, Clay-Gilmour A, Cozen W, Försti A, Giaccherini M, Corradi C, Sainz J, Niazi Y, Ter Horst R, Li Y, Netea MG, Vogel U, Hemminki K, Slager SL, Varkonyi J, Andersen V, Iskierka-Jazdzewska E, Mártinez-Lopez J, Zaucha J, Camp NJ, Rajkumar SV, Druzd-Sitek A, Bhatti P, Chanock SJ, Kumar SK, Subocz E, Mazur G, Landi S, Machiela MJ, Jerez A, Norman AD, Hildebrandt MAT, Kadar K, Berndt SI, Ziv E, Buda G, Nagler A, Dumontet C, Razny M, Watek M, Butrym A, Grzasko N, Dudzinski M, Rybicka-Ramos M, Matera EL, García-Sanz R, Goldschmidt H, Jamroziak K, Jurczyszyn A, Clavero E, Giles GG, Pelosini M, Zawirska D, Kruszewski M, Marques H, Haastrup E, Sánchez-Maldonado JM, Bertsch U, Rymko M, Raab MS, Brown EE, Hofmann JN, Vachon C, Campa D, Canzian F. Identification of novel genetic loci for risk of multiple myeloma by functional annotation. Leukemia 37(11):2326-2329, 2023. e-Pub 2023. PMID: 37723249.
33. Wooten SV, Wang F, Roth ME, Liu G, Livingston JA, Amini B, Gilchrist SC, Hildebrandt M, Kleinerman ES. Early skeletal muscle loss in adolescent and young adult cancer patients treated with anthracycline chemotherapy. Cancer Med 12(22):20798-20809, 2023. e-Pub 2023. PMID: 37902220.
34. Ferreri CJ, Hildebrandt MAT, Hashmi H, Shune LO, McGuirk JP, Sborov DW, Wagner CB, Kocoglu MH, Rapoport A, Atrash S, Voorhees PM, Khouri J, Dima D, Afrough A, Kaur G, Anderson LD, Simmons G, Davis JA, Kalariya N, Peres LC, Lin Y, Janakiram M, Nadeem O, Alsina M, Locke FL, Sidana S, Hansen DK, Patel KK, Castaneda Puglianini OA. Real-world experience of patients with multiple myeloma receiving ide-cel after a prior BCMA-targeted therapy. Blood Cancer J 13(1):117, 2023. e-Pub 2023. PMID: 37558706.
35. Koutros S, Kiemeney LA, Pal Choudhury P, Milne RL, Lopez de Maturana E, Ye Y, Joseph V, Florez-Vargas O, Dyrskjøt L, Figueroa J, Dutta D, Giles GG, Hildebrandt MAT, Offit K, Kogevinas M, Weiderpass E, McCullough ML, Freedman ND, Albanes D, Kooperberg C, Cortessis VK, Karagas MR, Johnson A, Schwenn MR, Baris D, Furberg H, Bajorin DF, Cussenot O, Cancel-Tassin G, Benhamou S, Kraft P, Porru S, Carta A, Bishop T, Southey MC, Matullo G, Fletcher T, Kumar R, Taylor JA, Lamy P, Prip F, Kalisz M, Weinstein SJ, Hengstler JG, Selinski S, Harland M, Teo M, Kiltie AE, Tardón A, Serra C, Carrato A, García-Closas R, Lloreta J, Schned A, Lenz P, Riboli E, Brennan P, Tjønneland A, Otto T, Ovsiannikov D, Volkert F, Vermeulen SH, Aben KK, Galesloot TE, Turman C, De Vivo I, Giovannucci E, Hunter DJ, Hohensee C, Hunt R, Patel AV, Huang WY, Thorleifsson G, Gago-Dominguez M, Amiano P, Golka K, Stern MC, Consortium U, Yan W, Liu J, Li SA, Katta S, Hutchinson A, Hicks B, Wheeler WA, Purdue MP, McGlynn KA, Kitahara CM, Haiman CA, Greene MH, Rafnar T, Chatterjee N, Chanock SJ, Wu X, Real FX, Silverman DT, Garcia-Closas M, Stefansson K, Prokunina-Olsson L, Malats N, Rothman N. Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights. Eur Urol 84(1):127-137, 2023. e-Pub 2023. PMID: 37210288.
36. Clavero E, Sanchez-Maldonado JM, Macauda A, Ter Horst R, Sampaio-Marques B, Jurczyszyn A, Clay-Gilmour A, Stein A, Hildebrandt MAT, Weinhold N, Buda G, García-Sanz R, Tomczak W, Vogel U, Jerez A, Zawirska D, Watek M, Hofmann JN, Landi S, Spinelli JJ, Butrym A, Kumar A, Martínez-López J, Galimberti S, Sarasquete ME, Subocz E, Iskierka-Jazdzewska E, Giles GG, Rybicka-Ramos M, Kruszewski M, Abildgaard N, Verdejo FG, Sánchez Rovira P, da Silva Filho MI, Kadar K, Razny M, Cozen W, Pelosini M, Jurado M, Bhatti P, Dudzinski M, Druzd-Sitek A, Orciuolo E, Li Y, Norman AD, Zaucha JM, Reis RM, Markiewicz M, Rodríguez Sevilla JJ, Andersen V, Jamroziak K, Hemminki K, Berndt SI, Rajkumar V, Mazur G, Kumar SK, Ludovico P, Nagler A, Chanock SJ, Dumontet C, Machiela MJ, Varkonyi J, Camp NJ, Ziv E, Vangsted AJ, Brown EE, Campa D, Vachon CM, Netea MG, Canzian F, Försti A, Sainz J. Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization. Int J Mol Sci 24(10), 2023. e-Pub 2023. PMID: 37239846.
37. Berkman AM, Andersen CR, Hildebrandt MAT, Livingston JA, Green AL, Puthenpura V, Peterson SK, Milam J, Miller KA, Freyer DR, Roth ME. Risk of early death in adolescents and young adults with cancer: a population-based study. J Natl Cancer Inst 115(4):447-455, 2023. e-Pub 2023. PMID: 36682385.
38. Dicanio M, Giaccherini M, Clay-Gilmour A, Macauda A, Sainz J, Machiela MJ, Rybicka-Ramos M, Norman AD, Tyczynska A, Chanock SJ, Barington T, Kumar SK, Bhatti P, Cozen W, Brown EE, Suska A, Haastrup EK, Orlowski RZ, Dudzinski M, Garcia-Sanz R, Kruszewski M, Martinez-Lopez J, Beider K, Iskierka-Jazdzewska E, Pelosini M, Berndt SI, Razny M, Jamroziak K, Rajkumar SV, Jurczyszyn A, Vangsted AJ, Collado PG, Vogel U, Hofmann JN, Petrini M, Butrym A, Slager SL, Ziv E, Subocz E, Giles GG, Andersen NF, Mazur G, Watek M, Lesueur F, Hildebrandt MAT, Zawirska D, Ebbesen LH, Marques H, Gemignani F, Dumontet C, Várkonyi J, Buda G, Nagler A, Druzd-Sitek A, Wu X, Kadar K, Camp NJ, Grzasko N, Waller RG, Vachon C, Canzian F, Campa D. A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk. Int J Cancer 152(2):239-248, 2023. e-Pub 2023. PMID: 36082445.
39. Strati P, Jallouk AP, Sun R, Choi J, Das K, Cherng HJ, Ahmed S, Lee HJ, Iyer SP, Nair R, Nastoupil LJ, Steiner RE, Huff CD, Yu Y, Mistry H, Pulsifer B, Noorani M, Saini N, Shpall EJ, Kebriaei P, Flowers CR, Westin JR, Hildebrandt MAT, Neelapu SS. Impact of conditioning chemotherapy on lymphocyte kinetics and outcomes in LBCL patients treated with CAR T-cell therapy. Leukemia 36(11):2669-2677, 2022. e-Pub 2022. PMID: 36127509.
40. DeVries AA, Dennis J, Tyrer JP, Peng PC, Coetzee SG, Reyes AL, Plummer JT, Davis BD, Chen SS, Dezem FS, Aben KKH, Anton-Culver H, Antonenkova NN, Beckmann MW, Beeghly-Fadiel A, Berchuck A, Bogdanova NV, Bogdanova-Markov N, Brenton JD, Butzow R, Campbell I, Chang-Claude J, Chenevix-Trench G, Cook LS, DeFazio A, Doherty JA, Dörk T, Eccles DM, Eliassen AH, Fasching PA, Fortner RT, Giles GG, Goode EL, Goodman MT, Gronwald J, Group OS, Group A, Håkansson N, Hildebrandt MAT, Huff C, Huntsman DG, Jensen A, Kar S, Karlan BY, Khusnutdinova EK, Kiemeney LA, Kjaer SK, Kupryjanczyk J, Labrie M, Lambrechts D, Le ND, Lubinski J, May T, Menon U, Milne RL, Modugno F, Monteiro AN, Moysich KB, Odunsi K, Olsson H, Pearce CL, Pejovic T, Ramus SJ, Riboli E, Riggan MJ, Romieu I, Sandler DP, Schildkraut JM, Setiawan VW, Sieh W, Song H, Sutphen R, Terry KL, Thompson PJ, Titus L, Tworoger SS, Van Nieuwenhuysen E, Edwards DV, Webb PM, Wentzensen N, Whittemore AS, Wolk A, Wu AH, Ziogas A, Freedman ML, Lawrenson K, Pharoah PDP, Easton DF, Gayther SA, Jones MR. Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci. J Natl Cancer Inst 114(11):1533-1544, 2022. e-Pub 2022. PMID: 36210504.
41. Macauda A, Clay-Gilmour A, Hielscher T, Hildebrandt MAT, Kruszewski M, Orlowski RZ, Kumar SK, Ziv E, Orciuolo E, Brown EE, Försti A, Waller RG, Machiela MJ, Chanock SJ, Camp NJ, Rymko M, Razny M, Cozen W, Várkonyi J, Piredda C, Pelosini M, Belachew AA, Subocz E, Hemminki K, Rybicka-Ramos M, Giles GG, Milne RL, Hofmann JN, Zaucha JM, Vangsted AJ, Goldschmidt H, Rajkumar SV, Tomczak W, Sainz J, Butrym A, Watek M, Iskierka-Jazdzewska E, Buda G, Robinson DP, Jurczyszyn A, Dudzinski M, Martinez-Lopez J, Sinnwell JP, Slager SL, Jamroziak K, Reis RMV, Weinhold N, Bhatti P, Carvajal-Carmona LG, Zawirska D, Norman AD, Mazur G, Berndt SI, Campa D, Vachon CM, Canzian F. Does a Multiple Myeloma Polygenic Risk Score Predict Overall Survival of Myeloma Patients?. Cancer Epidemiol Biomarkers Prev 31(9):1863-1866, 2022. e-Pub 2022. PMID: 35700034.
42. Wooten SV, Roth M, Livingston JA, Hildebrandt MAT, Chandra J, Amini B, Kleinerman ES, Gilchrist SC. Short-term Changes in Skeletal Muscle Mass After Anthracycline Administration in Adolescent and Young Adult Sarcoma Patients. J Adolesc Young Adult Oncol 11(3):320-322, 2022. e-Pub 2022. PMID: 34388045.
43. Clay-Gilmour A, Chattopadhyay S, Hildebrandt MAT, Thomsen H, Weinhold N, Vodicka P, Vodickova L, Hoffmann P, Nöthen MM, Jöckel KH, Schmidt B, Langer C, Hajek R, Hallmans G, Pettersson-Kymmer U, Ohlsson C, Späth F, Houlston R, Goldschmidt H, Manasanch EE, Norman A, Kumar S, Rajkumar SV, Slager S, Försti A, Vachon CM, Hemminki K. Genome-wide meta-analysis of monoclonal gammopathy of undetermined significance (MGUS) identifies risk loci impacting IRF-6. Blood Cancer J 12(4):60, 2022. e-Pub 2022. PMID: 35418122.
44. Dareng EO, Tyrer JP, Barnes DR, Jones MR, Yang X, Aben KKH, Adank MA, Agata S, Andrulis IL, Anton-Culver H, Antonenkova NN, Aravantinos G, Arun BK, Augustinsson A, Balmana J, Bandera EV, Barkardottir RB, Barrowdale D, Beckmann MW, Beeghly-Fadiel A, Benitez J, Bermisheva M, Bernardini MQ, Bjorge L, Black A, Bogdanova NV, Bonanni B, Borg A, Brenton JD, Budzilowska A, Butzow R, Buys SS, Cai H, Caligo MA, Campbell I, Cannioto R, Cassingham H, Chang-Claude J, Chanock SJ, Chen K, Chiew YE, Chung WK, Claes KBM, Colonna S, Cook LS, Couch FJ, Daly MB, Dao F, Davies E, de la Hoya M, de Putter R, Dennis J, DePersia A, Devilee P, Diez O, Ding YC, Doherty JA, Domchek SM, Dork T, du Bois A, Durst M, Eccles DM, Eliassen HA, Engel C, Evans GD, Fasching PA, Flanagan JM, Fortner RT, Machackova E, Friedman E, Ganz PA, Garber J, Gensini F, Giles GG, Glendon G, Godwin AK, Goodman MT, Greene MH, Gronwald J, Hahnen E, Haiman CA, Hakansson N, Hamann U, Hansen TVO, Harris HR, Hartman M, Heitz F, Hildebrandt MAT, Hogdall E, Hogdall CK, Hopper JL, Huang RY, Huff C, Hulick PJ, Huntsman DG, Imyanitov EN, Isaacs C, Jakubowska A, James PA, Janavicius R, Jensen A, Johannsson OT, John EM, Jones ME, Kang D, Karlan BY, Karnezis A, Kelemen LE, Khusnutdinova E, Kiemeney LA, Kim BG, Kjaer SK, Komenaka I, Kupryjanczyk J, Kurian AW, Kwong A, Lambrechts D, Larson MC, Lazaro C, Le ND, Leslie G, Lester J, Lesueur F, Levine DA, Li L, Li J, Loud JT, Lu KH, Lubinski J, Mai PL, Manoukian S, Marks JR, Matsuno RK, Matsuo K, May T, McGuffog L, McLaughlin JR, McNeish IA, Mebirouk N, Menon U, Miller A, Milne RL, Minlikeeva A, Modugno F, Montagna M, Moysich KB, Munro E, Nathanson KL, Neuhausen SL, Nevanlinna H, Yie JNY, Nielsen HR, Nielsen FC, Nikitina-Zake L, Odunsi K, Offit K, Olah E, Olbrecht S, Olopade OI, Olson SH, Olsson H, Osorio A, Papi L, Park SK, Parsons MT, Pathak H, Pedersen IS, Peixoto A, Pejovic T, Perez-Segura P, Permuth JB, Peshkin B, Peterlongo P, Piskorz A, Prokofyeva D, Radice P, Rantala J, Riggan MJ, Risch HA, Rodriguez-Antona C, Ross E, Rossing MA, Runnebaum I, Sandler DP, Santamarina M, Soucy P, Schmutzler RK, Setiawan VW, Shan K, Sieh W, Simard J, Singer CF, Sokolenko AP, Song H, Southey MC, Steed H, Stoppa-Lyonnet D, Sutphen R, Swerdlow AJ, Tan YY, Teixeira MR, Teo SH, Terry KL, Terry MB, Thomassen M, Thompson PJ, Thomsen LCV, Thull DL, Tischkowitz M, Titus L, Toland AE, Torres D, Trabert B, Travis R, Tung N, Tworoger SS, Valen E, van Altena AM, van der Hout AH, Van Nieuwenhuysen E, van Rensburg EJ, Vega A, Edwards DV, Vierkant RA, Wang F, Wappenschmidt B, Webb PM, Weinberg CR, Weitzel JN, Wentzensen N, White E, Whittemore AS, Winham SJ, Wolk A, Woo YL, Wu AH, Yan L, Yannoukakos D, Zavaglia KM, Zheng W, Ziogas A, Zorn KK, Kleibl Z, Easton D, Lawrenson K, DeFazio A, Sellers TA, Ramus SJ, Pearce CL, Monteiro AN, Cunningham J, Goode EL, Schildkraut JM, Berchuck A, Chenevix-Trench G, Gayther SA, Antoniou AC, Pharoah PDP. Polygenic risk modeling for prediction of epithelial ovarian cancer risk. Eur J Hum Genet 30(3):349-362, 2022. e-Pub 2022. PMID: 35027648.
45. Roth M, Berkman A, Andersen CR, Cuglievan B, Andrew Livingston J, Hildebrandt M, Bleyer A. Improved Survival of Young Adults with Cancer Following the Passage of the Affordable Care Act. Oncologist 27(2):135-143, 2022. e-Pub 2022. PMID: 35641206.
46. Yu Y, Chang K, Chen JS, Bohlender RJ, Fowler J, Zhang D, Huang M, Chang P, Li Y, Wong J, Wang H, Gu J, Wu X, Schildkraut J, Cannon-Albright L, Ye Y, Zhao H, Hildebrandt MAT, Permuth JB, Li D, Scheet P, Huff CD. A whole-exome case-control association study to characterize the contribution of rare coding variation to pancreatic cancer risk. HGG Adv 3(1):100078, 2022. e-Pub 2022. PMID: 35047863.
47. Pluta J, Pyle LC, Nead KT, Wilf R, Li M, Mitra N, Weathers B, D'Andrea K, Almstrup K, Anson-Cartwright L, Benitez J, Brown CD, Chanock S, Chen C, Cortessis VK, Ferlin A, Foresta C, Gamulin M, Gietema JA, Grasso C, Greene MH, Grotmol T, Hamilton RJ, Haugen TB, Hauser R, Hildebrandt MAT, Johnson ME, Karlsson R, Kiemeney LA, Lessel D, Lothe RA, Loud JT, Loveday C, Martin-Gimeno P, Meijer C, Nsengimana J, Quinn DI, Rafnar T, Ramdas S, Richiardi L, Skotheim RI, Stefansson K, Turnbull C, Vaughn DJ, Wiklund F, Wu X, Yang D, Zheng T, Wells AD, Grant SFA, Rajpert-De Meyts E, Schwartz SM, Bishop DT, McGlynn KA, Kanetsky PA, Nathanson KL, Consortium TC. Identification of 22 susceptibility loci associated with testicular germ cell tumors. Nat Commun 12(1):4487, 2021. e-Pub 2021. PMID: 34301922.
48. Berkman AM, Andersen CR, Puthenpura V, Livingston JA, Ahmed S, Cuglievan B, Hildebrandt MAT, Roth ME. Disparities in the long-term survival of adolescent and young adult diffuse large B cell lymphoma survivors. Cancer Epidemiol 75:102044, 2021. e-Pub 2021. PMID: 34597882.
49. Berkman AM, Andersen CR, Puthenpura V, Livingston JA, Ahmed S, Cuglievan B, Hildebrandt MAT, Roth ME. Impact of race, ethnicity and socioeconomic status over time on the long-term survival of adolescent and young adult Hodgkin lymphoma survivors. Cancer Epidemiol Biomarkers Prev 30(9):1717-1725, 2021. e-Pub 2021. PMID: 34244160.
50. Belachew AA, Wu X, Callender R, Waller R, Orlowski RZ, Vachon CM, Camp NJ, Ziv E, Hildebrandt MAT. Genetic determinants of multiple myeloma risk within the Wnt/beta-catenin signaling pathway. Cancer Epidemiol 73:101972, 2021. e-Pub 2021. PMID: 34216957.
51. Macauda A, Piredda C, Clay-Gilmour AI, Sainz J, Buda G, Markiewicz M, Barington T, Ziv E, Hildebrandt MAT, Belachew AA, Varkonyi J, Prejzner W, Druzd-Sitek A, Spinelli J, Andersen NF, Hofmann JN, Dudzinski M, Martinez-Lopez J, Iskierka-Jazdzewska E, Milne RL, Mazur G, Giles GG, Ebbesen LH, Rymko M, Jamroziak K, Subocz E, Reis RM, Garcia-Sanz R, Suska A, Haastrup EK, Zawirska D, Grzasko N, Vangsted AJ, Dumontet C, Kruszewski M, Dutka M, Camp NJ, Waller RG, Tomczak W, Pelosini M, Razny M, Marques H, Abildgaard N, Watek M, Jurczyszyn A, Brown EE, Berndt S, Butrym A, Vachon CM, Norman AD, Slager SL, Gemignani F, Canzian F, Campa D. Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients. Int J Cancer 149(2):327-336, 2021. e-Pub 2021. PMID: 33675538.
52. Song H, Dicks EM, Tyrer J, Intermaggio M, Chenevix-Trench G, Bowtell DD, Traficante N, Group A, Brenton J, Goranova T, Hosking K, Piskorz A, van Oudenhove E, Doherty J, Harris HR, Rossing MA, Duerst M, Dork T, Bogdanova NV, Modugno F, Moysich K, Odunsi K, Ness R, Karlan BY, Lester J, Jensen A, Krüger Kjaer S, Høgdall E, Campbell IG, Lázaro C, Pujara MA, Cunningham J, Vierkant R, Winham SJ, Hildebrandt M, Huff C, Li D, Wu X, Yu Y, Permuth JB, Levine DA, Schildkraut JM, Riggan MJ, Berchuck A, Webb PM, Group OS, Cybulski C, Gronwald J, Jakubowska A, Lubinski J, Alsop J, Harrington P, Chan I, Menon U, Pearce CL, Wu AH, de Fazio A, Kennedy CJ, Goode E, Ramus S, Gayther S, Pharoah P. Population based targeted sequencing of 54 candidate genes identifies PALB2 as a susceptibility gene for high grade serous ovarian cancer. J Med Genet 58(5):305-313, 2021. e-Pub 2021. PMID: 32546565.
53. Glubb DM, Thompson DJ, Aben KKH, Alsulimani A, Amant F, Annibali D, Attia J, Barricarte A, Beckmann MW, Berchuck A, Bermisheva M, Bernardini MQ, Bischof K, Bjorge L, Bodelon C, Brand AH, Brenton JD, Brinton LA, Bruinsma F, Buchanan DD, Burghaus S, Butzow R, Cai H, Carney ME, Chanock SJ, Chen C, Chen XQ, Chen Z, Cook LS, Cunningham JM, De Vivo I, deFazio A, Doherty JA, Dörk T, du Bois A, Dunning AM, Dürst M, Edwards T, Edwards RP, Ekici AB, Ewing A, Fasching PA, Ferguson S, Flanagan JM, Fostira F, Fountzilas G, Friedenreich CM, Gao B, Gaudet MM, Gawelko J, Gentry-Maharaj A, Giles GG, Glasspool R, Goodman MT, Gronwald J, Harris HR, Harter P, Hein A, Heitz F, Hildebrandt MAT, Hillemanns P, Høgdall E, Høgdall CK, Holliday EG, Huntsman DG, Huzarski T, Jakubowska A, Jensen A, Jones ME, Karlan BY, Karnezis A, Kelley JL, Khusnutdinova E, Killeen JL, Kjaer SK, Klapdor R, Köbel M, Konopka B, Konstantopoulou I, Kopperud RK, Koti M, Kraft P, Kupryjanczyk J, Lambrechts D, Larson MC, Le Marchand L, Lele S, Lester J, Li AJ, Liang D, Liebrich C, Lipworth L, Lissowska J, Lu L, Lu KH, Macciotta A, Mattiello A, May T, McAlpine JN, McGuire V, McNeish IA, Menon U, Modugno F, Moysich KB, Nevanlinna H, Odunsi K, Olsson H, Orsulic S, Osorio A, Palli D, Park-Simon TW, Pearce CL, Pejovic T, Permuth JB, Podgorska A, Ramus SJ, Rebbeck TR, Riggan MJ, Risch HA, Rothstein JH, Runnebaum IB, Scott RJ, Sellers TA, Senz J, Setiawan VW, Siddiqui N, Sieh W, Spiewankiewicz B, Sutphen R, Swerdlow AJ, Szafron LM, Teo SH, Thompson PJ, Thomsen LCV, Titus L, Tone A, Tumino R, Turman C, Vanderstichele A, Edwards DV, Vergote I, Vierkant RA, Wang Z, Wang-Gohrke S, Webb PM, Group OS, Group A, White E, Whittemore AS, Winham SJ, Wu X, Wu AH, Yannoukakos D, Spurdle AB, O'Mara TA. Cross-cancer genome-wide association study of endometrial cancer and epithelial ovarian cancer identifies genetic risk regions associated with risk of both cancers. Cancer Epidemiol Biomarkers Prev 30(1):217-228, 2021. e-Pub 2021. PMID: 33144283.
54. Belachew AA, Reyes ME, Ye Y, Raju GS, Rodriguez MA, Wu X, Hildebrandt MAT. Patterns of racial/ethnic disparities in baseline health-related quality of life and relationship with overall survival in patients with colorectal cancer. Qual Life Res 29(11):2977-2986, 2020. e-Pub 2020. PMID: 32621260.
55. Berkman AM, Livingston JA, Merriman K, Hildebrandt M, Wang J, Dibaj S, McQuade J, You N, Ying A, Barcenas C, Bodurka D, DePombo A, Lee HJ, de Groot J, Roth M. Long-Term Survival Among 5-Year Survivors of Adolescent and Young Adult Cancer. Cancer 126(16):3708-3718, 2020. e-Pub 2020. PMID: 32484922.
56. Clay-Gilmour AI, Hildebrandt MAT, Brown EE, Hofmann JN, Spinelli JJ, Giles GG, Cozen W, Bhatti P, Wu X, Waller RG, Belachew AA, Robinson DP, Norman AD, Sinnwell JP, Berndt SI, Rajkumar SV, Kumar SK, Chanock SJ, Machiela MJ, Milne RL, Slager SL, Camp NJ, Ziv E, Vachon CM. Co-inherited genetics of multiple myeloma and its precursor, monoclonal gammopathy of undetermined significance. Blood Adv 4(12):2789-2797, 2020. e-Pub 2020. PMID: 32569378.
57. Kleinstern G, Yan H, Hildebrandt MAT, Vijai J, Berndt SI, Ghesquières H, McKay J, Wang SS, Nieters A, Ye Y, Monnereau A, Brooks-Wilson AR, Lan Q, Melbye M, Jackson RD, Teras LR, Purdue MP, Vajdic CM, Vermeulen RCH, Giles GG, Cocco PL, Birmann BM, Kraft P, Albanes D, Zeleniuch-Jacquotte A, Crouch S, Zhang Y, Sarangi V, Asmann Y, Offit K, Salles G, Wu X, Smedby KE, Skibola CF, Slager SL, Rothman N, Chanock SJ, Cerhan JR. Inherited variants at 3q13.33 and 3p24.1 are associated with risk of diffuse large B-cell lymphoma and implicate immune pathways. Hum Mol Genet 29(1):70-79, 2020. e-Pub 2020. PMID: 31600786.
58. Gilchrist SC, Roth M, Livingston JA, Hildebrandt MAT, Kleinerman ES, Banchs J. Short-Term Changes in Cardiac Function in Osteosarcoma Patients Receiving Anthracyclines. J Adolesc Young Adult Oncol 8(3):385-386, 2019. e-Pub 2019. PMID: 30794081.
59. Chien A, Callender RA, Yokota H, Salamon N, Colby GP, Wang AC, Szeder V, Jahan R, Tateshima S, Villablanca J, Duckwiler G, Vinuela F, Ye Y, Hildebrandt MAT. Unruptured intracranial aneurysm growth trajectory: occurrence and rate of enlargement in 520 longitudinally followed cases. J Neurosurg 132(4):1-11, 2019. e-Pub 2019. PMID: 30835694.
60. Yang Y, Wu L, Shu X, Lu Y, Shu XO, Cai Q, Beeghly-Fadiel A, Li B, Ye F, Berchuck A, Anton-Culver H, Banerjee S, Benitez J, Bjørge L, Brenton JD, Butzow R, Campbell IG, Chang-Claude J, Chen K, Cook LS, Cramer DW, deFazio A, Dennis J, Doherty JA, Dörk T, Eccles DM, Edwards DV, Fasching PA, Fortner RT, Gayther SA, Giles GG, Glasspool RM, Goode EL, Goodman MT, Gronwald J, Harris HR, Heitz F, Hildebrandt MA, Høgdall E, Høgdall CK, Huntsman DG, Kar SP, Karlan BY, Kelemen LE, Kiemeney LA, Kjaer SK, Koushik A, Lambrechts D, Le ND, Levine DA, Massuger LF, Matsuo K, May T, McNeish IA, Menon U, Modugno F, Monteiro AN, Moorman PG, Moysich KB, Ness RB, Nevanlinna H, Olsson H, Onland-Moret NC, Park SK, Paul J, Pearce CL, Pejovic T, Phelan CM, Pike MC, Ramus SJ, Riboli E, Rodriguez-Antona C, Romieu I, Sandler DP, Schildkraut JM, Setiawan VW, Shan K, Siddiqui N, Sieh W, Stampfer MJ, Sutphen R, Swerdlow AJ, Szafron LM, Teo SH, Tworoger SS, Tyrer JP, Webb PM, Wentzensen N, White E, Willett WC, Wolk A, Woo YL, Wu AH, Yan L, Yannoukakos D, Chenevix-Trench G, Sellers TA, Pharoah PDP, Zheng W, Long J. Genetic data from nearly 63,000 women of European descent predicts DNA methylation biomarkers and epithelial ovarian cancer risk. Cancer Res 79(3):505-517, 2019. e-Pub 2019. PMID: 30559148.
61. Manasanch EE, Shah JJ, Lee HC, Weber DM, Thomas SK, Amini B, Feng L, Berkova Z, Hildebrandt M, Orlowski RZ. Bortezomib, lenalidomide, and dexamethasone with panobinostat for front-line treatment of patients with multiple myeloma who are eligible for transplantation: a phase 1 trial. Lancet Haematol 5(12):e628-e640, 2018. e-Pub 2018. PMID: 30501870.
62. Reyes ME, Ma J, Grove ML, Ater JL, Morrison AC, Hildebrandt MAT. RNA sequence analysis of inducible pluripotent stem cell-derived cardiomyocytes reveals altered expression of DNA damage and cell cycle genes in response to doxorubicin. Toxicol Appl Pharmacol 356:44-53, 2018. e-Pub 2018. PMID: 30031762.
63. Lu Y, Beeghly-Fadiel A, Wu L, Guo X, Li B, Schildkraut JM, Im HK, Chen YA, Permuth JB, Reid BM, Teer JK, Moysich KB, Andrulis IL, Anton-Culver H, Arun BK, Bandera EV, Barkardottir RB, Barnes DR, Benitez J, Bjorge L, Brenton J, Butzow R, Caldes T, Caligo MA, Campbell I, Chang-Claude J, Claes KBM, Couch FJ, Cramer DW, Daly MB, deFazio A, Dennis J, Diez O, Domchek SM, Dörk T, Easton DF, Eccles DM, Fasching PA, Fortner RT, Fountzilas G, Friedman E, Ganz PA, Garber J, Giles GG, Godwin AK, Goldgar DE, Goodman MT, Greene MH, Gronwald J, Hamann U, Heitz F, Hildebrandt MAT, Høgdall CK, Hollestelle A, Hulick PJ, Huntsman DG, Imyanitov EN, Isaacs C, Jakubowska A, James P, Karlan BY, Kelemen LE, Kiemeney LA, Kjaer SK, Kwong A, Le ND, Leslie G, Lesueur F, Levine DA, Mattiello A, May T, McGuffog L, McNeish IA, Merritt MA, Modugno F, Montagna M, Neuhausen SL, Nevanlinna H, Nielsen FC, Nikitina-Zake L, Nussbaum RL, Offit K, Olah E, Olopade OI, Olson SH, Olsson H, Osorio A, Park SK, Parsons MT, Peeters PHM, Pejovic T, Peterlongo P, Phelan CM, Pujana MA, Ramus SJ, Rennert G, Risch H, Rodriguez GC, Rodríguez-Antona C, Romieu I, Rookus MA, Rossing MA, Rzepecka IK, Sandler DP, Schmutzler RK, Setiawan VW, Sharma P, Sieh W, Simard J, Singer CF, Song H, Southey MC, Spurdle AB, Sutphen R, Swerdlow AJ, Teixeira MR, Teo SH, Thomassen M, Tischkowitz M, Toland AE, Trichopoulou A, Tung N, Tworoger SS, van Rensburg EJ, Vanderstichele A, Vega A, Edwards DV, Webb PM, Weitzel JN, Wentzensen N, White E, Wolk A, Wu AH, Yannoukakos D, Zorn KK, Gayther SA, Antoniou AC, Berchuck A, Goode EL, Chenevix-Trench G, Sellers TA, Pharoah PDP, Zheng W, Long J. A transcriptome-wide association study among 97,898 women to identify candidate susceptibility genes for epithelial ovarian cancer risk. Cancer Res 78(18):5419-5430, 2018. e-Pub 2018. PMID: 30054336.
64. Kelemen LE, Earp M, Fridley BL, Chenevix-Trench G, Study Group AOC, Fasching PA, Beckmann MW, Ekici AB, Hein A, Lambrechts D, Lambrechts S, Van Nieuwenhuysen E, Vergote I, Rossing MA, Doherty JA, Chang-Claude J, Behrens S, Moysich KB, Cannioto R, Lele S, Odunsi K, Goodman MT, Shvetsov YB, Thompson PJ, Wilkens LR, Dörk T, Antonenkova N, Bogdanova N, Hillemanns P, Runnebaum IB, du Bois A, Harter P, Heitz F, Schwaab I, Butzow R, Pelttari LM, Nevanlinna H, Modugno F, Edwards RP, Kelley JL, Ness RB, Karlan BY, Lester J, Orsulic S, Walsh C, Kjaer SK, Jensen A, Cunningham JM, Vierkant RA, Giles GG, Bruinsma F, Southey MC, Hildebrandt MAT, Liang D, Lu K, Wu X, Sellers TA, Levine DA, Schildkraut JM, Iversen ES, Terry KL, Cramer DW, Tworoger SS, Poole EM, Bandera EV, Olson SH, Orlow I, Vestrheim Thomsen LC, Bjorge L, Krakstad C, Tangen IL, Kiemeney LA, Aben KKH, LFAG M, van Altena AM, Pejovic T, Bean Y, Kellar M, Cook LS, Le ND, Brooks-Wilson A, Gronwald J, Cybulski C, Jakubowska A, Lubinski J, Wentzensen N, Brinton LA, Lissowska J, Hogdall E, Engelholm SA, Hogdall C, Lundvall L, Nedergaard L, Pharoah PDP, Dicks E, Song H, Tyrer JP, McNeish I, Siddiqui N, Carty K, Glasspool R, Paul J, Campbell IG, Eccles D, Whittemore AS, McGuire V, Rothstein JH, Sieh W, Narod SA, Phelan CM, McLaughlin JR, Risch HA, Anton-Culver H, Ziogas A, Menon U, Gayther SA, Gentry-Maharaj A, Ramus SJ, Wu AH, Pearce CL, Lee AW, Pike MC, Kupryjanczyk J, Podgorska A, Plisiecka-Halasa J, Sawicki W, Goode EL, Berchuck A, Association Consortium OC. rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology. Int J Mol Sci 19(9), 2018. e-Pub 2018. PMID: 30134598.
65. Pierzynski JA, Ye Y, Lippman SM, Rodriguez MA, Wu X, Hildebrandt MAT. Socio-demographic, Clinical, and Genetic Determinants of Quality of Life in Lung Cancer Patients. Sci Rep 8(1):10640, 2018. e-Pub 2018. PMID: 30006595.
66. Lin SH, Raju GS, Huff C, Ye Y, Gu J, Chen JS, Hildebrandt MAT, Liang H, Menter DG, Morris J, Hawk E, Stroehlein JR, Futreal A, Kopetz S, Mishra L, Wu X. The Somatic Mutation Landscape of Premalignant Colorectal Adenoma. Gut 67(7):1299-1305, 2018. e-Pub 2018. PMID: 28607096.
67. Dixon-Suen SC, Nagle CM, Thrift AP, Pharoah PDP, Ewing A, Pearce CL, Zheng W, Study Group AOC, Chenevix-Trench G, Fasching PA, Beckmann MW, Lambrechts D, Vergote I, Lambrechts S, Van Nieuwenhuysen E, Rossing MA, Doherty JA, Wicklund KG, Chang-Claude J, Jung AY, Moysich KB, Odunsi K, Goodman MT, Wilkens LR, Thompson PJ, Shvetsov YB, Dörk T, Park-Simon TW, Hillemanns P, Bogdanova N, Butzow R, Nevanlinna H, Pelttari LM, Leminen A, Modugno F, Ness RB, Edwards RP, Kelley JL, Heitz F, du Bois A, Harter P, Schwaab I, Karlan BY, Lester J, Orsulic S, Rimel BJ, Kjær SK, Høgdall E, Jensen A, Goode EL, Fridley BL, Cunningham JM, Winham SJ, Giles GG, Bruinsma F, Milne RL, Southey MC, Hildebrandt MAT, Wu X, Lu KH, Liang D, Levine DA, Bisogna M, Schildkraut JM, Berchuck A, Cramer DW, Terry KL, Bandera EV, Olson SH, Salvesen HB, Thomsen LCV, Kopperud RK, Bjorge L, Kiemeney LA, LFAG M, Pejovic T, Bruegl A, Cook LS, Le ND, Swenerton KD, Brooks-Wilson A, Kelemen LE, Lubinski J, Huzarski T, Gronwald J, Menkiszak J, Wentzensen N, Brinton L, Yang H, Lissowska J, Høgdall CK, Lundvall L, Song H, Tyrer JP, Campbell I, Eccles D, Paul J, Glasspool R, Siddiqui N, Whittemore AS, Sieh W, McGuire V, Rothstein JH, Narod SA, Phelan C, Risch HA, McLaughlin JR, Anton-Culver H, Ziogas A, Menon U, Gayther SA, Ramus SJ, Gentry-Maharaj A, Wu AH, Pike MC, Tseng CC, Kupryjanczyk J, Dansonka-Mieszkowska A, Budzilowska A, Rzepecka IK, Webb PM, Association Consortium OC. Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study. Br J Cancer 118(8):1123-1129, 2018. e-Pub 2018. PMID: 29555990.
68. Ong JS, Hwang LD, Cuellar-Partida G, Martin NG, Chenevix-Trench G, Quinn MCJ, Cornelis MC, Gharahkhani P, Webb PM, MacGregor S, Association Consortium OC. Assessment of moderate coffee consumption and risk of epithelial ovarian cancer: a Mendelian randomization study. Int J Epidemiol 47(2):450-459, 2018. e-Pub 2018. PMID: 29186515.
69. Yu Y, Hu H, Bohlender RJ, Hu F, Chen JS, Holt C, Fowler J, Guthery SL, Scheet P, Hildebrandt MAT, Yandell M, Huff CD. XPAT: A toolkit to conduct cross-platform association studies with heterogeneous sequencing datasets. Nucleic Acids Res 46(6):e32, 2018. e-Pub 2018. PMID: 29294048.
70. Deng Y, Tu H, Pierzynski JA, Miller ED, Gu X, Huang M, Chang DW, Ye Y, Hildebrandt MAT, Klein AP, Zhao R, Lippman SM, Wu X. Determinants and prognostic value of quality of life in patients with pancreatic ductal adenocarcinoma. Eur J Cancer 92:20-32, 2018. e-Pub 2018. PMID: 29413686.
71. Earp M, Tyrer JP, Winham SJ, Lin HY, Chornokur G, Dennis J, Aben KKH, Anton-Culver H, Antonenkova N, Bandera EV, Bean YT, Beckmann MW, Bjorge L, Bogdanova N, Brinton LA, Brooks-Wilson A, Bruinsma F, Bunker CH, Butzow R, Campbell IG, Carty K, Chang-Claude J, Cook LS, Cramer DW, Cunningham JM, Cybulski C, Dansonka-Mieszkowska A, Despierre E, Doherty JA, Dörk T, du Bois A, Dürst M, Easton DF, Eccles DM, Edwards RP, Ekici AB, Fasching PA, Fridley BL, Gentry-Maharaj A, Giles GG, Glasspool R, Goodman MT, Gronwald J, Harter P, Hein A, Heitz F, Hildebrandt MAT, Hillemanns P, Hogdall CK, Høgdall E, Hosono S, Iversen ES, Jakubowska A, Jensen A, Ji BT, Jung AY, Karlan BY, Kellar M, Kiemeney LA, Kiong Lim B, Kjaer SK, Krakstad C, Kupryjanczyk J, Lambrechts D, Lambrechts S, Le ND, Lele S, Lester J, Levine DA, Li Z, Liang D, Lissowska J, Lu K, Lubinski J, Lundvall L, LFAG M, Matsuo K, McGuire V, McLaughlin JR, McNeish I, Menon U, Milne RL, Modugno F, Moysich KB, Ness RB, Nevanlinna H, Odunsi K, Olson SH, Orlow I, Orsulic S, Paul J, Pejovic T, Pelttari LM, Permuth JB, Pike MC, Poole EM, Rosen B, Rossing MA, Rothstein JH, Runnebaum IB, Rzepecka IK, Schernhammer E, Schwaab I, Shu XO, Shvetsov YB, Siddiqui N, Sieh W, Song H, Southey MC, Spiewankiewicz B, Sucheston-Campbell L, Tangen IL, Teo SH, Terry KL, Thompson PJ, Thomsen L, Tworoger SS, van Altena AM, Vergote I, Vestrheim Thomsen LC, Vierkant RA, Walsh CS, Wang-Gohrke S, Wentzensen N, Whittemore AS, Wicklund KG, Wilkens LR, Woo YL, Wu AH, Wu X, Xiang YB, Yang H, Zheng W, Ziogas A, Lee AW, Pearce CL, Berchuck A, Schildkraut JM, Ramus SJ, Monteiro ANA, Narod SA, Sellers TA, Gayther SA, Kelemen LE, Chenevix-Trench G, Risch HA, Pharoah PDP, Goode EL, Phelan CM. Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility. PLoS One 13(7):e0197561, 2018. e-Pub 2018. PMID: 29979793.
72. Long Y, Sanchez-Espiridion B, Lin M, White L, Mishra L, Raju GS, Kopetz S, Eng C, Hildebrandt MAT, Chang DW, Ye Y, Liang D, Wu X. Global and targeted serum metabolic profiling of colorectal cancer progression. Cancer 123(20):4066-4074, 2017. e-Pub 2017. PMID: 28640361.
73. Lin M, Zhang L, Hildebrandt MAT, Huang M, Wu X, Ye Y. Common, germline genetic variations in the novel tumor suppressor BAP1 and risk of developing different types of cancer. Oncotarget 8(43):74936-74946, 2017. e-Pub 2017. PMID: 29088836.
74. Hildebrandt MAT, Reyes M, Wu X, Pu X, Thompson KA, Ma J, Landstrom AP, Morrison AC, Ater JL. Hypertension Susceptibility Loci are Associated with Anthracycline-related Cardiotoxicity in Long-term Childhood Cancer Survivors. Sci Rep 7(1):9698, 2017. e-Pub 2017. PMID: 28851949.
75. Wu X, Ye Y, Barcenas CH, Chow WH, Meng QH, Chavez-MacGregor M, Hildebrandt MA, Zhao H, Gu X, Deng Y, Wagar E, Esteva FJ, Tripathy D, Hortobagyi GN. Personalized Prognostic Prediction Models for Breast Cancer Recurrence and Survival Incorporating Multidimensional Data. J Natl Cancer Inst 109(7), 2017. e-Pub 2017. PMID: 28376179.
76. Wang Z, McGlynn KA, Rajpert-De Meyts E, Bishop DT, Chung CC, Dalgaard MD, Greene MH, Gupta R, Grotmol T, Haugen TB, Karlsson R, Litchfield K, Mitra N, Nielsen K, Pyle LC, Schwartz SM, Thorsson V, Vardhanabhuti S, Wiklund F, Turnbull C, Chanock SJ, Kanetsky PA, Nathanson KL, Consortium TC. Meta-analysis of five genome-wide association studies identifies multiple new loci associated with testicular germ cell tumor. Nat Genet 49(7):1141-1147, 2017. e-Pub 2017. PMID: 28604732.
77. Phelan CM, Kuchenbaecker KB, Tyrer JP, Kar SP, Lawrenson K, Winham SJ, Dennis J, Pirie A, Riggan MJ, Chornokur G, Earp MA, Lyra PC Jr, Lee JM, Coetzee S, Beesley J, McGuffog L, Soucy P, Dicks E, Lee A, Barrowdale D, Lecarpentier J, Leslie G, Aalfs CM, Aben KKH, Adams M, Adlard J, Andrulis IL, Anton-Culver H, Antonenkova N, Aravantinos G, Arnold N, Arun BK, Arver B, Azzollini J, Balmana J, Banerjee SN, Barjhoux L, Barkardottir RB, Bean Y, Beckmann MW, Beeghly-Fadiel A, Benitez J, Bermisheva M, Bernardini MQ, Birrer MJ, Bjorge L, Black A, Blankstein K, Blok MJ, Bodelon C, Bogdanova N, Bojesen A, Bonanni B, Borg A, Bradbury AR, Brenton JD, Brewer C, Brinton L, Broberg P, Brooks-Wilson A, Bruinsma F, Brunet J, Buecher B, Butzow R, Buys SS, Caldes T, Caligo MA, Campbell I, Cannioto R, Carney ME, Cescon T, Chan SB, Chang-Claude J, Chanock S, Chen XQ, Chiew YE, Chiquette J, Chung WK, Claes KBM, Conner T, Cook LS, Cook J, Cramer DW, Cunningham JM, D'Aloisio AA, Daly MB, Damiola F, Damirovna SD, Dansonka-Mieszkowska A, Dao F, Davidson R, DeFazio A, Delnatte C, Doheny KF, Diez O, Ding YC, Doherty JA, Domchek SM, Dorfling CM, Dork T, Dossus L, Duran M, Durst M, Dworniczak B, Eccles D, Edwards T, Eeles R, Eilber U, Ejlertsen B, Ekici AB, Ellis S, Elvira M, Eng KH, Engel C, Evans DG, Fasching PA, Ferguson S, Ferrer SF, Flanagan JM, Fogarty ZC, Fortner RT, Fostira F, Foulkes WD, Fountzilas G, Fridley BL, Friebel TM, Friedman E, Frost D, Ganz PA, Garber J, Garcia MJ, Garcia-Barberan V, Gehrig A, Gentry-Maharaj A, Gerdes AM, Giles GG, Glasspool R, Glendon G, Godwin AK, Goldgar DE, Goranova T, Gore M, Greene MH, Gronwald J, Gruber S, Hahnen E, Haiman CA, Hakansson N, Hamann U, Hansen TVO, Harrington PA, Harris HR, Hauke J, Hein A, Henderson A, Hildebrandt MAT, Hillemanns P, Hodgson S, Hogdall CK, Hogdall E, Hogervorst FBL, Holland H, Hooning MJ, Hosking K, Huang RY, Hulick PJ, Hung J, Hunter DJ, Huntsman DG, Huzarski T, Imyanitov EN, Isaacs C, Iversen ES, Izatt L, Izquierdo A, Jakubowska A, James P, Janavicius R, Jernetz M, Jensen A, Jensen UB, John EM, Johnatty S, Jones ME, Kannisto P, Karlan BY, Karnezis A, Kast K, Kennedy CJ, Khusnutdinova E, Kiemeney LA, Kiiski JI, Kim SW, Kjaer SK, Kobel M, Kopperud RK, Kruse TA, Kupryjanczyk J, Kwong A, Laitman Y, Lambrechts D, Larranaga N, Larson MC, Lazaro C, Le ND, Le Marchand L, Lee JW, Lele SB, Leminen A, Leroux D, Lester J, Lesueur F, Levine DA, Liang D, Liebrich C, Lilyquist J, Lipworth L, Lissowska J, Lu KH, Lubinnski J, Luccarini C, Lundvall L, Mai PL, Mendoza-Fandino G, Manoukian S, Massuger LFAG, May T, Mazoyer S, McAlpine JN, McGuire V, McLaughlin JR, McNeish I, Meijers-Heijboer H, Meindl A, Menon U, Mensenkamp AR, Merritt MA, Milne RL, Mitchell G, Modugno F, Moes-Sosnowska J, Moffitt M, Montagna M, Moysich KB, Mulligan AM, Musinsky J, Nathanson KL, Nedergaard L, Ness RB, Neuhausen SL, Nevanlinna H, Niederacher D, Nussbaum RL, Odunsi K, Olah E, Olopade OI, Olsson H, Olswold C, O'Malley DM, Ong KR, Onland-Moret NC, Orr N, Orsulic S, Osorio A, Palli D, Papi L, Park-Simon TW, Paul J, Pearce CL, Pedersen IS, Peeters PHM, Peissel B, Peixoto A, Pejovic T, Pelttari LM, Permuth JB, Peterlongo P, Pezzani L, Pfeiler G, Phillips KA, Piedmonte M, Pike MC, Piskorz AM, Poblete SR, Pocza T, Poole EM, Poppe B, Porteous ME, Prieur F, Prokofyeva D, Pugh E, Pujana MA, Pujol P, Radice P, Rantala J, Rappaport-Fuerhauser C, Rennert G, Rhiem K, Rice P, Richardson A, Robson M, Rodriguez GC, Rodriguez-Antona C, Romm J, Rookus MA, Rossing MA, Rothstein JH, Rudolph A, Runnebaum IB, Salvesen HB, Sandler DP, Schoemaker MJ, Senter L, Setiawan VW, Severi G, Sharma P, Shelford T, Siddiqui N, Side LE, Sieh W, Singer CF, Sobol H, Song H, Southey MC, Spurdle AB, Stadler Z, Steinemann D, Stoppa-Lyonnet D, Sucheston-Campbell LE, Sukiennicki G, Sutphen R, Sutter C, Swerdlow AJ, Szabo CI, Szafron L, Tan YY, Taylor JA, Tea MK, Teixeira MR, Teo SH, Terry KL, Thompson PJ, Thomsen LCV, Thull DL, Tihomirova L, Tinker AV, Tischkowitz M, Tognazzo S, Toland AE, Tone A, Trabert B, Travis RC, Trichopoulou A, Tung N, Tworoger SS, van Altena AM, Van Den Berg D, van der Hout AH, van der Luijt RB, Van Heetvelde M, Van Nieuwenhuysen E, van Rensburg EJ, Vanderstichele A, Varon-Mateeva R, Vega A, Edwards DV, Vergote I, Vierkant RA, Vijai J, Vratimos A, Walker L, Walsh C, Wand D, Wang-Gohrke S, Wappenschmidt B, Webb PM, Weinberg CR, Weitzel JN, Wentzensen N, Whittemore AS, Wijnen JT, Wilkens LR, Wolk A, Woo M, Wu X, Wu AH, Yang H, Yannoukakos D, Ziogas A, Zorn KK, Narod SA, Easton DF, Amos CI, Schildkraut JM, Ramus SJ, Ottini L, Goodman MT, Park SK, Kelemen LE, Risch HA, Thomassen M, Offit K, Simard J, Schmutzler RK, Hazelett D, Monteiro AN, Couch FJ, Berchuck A, Chenevix-Trench G, Goode EL, Sellers TA, Gayther SA, Antoniou AC, Pharoah PDP. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer. Nat Genet 49(5):680-691, 2017. e-Pub 2017. PMID: 28346442.
78. Zhang L, Ye Y, Tu H, Hildebrandt MA, Zhao L, Heymach JV, Roth JA, Wu X. MicroRNA-related genetic variants in iron regulatory genes, dietary iron intake, microRNAs and lung cancer risk. Ann Oncol 28(5):1124-1129, 2017. e-Pub 2017. PMID: 28453699.
79. Thompson KA, Hildebrandt MA, Ater JL. Cardiac Outcomes With Pregnancy After Cardiotoxic Therapy for Childhood Cancer. J Am Coll Cardiol 69(5):594-595, 2017. e-Pub 2017. PMID: 28153113.
80. Reyes ME, Ye Y, Zhou Y, Liang A, Kopetz S, Rodriquez MA, Wu X, Hildebrandt MA. Predictors of health-related quality of life and association with survival may identify colorectal cancer patients at high risk of poor prognosis. Qual Life Res 26(2):319-330, 2017. e-Pub 2017. PMID: 27492454.
81. Kar SP, Adler E, Tyrer J, Hazelett D, Anton-Culver H, Bandera EV, Beckmann MW, Berchuck A, Bogdanova N, Brinton L, Butzow R, Campbell I, Carty K, Chang-Claude J, Cook LS, Cramer DW, Cunningham JM, Dansonka-Mieszkowska A, Doherty JA, Dörk T, Dürst M, Eccles D, Fasching PA, Flanagan J, Gentry-Maharaj A, Glasspool R, Goode EL, Goodman MT, Gronwald J, Heitz F, Hildebrandt MA, Høgdall E, Høgdall CK, Huntsman DG, Jensen A, Karlan BY, Kelemen LE, Kiemeney LA, Kjaer SK, Kupryjanczyk J, Lambrechts D, Levine DA, Li Q, Lissowska J, Lu KH, Lubinski J, Massuger LF, McGuire V, McNeish I, Menon U, Modugno F, Monteiro AN, Moysich KB, Ness RB, Nevanlinna H, Paul J, Pearce CL, Pejovic T, Permuth JB, Phelan C, Pike MC, Poole EM, Ramus SJ, Risch HA, Rossing MA, Salvesen HB, Schildkraut JM, Sellers TA, Sherman M, Siddiqui N, Sieh W, Song H, Southey M, Terry KL, Tworoger SS, Walsh C, Wentzensen N, Whittemore AS, Wu AH, Yang H, Zheng W, Ziogas A, Freedman ML, Gayther SA, Pharoah PD, Lawrenson K. Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci. Br J Cancer 116(4):524-535, 2017. e-Pub 2017. PMID: 28103614.
82. Reid BM, Permuth JB, Chen YA, Teer JK, Monteiro AN, Chen Z, Tyrer J, Berchuck A, Chenevix-Trench G, Doherty JA, Goode EL, Iverson ES, Lawrenson K, Pearce CL, Pharoah PD, Phelan CM, Ramus SJ, Rossing MA, Schildkraut JM, Cheng JQ, Gayther SA, Sellers TA, Association Consortium OC, Study Group AOC, Association Consortium TOC, Association Consortium OC. Integration of Population-Level Genotype Data with Functional Annotation Reveals Over-Representation of Long Noncoding RNAs at Ovarian Cancer Susceptibility Loci. Cancer Epidemiol Biomarkers Prev 26(1):116-125, 2017. e-Pub 2017. PMID: 28035019.
83. Shu X, Hildebrandt MA, Gu J, Tannir NM, Matin SF, Karam JA, Wood CG, Wu X. MicroRNA profiling in clear cell renal cell carcinoma tissues potentially links tumorigenesis and recurrence with obesity. Br J Cancer 116(1):77-84, 2017. e-Pub 2017. PMID: 27907930.
84. Southey MC, Goldgar DE, Winqvist R, Pylkas K, Couch F, Tischkowitz M, Foulkes WD, Dennis J, Michailidou K, van Rensburg EJ, Heikkinen T, Nevanlinna H, Hopper JL, Dork T, Claes KB, Reis-Filho J, Teo ZL, Radice P, Catucci I, Peterlongo P, Tsimiklis H, Odefrey FA, Dowty JG, Schmidt MK, Broeks A, Hogervorst FB, Verhoef S, Carpenter J, Clarke C, Scott RJ, Fasching PA, Haeberle L, Ekici AB, Beckmann MW, Peto J, Dos-Santos-Silva I, Fletcher O, Johnson N, Bolla MK, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Marme F, Burwinkel B, Yang R, Guenel P, Truong T, Menegaux F, Sanchez M, Bojesen S, Nielsen SF, Flyger H, Benitez J, Zamora MP, Perez JI, Menendez P, Anton-Culver H, Neuhausen S, Ziogas A, Clarke CA, Brenner H, Arndt V, Stegmaier C, Brauch H, Bruning T, Ko YD, Muranen TA, Aittomaki K, Blomqvist C, Bogdanova NV, Antonenkova NN, Lindblom A, Margolin S, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Spurdle AB, Investigators K, Wauters E, Smeets D, Beuselinck B, Floris G, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Olson JE, Vachon C, Pankratz VS, McLean C, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Kristensen V, Alnaes GG, Zheng W, Hunter DJ, Lindstrom S, Hankinson SE, Kraft P, Andrulis I, Knight JA, Glendon G, Mulligan AM, Jukkola-Vuorinen A, Grip M, Kauppila S, Devilee P, Tollenaar RA, Seynaeve C, Hollestelle A, Garcia-Closas M, Figueroa J, Chanock SJ, Lissowska J, Czene K, Darabi H, Eriksson M, Eccles DM, Rafiq S, Tapper WJ, Gerty SM, Hooning MJ, Martens JW, Collee JM, Tilanus-Linthorst M, Hall P, Li J, Brand JS, Humphreys K, Cox A, Reed MW, Luccarini C, Baynes C, Dunning AM, Hamann U, Torres D, Ulmer HU, Rudiger T, Jakubowska A, Lubinski J, Jaworska K, Durda K, Slager S, Toland AE, Ambrosone CB, Yannoukakos D, Swerdlow A, Ashworth A, Orr N, Jones M, Gonzalez-Neira A, Pita G, Alonso MR, Alvarez N, Herrero D, Tessier DC, Vincent D, Bacot F, Simard J, Dumont M, Soucy P, Eeles R, Muir K, Wiklund F, Gronberg H, Schleutker J, Nordestgaard BG, Weischer M, Travis RC, Neal D, Donovan JL, Hamdy FC, Khaw KT, Stanford JL, Blot WJ, Thibodeau S, Schaid DJ, Kelley JL, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Butterbach K, Park J, Kaneva R, Batra J, Teixeira MR, Kote-Jarai Z, Olama AA, Benlloch S, Renner SP, Hartmann A, Hein A, Ruebner M, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Lambretchs S, Doherty JA, Rossing MA, Nickels S, Eilber U, Wang-Gohrke S, Odunsi K, Sucheston-Campbell LE, Friel G, Lurie G, Killeen JL, Wilkens LR, Goodman MT, Runnebaum I, Hillemanns PA, Pelttari LM, Butzow R, Modugno F, Edwards RP, Ness RB, Moysich KB, du Bois A, Heitz F, Harter P, Kommoss S, Karlan BY, Walsh C, Lester J, Jensen A, Kjaer SK, Hogdall E, Peissel B, Bonanni B, Bernard L, Goode EL, Fridley BL, Vierkant RA, Cunningham JM, Larson MC, Fogarty ZC, Kalli KR, Liang D, Lu KH, Hildebrandt MA, Wu X, Levine DA, Dao F, Bisogna M, Berchuck A, Iversen ES, Marks JR, Akushevich L, Cramer DW, Schildkraut J, Terry KL, Poole EM, Stampfer M, Tworoger SS, Bandera EV, Orlow I, Olson SH, Bjorge L, Salvesen HB, van Altena AM, Aben KK, Kiemeney LA, Massuger LF, Pejovic T, Bean Y, Brooks-Wilson A, Kelemen LE, Cook LS, Le ND, Gorski B, Gronwald J, Menkiszak J, Hogdall CK, Lundvall L, Nedergaard L, Engelholm SA, Dicks E, Tyrer J, Campbell I, McNeish I, Paul J, Siddiqui N, Glasspool R, Whittemore AS, Rothstein JH, McGuire V, Sieh W, Cai H, Shu XO, Teten RT, Sutphen R, McLaughlin JR, Narod SA, Phelan CM, Monteiro AN, Fenstermacher D, Lin HY, Permuth JB, Sellers TA, Chen YA, Tsai YY, Chen Z, Gentry-Maharaj A, Gayther SA, Ramus SJ, Menon U, Wu AH, Pearce CL, Van Den Berg D, Pike MC, Dansonka-Mieszkowska A, Plisiecka-Halasa J, Moes-Sosnowska J, Kupryjanczyk J, Pharoah PD, Song H, Winship I, Chenevix-Trench G, Giles GG, Tavtigian SV, Easton DF, Milne RL. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. J Med Genet 53(12):800-811, 2016. e-Pub 2016. PMID: 27595995.
85. Hampras SS, Sucheston-Campbell LE, Cannioto R, Chang-Claude J, Modugno F, Dörk T, Hillemanns P, Preus L, Knutson KL, Wallace PK, Hong CC, Friel G, Davis W, Nesline M, Pearce CL, Kelemen LE, Goodman MT, Bandera EV, Terry KL, Schoof N, Eng KH, Clay A, Singh PK, Joseph JM, Aben KK, Anton-Culver H, Antonenkova N, Baker H, Bean Y, Beckmann MW, Bisogna M, Bjorge L, Bogdanova N, Brinton LA, Brooks-Wilson A, Bruinsma F, Butzow R, Campbell IG, Carty K, Cook LS, Cramer DW, Cybulski C, Dansonka-Mieszkowska A, Dennis J, Despierre E, Dicks E, Doherty JA, du Bois A, Dürst M, Easton D, Eccles D, Edwards RP, Ekici AB, Fasching PA, Fridley BL, Gao YT, Gentry-Maharaj A, Giles GG, Glasspool R, Gronwald J, Harrington P, Harter P, Hasmad HN, Hein A, Heitz F, Hildebrandt MA, Hogdall C, Hogdall E, Hosono S, Iversen ES, Jakubowska A, Jensen A, Ji BT, Karlan BY, Kellar M, Kelley JL, Kiemeney LA, Klapdor R, Kolomeyevskaya N, Krakstad C, Kjaer SK, Kruszka B, Kupryjanczyk J, Lambrechts D, Lambrechts S, Le ND, Lee AW, Lele S, Leminen A, Lester J, Levine DA, Liang D, Lissowska J, Liu S, Lu K, Lubinski J, Lundvall L, Massuger LF, Matsuo K, McGuire V, McLaughlin JR, McNeish I, Menon U, Moes-Sosnowska J, Narod SA, Nedergaard L, Nevanlinna H, Nickels S, Olson SH, Orlow I, Weber RP, Paul J, Pejovic T, Pelttari LM, Perkins B, Permuth-Wey J, Pike MC, Plisiecka-Halasa J, Poole EM, Risch HA, Rossing MA, Rothstein JH, Rudolph A, Runnebaum IB, Rzepecka IK, Salvesen HB, Schernhammer E, Schmitt K, Schwaab I, Shu XO, Shvetsov YB, Siddiqui N, Sieh W, Song H, Southey MC, Tangen IL, Teo SH, Thompson PJ, Timorek A, Tsai YY, Tworoger SS, Tyrer J, van Altena AM, Vergote I, Vierkant RA, Walsh C, Wang-Gohrke S, Wentzensen N, Whittemore AS, Wicklund KG, Wilkens LR, Wu AH, Wu X, Woo YL, Yang H, Zheng W, Ziogas A, Gayther SA, Ramus SJ, Sellers TA, Schildkraut JM, Phelan CM, Berchuck A, Chenevix-Trench G, Cunningham JM, Pharoah PP, Ness RB, Odunsi K, Goode EL, Moysich KB. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer. Oncotarget 7(43):69097-69110, 2016. e-Pub 2016. PMID: 27533245.
86. Ong JS, Cuellar-Partida G, Lu Y, Ovarian Cancer Study A, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Vanderstichele A, Anne Doherty J, Anne Rossing M, Chang-Claude J, Eilber U, Rudolph A, Wang-Gohrke S, Goodman MT, Bogdanova N, Dörk T, Dürst M, Hillemanns P, Runnebaum IB, Antonenkova N, Butzow R, Leminen A, Nevanlinna H, Pelttari LM, Edwards RP, Kelley JL, Modugno F, Moysich KB, Ness RB, Cannioto R, Høgdall E, Høgdall CK, Jensen A, Giles GG, Bruinsma F, Kjaer SK, Hildebrandt MA, Liang D, Lu KH, Wu X, Bisogna M, Dao F, Levine DA, Cramer DW, Terry KL, Tworoger SS, Stampfer M, Missmer S, Bjorge L, Salvesen HB, Kopperud RK, Bischof K, Aben KK, Kiemeney LA, Massuger LF, Brooks-Wilson A, Olson SH, McGuire V, Rothstein JH, Sieh W, Whittemore AS, Cook LS, Le ND, Blake Gilks C, Gronwald J, Jakubowska A, Lubinski J, Kluz T, Song H, Tyrer JP, Wentzensen N, Brinton L, Trabert B, Lissowska J, McLaughlin JR, Narod SA, Phelan C, Anton-Culver H, Ziogas A, Eccles D, Campbell I, Gayther SA, Gentry-Maharaj A, Menon U, Ramus SJ, Wu AH, Dansonka-Mieszkowska A, Kupryjanczyk J, Timorek A, Szafron L, Cunningham JM, Fridley BL, Winham SJ, Bandera EV, Poole EM, Morgan TK, Risch HA, Goode EL, Schildkraut JM, Pearce CL, Berchuck A, Pharoah PD, Chenevix-Trench G, Gharahkhani P, Neale RE, Webb PM, MacGregor S. Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study. Int J Epidemiol 45(5):1619-1630, 2016. e-Pub 2016. PMID: 27594614.
87. Kar SP, Beesley J, Amin Al Olama A, Michailidou K, Tyrer J, Kote-Jarai Z, Lawrenson K, Lindstrom S, Ramus SJ, Thompson DJ, Investigators A, Kibel AS, Dansonka-Mieszkowska A, Michael A, Dieffenbach AK, Gentry-Maharaj A, Whittemore AS, Wolk A, Monteiro A, Peixoto A, Kierzek A, Cox A, Rudolph A, Gonzalez-Neira A, Wu AH, Lindblom A, Swerdlow A, Group AS, (Ovarian Cancer) ACS, BioResource A, Ziogas A, Ekici AB, Burwinkel B, Karlan BY, Nordestgaard BG, Blomqvist C, Phelan C, McLean C, Pearce CL, Vachon C, Cybulski C, Slavov C, Stegmaier C, Maier C, Ambrosone CB, Høgdall CK, Teerlink CC, Kang D, Tessier DC, Schaid DJ, Stram DO, Cramer DW, Neal DE, Eccles D, Flesch-Janys D, Edwards DR, Wokozorczyk D, Levine DA, Yannoukakos D, Sawyer EJ, Bandera EV, Poole EM, Goode EL, Khusnutdinova E, Høgdall E, Song F, Bruinsma F, Heitz F, Modugno F, Hamdy FC, Wiklund F, Giles GG, Olsson H, Wildiers H, Ulmer HU, Pandha H, Risch HA, Darabi H, Salvesen HB, Nevanlinna H, Gronberg H, Brenner H, Brauch H, Anton-Culver H, Song H, Lim HY, McNeish I, Campbell I, Vergote I, Gronwald J, Lubinski J, Stanford JL, Benítez J, Doherty JA, Permuth JB, Chang-Claude J, Donovan JL, Dennis J, Schildkraut JM, Schleutker J, Hopper JL, Kupryjanczyk J, Park JY, Figueroa J, Clements JA, Knight JA, Peto J, Cunningham JM, Pow-Sang J, Batra J, Czene K, Lu KH, Herkommer K, Khaw KT, Investigators K, Matsuo K, Muir K, Offitt K, Chen K, Moysich KB, Aittomäki K, Odunsi K, Kiemeney LA, Massuger LF, Fitzgerald LM, Cook LS, Cannon-Albright L, Hooning MJ, Pike MC, Bolla MK, Luedeke M, Teixeira MR, Goodman MT, Schmidt MK, Riggan M, Aly M, Rossing MA, Beckmann MW, Moisse M, Sanderson M, Southey MC, Jones M, Hildebrandt MA, Hou MF, Schoemaker MJ, Garcia-Closas M, Bogdanova N, Rahman N, Investigators N, Le ND, Orr N, Wentzensen N, Pashayan N, Peterlongo P, Guénel P, Brennan P, Paulo P, Webb PM, Broberg P, Fasching PA, Devilee P, Wang Q, Cai Q, Li Q, Kaneva R, Butzow R, Kopperud. Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types. Cancer Discov 6(9):1052-67, 2016. e-Pub 2016. PMID: 27432226.
88. Permuth JB, Reid B, Earp M, Chen YA, Monteiro AN, Chen Z, Group AS, Chenevix-Trench G, Fasching PA, Beckmann MW, Lambrechts D, Vanderstichele A, Van Niewenhuyse E, Vergote I, Rossing MA, Doherty JA, Chang-Claude J, Moysich K, Odunsi K, Goodman MT, Shvetsov YB, Wilkens LR, Thompson PJ, Dörk T, Bogdanova N, Butzow R, Nevanlinna H, Pelttari L, Leminen A, Modugno F, Edwards RP, Ness RB, Kelley J, Heitz F, Karlan B, Lester J, Kjaer SK, Jensen A, Giles G, Hildebrandt M, Liang D, Lu KH, Wu X, Levine DA, Bisogna M, Berchuck A, Cramer DW, Terry KL, Tworoger SS, Poole EM, Bandera EV, Fridley B, Cunningham J, Winham SJ, Olson SH, Orlow I, Bjorge L, Kiemeney LA, Massuger L, Pejovic T, Moffitt M, Le N, Cook LS, Brooks-Wilson A, Kelemen LE, Gronwald J, Lubinski J, Wentzensen N, Brinton LA, Lissowska J, Yang H, Hogdall E, Hogdall C, Lundvall L, Pharoah PD, Song H, Campbell I, Eccles D, McNeish I, Whittemore A, McGuire V, Sieh W, Rothstein J, Phelan CM, Risch H, Narod S, McLaughlin J, Anton-Culver H, Ziogas A, Menon U, Gayther S, Ramus SJ, Gentry-Maharaj A, Pearce CL, Wu AH, Kupryjanczyk J, Dansonka-Mieszkowska A, Schildkraut JM, Cheng JQ, Goode EL, Sellers TA. Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration. Oncotarget 7(45):72381-72394, 2016. e-Pub 2016. PMID: 27911851.
89. Cuellar-Partida G, Lu Y, Dixon SC, Cancer Study AO, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Vanderstichele A, Doherty JA, Rossing MA, Chang-Claude J, Rudolph A, Wang-Gohrke S, Goodman MT, Bogdanova N, Dörk T, Dürst M, Hillemanns P, Runnebaum IB, Antonenkova N, Butzow R, Leminen A, Nevanlinna H, Pelttari LM, Edwards RP, Kelley JL, Modugno F, Moysich KB, Ness RB, Cannioto R, Høgdall E, Høgdall C, Jensen A, Giles GG, Bruinsma F, Kjaer SK, Hildebrandt MA, Liang D, Lu KH, Wu X, Bisogna M, Dao F, Levine DA, Cramer DW, Terry KL, Tworoger SS, Stampfer M, Missmer S, Bjorge L, Salvesen HB, Kopperud RK, Bischof K, Aben KK, Kiemeney LA, Massuger LF, Brooks-Wilson A, Olson SH, McGuire V, Rothstein JH, Sieh W, Whittemore AS, Cook LS, Le ND, Blake Gilks C, Gronwald J, Jakubowska A, Lubinski J, Kluz T, Song H, Tyrer JP, Wentzensen N, Brinton L, Trabert B, Lissowska J, McLaughlin JR, Narod SA, Phelan C, Anton-Culver H, Ziogas A, Eccles D, Campbell I, Gayther SA, Gentry-Maharaj A, Menon U, Ramus SJ, Wu AH, Dansonka-Mieszkowska A, Kupryjanczyk J, Timorek A, Szafron L, Cunningham JM, Fridley BL, Winham SJ, Bandera EV, Poole EM, Morgan TK, Goode EL, Schildkraut JM, Pearce CL, Berchuck A, Pharoah PD, Webb PM, Chenevix-Trench G, Risch HA, MacGregor S. Assessing the genetic architecture of epithelial ovarian cancer histological subtypes. Hum Genet 135(7):741-56, 2016. e-Pub 2016. PMID: 27075448.
90. Wu X, Hildebrandt MA, Ye Y, Chow WH, Gu J, Cunningham S, Zhao H, Hawk ET, Wagar E, Rodriguez A, Hamilton SR. Cohort Profile: The MD Anderson Cancer Patients and Survivors Cohort (MDA-CPSC). Int J Epidemiol 45(3):713-713f, 2016. e-Pub 2016. PMID: 26686840.
91. Dixon SC, Nagle CM, Thrift AP, Pharoah PD, Pearce CL, Zheng W, Painter JN, Group A, (Ovarian Cancer) ACS, Chenevix-Trench G, Fasching PA, Beckmann MW, Lambrechts D, Vergote I, Lambrechts S, Van Nieuwenhuysen E, Rossing MA, Doherty JA, Wicklund KG, Chang-Claude J, Rudolph A, Moysich KB, Odunsi K, Goodman MT, Wilkens LR, Thompson PJ, Shvetsov YB, Dörk T, Park-Simon TW, Hillemanns P, Bogdanova N, Butzow R, Nevanlinna H, Pelttari LM, Leminen A, Modugno F, Ness RB, Edwards RP, Kelley JL, Heitz F, Karlan BY, Kjær SK, Høgdall E, Jensen A, Goode EL, Fridley BL, Cunningham JM, Winham SJ, Giles GG, Bruinsma F, Milne RL, Southey MC, Hildebrandt MA, Wu X, Lu KH, Liang D, Levine DA, Bisogna M, Schildkraut JM, Berchuck A, Cramer DW, Terry KL, Bandera EV, Olson SH, Salvesen HB, Thomsen LC, Kopperud RK, Bjorge L, Kiemeney LA, Massuger LF, Pejovic T, Cook LS, Le ND, Swenerton KD, Brooks-Wilson A, Kelemen LE, Lubinski J, Huzarski T, Gronwald J, Menkiszak J, Wentzensen N, Brinton L, Yang H, Lissowska J, Høgdall CK, Lundvall L, Song H, Tyrer JP, Campbell I, Eccles D, Paul J, Glasspool R, Siddiqui N, Whittemore AS, Sieh W, McGuire V, Rothstein JH, Narod SA, Phelan C, Risch HA, McLaughlin JR, Anton-Culver H, Ziogas A, Menon U, Gayther SA, Ramus SJ, Gentry-Maharaj A, Wu AH, Pike MC, Tseng CC, Kupryjanczyk J, Dansonka-Mieszkowska A, Budzilowska A, Spiewankiewicz B, Webb PM, Association Consortium OC. Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study. Int J Epidemiol 45(3):884-95, 2016. e-Pub 2016. PMID: 27401727.
92. Ovarian Cancer Association Consortium, Breast Cancer Association Consortium, Consortium of Modifiers of BRCA1 and BRCA2, Hollestelle A, van der Baan FH, Berchuck A..., Hildebrandt MAT, ... Pharoah PD, Rookus MA, Hooning MJ, Goode EL. No clinical utility of KRAS variant rs61764370 for breast or ovarian cancer. Gynecologic Oncology 141(2):386-401, 2016. e-Pub 2016.
93. Hildebrandt MA, Reyes ME, Lin M, He Y, Nguyen SV, Hawk ET, Wu X. Germline genetic variants in the Wnt/β-catenin pathway as predictors of colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 25(3):540-6, 2016. e-Pub 2016. PMID: 26809274.
94. Lee AW, Templeman C, Stram DA, Beesley J, Tyrer J, Berchuck A, Pharoah PP, Chenevix-Trench G, Pearce CL, Association Consortium OC. Evidence of a genetic link between endometriosis and ovarian cancer. Fertil Steril 105(1):35-43.e1-10, 2016. e-Pub 2016. PMID: 26477498.
95. Amankwah EK, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Chornokur G, Aben KK, Anton-Culver H, Antonenkova N, Bruinsma F, Bandera EV, Bean YT, Beckmann MW, Bisogna M, Bjorge L, Bogdanova N, Brinton LA, Brooks-Wilson A, Bunker CH, Butzow R, Campbell IG, Carty K, Chen Z, Chen YA, Chang-Claude J, Cook LS, Cramer DW, Cunningham JM, Cybulski C, Dansonka-Mieszkowska A, du Bois A, Despierre E, Dicks E, Doherty JA, Dörk T, Dürst M, Easton DF, Eccles DM, Edwards RP, Ekici AB, Fasching PA, Fridley BL, Gao YT, Gentry-Maharaj A, Giles GG, Glasspool R, Goodman MT, Gronwald J, Harrington P, Harter P, Hasmad HN, Hein A, Heitz F, Hildebrandt MA, Hillemanns P, Hogdall CK, Hogdall E, Hosono S, Iversen ES, Jakubowska A, Jensen A, Ji BT, Karlan BY, Jim H, Kellar M, Kiemeney LA, Krakstad C, Kjaer SK, Kupryjanczyk J, Lambrechts D, Lambrechts S, Le ND, Lee AW, Lele S, Leminen A, Lester J, Levine DA, Liang D, Lim BK, Lissowska J, Lu K, Lubinski J, Lundvall L, Massuger LF, Matsuo K, McGuire V, McLaughlin JR, McNeish I, Menon U, Milne RL, Modugno F, Moysich KB, Ness RB, Nevanlinna H, Eilber U, Odunsi K, Olson SH, Orlow I, Orsulic S, Weber RP, Paul J, Pearce CL, Pejovic T, Pelttari LM, Permuth-Wey J, Pike MC, Poole EM, Risch HA, Rosen B, Rossing MA, Rothstein JH, Rudolph A, Runnebaum IB, Rzepecka IK, Salvesen HB, Schernhammer E, Schwaab I, Shu XO, Shvetsov YB, Siddiqui N, Sieh W, Song H, Southey MC, Spiewankiewicz B, Sucheston-Campbell L, Teo SH, Terry KL, Thompson PJ, Thomsen L, Tangen IL, Tworoger SS, van Altena AM, Vierkant RA, Vergote I, Walsh CS, Wang-Gohrke S, Wentzensen N, Whittemore AS, Wicklund KG, Wilkens LR, Wu AH, Wu X, Woo YL, Yang H, Zheng W, Ziogas A, Kelemen LE, Berchuck A, management group GCOBOTA, Schildkraut JM, Ramus SJ, Goode EL, Monteiro AN, Gayther SA, Narod SA, Pharoah PD, Sellers TA, Phelan CM. Epithelial-Mesenchymal Transition (EMT) gene variants and epithelial ovarian cancer (EOC) risk. Genet Epidemiol 39(8):689-97, 2015. e-Pub 2015. PMID: 26399219.
96. Pierzynski JA, Hildebrandt MA, Kamat AM, Lin J, Ye Y, Dinney CP, Wu X. Genetic variants within the Wnt/β-catenin signaling pathway as indicators of bladder cancer risk. J Urol 194(6):1771-6, 2015. e-Pub 2015. PMID: 26173102.
97. Lawrenson K, Iversen ES, Tyrer J, Weber RP, Concannon P, Hazelett DJ, Li Q, Marks JR, Berchuck A, Lee JM, Aben KK, Anton-Culver H, Antonenkova N, (Ovarian Cancer) ACS, Study Group AOC, Bandera EV, Bean Y, Beckmann MW, Bisogna M, Bjorge L, Bogdanova N, Brinton LA, Brooks-Wilson A, Bruinsma F, Butzow R, Campbell IG, Carty K, Chang-Claude J, Chenevix-Trench G, Chen A, Chen Z, Cook LS, Cramer DW, Cunningham JM, Cybulski C, Plisiecka-Halasa J, Dennis J, Dicks E, Doherty JA, Dörk T, du Bois A, Eccles D, Easton DT, Edwards RP, Eilber U, Ekici AB, Fasching PA, Fridley BL, Gao YT, Gentry-Maharaj A, Giles GG, Glasspool R, Goode EL, Goodman MT, Gronwald J, Harter P, Hasmad HN, Hein A, Heitz F, Hildebrandt MA, Hillemanns P, Hogdall E, Hogdall C, Hosono S, Jakubowska A, Paul J, Jensen A, Karlan BY, Kjaer SK, Kelemen LE, Kellar M, Kelley JL, Kiemeney LA, Krakstad C, Lambrechts D, Lambrechts S, Le ND, Lee AW, Cannioto R, Leminen A, Lester J, Levine DA, Liang D, Lissowska J, Lu K, Lubinski J, Lundvall L, Massuger LF, Matsuo K, McGuire V, McLaughlin JR, Nevanlinna H, McNeish I, Menon U, Modugno F, Moysich KB, Narod SA, Nedergaard L, Ness RB, Noor Azmi MA, Odunsi K, Olson SH, Orlow I, Orsulic S, Pearce CL, Pejovic T, Pelttari LM, Permuth-Wey J, Phelan CM, Pike MC, Poole EM, Ramus SJ, Risch HA, Rosen B, Rossing MA, Rothstein JH, Rudolph A, Runnebaum IB, Rzepecka IK, Salvesen HB, Budzilowska A, Sellers TA, Shu XO, Shvetsov YB, Siddiqui N, Sieh W, Song H, Southey MC, Sucheston L, Tangen IL, Teo SH, Terry KL, Thompson PJ, Timorek A, Tworoger SS, Van Nieuwenhuysen E, Vergote I, Vierkant RA, Wang-Gohrke S, Walsh C, Wentzensen N, Whittemore AS, Wicklund KG, Wilkens LR, Woo YL, Wu X, Wu AH, Yang H, Zheng W, Ziogas A, Coetzee GA, Freedman ML, Monteiro AN, Moes-Sosnowska J, Kupryjanczyk J, Pharoah PD, Gayther SA, Schildkraut JM. Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer. Carcinogenesis 36(11):1341-53, 2015. e-Pub 2015. PMID: 26424751.
98. Sanchez-Espiridion B, Liang D, Ajani JA, Liang S, Ye Y, Hildebrandt MA, Gu J, Wu X. Identification of serum markers of esophageal adenocarcinoma by global and targeted metabolic profiling. Clin Gastroenterol Hepatol 13(10):1730-1737.e9, 2015. e-Pub 2015. PMID: 25998788.
99. Kar SP, Tyrer JP, Li Q, Lawrenson K, Aben KK, Anton-Culver H, Antonenkova N, Chenevix-Trench G, Study AC, Study Group AOC, Baker H, Bandera EV, Bean YT, Beckmann MW, Berchuck A, Bisogna M, Bjørge L, Bogdanova N, Brinton L, Brooks-Wilson A, Butzow R, Campbell I, Carty K, Chang-Claude J, Chen YA, Chen Z, Cook LS, Cramer D, Cunningham JM, Cybulski C, Dansonka-Mieszkowska A, Dennis J, Dicks E, Doherty JA, Dörk T, du Bois A, Dürst M, Eccles D, Easton DF, Edwards RP, Ekici AB, Fasching PA, Fridley BL, Gao YT, Gentry-Maharaj A, Giles GG, Glasspool R, Goode EL, Goodman MT, Grownwald J, Harrington P, Harter P, Hein A, Heitz F, Hildebrandt MA, Hillemanns P, Hogdall E, Hogdall CK, Hosono S, Iversen ES, Jakubowska A, Paul J, Jensen A, Ji BT, Karlan BY, Kjaer SK, Kelemen LE, Kellar M, Kelley J, Kiemeney LA, Krakstad C, Kupryjanczyk J, Lambrechts D, Lambrechts S, Le ND, Lee AW, Lele S, Leminen A, Lester J, Levine DA, Liang D, Lissowska J, Lu K, Lubinski J, Lundvall L, Massuger L, Matsuo K, McGuire V, McLaughlin JR, McNeish IA, Menon U, Modugno F, Moysich KB, Narod SA, Nedergaard L, Ness RB, Nevanlinna H, Odunsi K, Olson SH, Orlow I, Orsulic S, Weber RP, Pearce CL, Pejovic T, Pelttari LM, Permuth-Wey J, Phelan CM, Pike MC, Poole EM, Ramus SJ, Risch HA, Rosen B, Rossing MA, Rothstein JH, Rudolph A, Runnebaum IB, Rzepecka IK, Salvesen HB, Schildkraut JM, Schwaab I, Shu XO, Shvetsov YB, Siddiqui N, Sieh W, Song H, Southey MC, Sucheston-Campbell LE, Tangen IL, Teo SH, Terry KL, Thompson PJ, Timorek A, Tsai YY, Tworoger SS, van Altena AM, Van Nieuwenhuysen E, Vergote I, Vierkant RA, Wang-Gohrke S, Walsh C, Wentzensen N, Whittemore AS, Wicklund KG, Wilkens LR, Woo YL, Wu X, Wu A, Yang H, Zheng W, Ziogas A, Sellers TA, Monteiro AN, Freedman ML, Gayther SA, Pharoah PD. Network-based integration of GWAS and gene expression identifies a HOX-centric network associated with serous ovarian cancer risk. Cancer Epidemiol Biomarkers Prev 24(10):1574-84, 2015. e-Pub 2015. PMID: 26209509.
100. Lu Y, Cuellar-Partida G, Painter JN, Nyholt DR, Cancer Study AO, Consortium (IEC) IE, Morris AP, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Vanderstichele A, Doherty JA, Rossing MA, Wicklund KG, Chang-Claude J, Eilber U, Rudolph A, Wang-Gohrke S, Goodman MT, Bogdanova N, Dörk T, Dürst M, Hillemanns P, Runnebaum IB, Antonenkova N, Butzow R, Leminen A, Nevanlinna H, Pelttari LM, Edwards RP, Kelley JL, Modugno F, Moysich KB, Ness RB, Cannioto R, Høgdall E, Jensen A, Giles GG, Bruinsma F, Kjaer SK, Hildebrandt MA, Liang D, Lu KH, Wu X, Bisogna M, Dao F, Levine DA, Cramer DW, Terry KL, Tworoger SS, Missmer S, Bjorge L, Salvesen HB, Kopperud RK, Bischof K, Aben KK, Kiemeney LA, Massuger LF, Brooks-Wilson A, Olson SH, McGuire V, Rothstein JH, Sieh W, Whittemore AS, Cook LS, Le ND, Gilks CB, Gronwald J, Jakubowska A, Lubinski J, Gawelko J, Song H, Tyrer JP, Wentzensen N, Brinton L, Trabert B, Lissowska J, Mclaughlin JR, Narod SA, Phelan C, Anton-Culver H, Ziogas A, Eccles D, Gayther SA, Gentry-Maharaj A, Menon U, Ramus SJ, Wu AH, Dansonka-Mieszkowska A, Kupryjanczyk J, Timorek A, Szafron L, Cunningham JM, Fridley BL, Winham SJ, Bandera EV, Poole EM, Morgan TK, Risch HA, Goode EL, Schildkraut JM, Webb PM, Pearce CL, Berchuck A, Pharoah PD, Montgomery GW, Zondervan KT, Chenevix-Trench G, MacGregor S. Shared genetics underlying epidemiological association between endometriosis and ovarian cancer. Hum Mol Genet 24(20):5955-64, 2015. e-Pub 2015. PMID: 26231222.
101. Kelemen LE, Lawrenson K, Tyrer J, Li Q, Lee JM, Seo JH, Phelan CM, Beesley J, Chen X, Spindler TJ, Aben KK, Anton-Culver H, Antonenkova N. Genome-wide significant risk associations for mucinous ovarian carcinoma. Nat Genet 47(8):888-97, 2015. e-Pub 2015. PMID: 26075790.
102. Coetzee SG, Shen HC, Hazelett DJ, Lawrenson K, Kuchenbaecker K, Tyrer J, Rhie SK, Levanon K, Karst A, Drapkin R, Ramus SJ, Association Consortium OC, of BRCA/ TCOIOM, Couch FJ, Offit K, Chenevix-Trench G, Monteiro AN, Antoniou A, Freedman M, Coetzee GA, Pharoah PD, Noushmehr H, Gayther SA, of BRCA/ OCACTCOIOM. Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci. Hum Mol Genet 24(13):3595-607, 2015. e-Pub 2015. PMID: 25804953.
103. Tan W, Gu J, Huang M, Wu X, Hildebrandt MA. Epigenetic analysis of microRNA genes in tumors from surgically resected lung cancer patients and association with survival. Mol Carcinog 54 Suppl 1(Special Issue: Recent Advances in Mechanisms, Prevention and Tre):E45-51, 2015. e-Pub 2015. PMID: 24665010.
104. Lee AW, Tyrer JP, Doherty JA, Stram DA, Kupryjanczyk J, Dansonka-Mieszkowska A, Plisiecka-Halasa J, Spiewankiewicz B, Myers EJ, (Ovarian Cancer) ACS, Study Group AOC, Chenevix-Trench G, Fasching PA, Beckmann MW, Ekici AB, Hein A, Vergote I, Van Nieuwenhuysen E, Lambrechts D, Wicklund KG, Eilber U, Wang-Gohrke S, Chang-Claude J, Rudolph A, Sucheston-Campbell L, Odunsi K, Moysich KB, Shvetsov YB, Thompson PJ, Goodman MT, Wilkens LR, Dörk T, Hillemanns P, Dürst M, Runnebaum IB, Bogdanova N, Pelttari LM, Nevanlinna H, Leminen A, Edwards RP, Kelley JL, Harter P, Schwaab I, Heitz F, du Bois A, Orsulic S, Lester J, Walsh C, Karlan BY, Hogdall E, Kjaer SK, Jensen A, Vierkant RA, Cunningham JM, Goode EL, Fridley BL, Southey MC, Giles GG, Bruinsma F, Wu X, Hildebrandt MA, Lu K, Liang D, Bisogna M, Levine DA, Weber RP, Schildkraut JM, Iversen ES, Berchuck A, Terry KL, Cramer DW, Tworoger SS, Poole EM, Olson SH, Orlow I, Bandera EV, Bjorge L, Tangen IL, Salvesen HB, Krakstad C, Massuger LF, Kiemeney LA, Aben KK, van Altena AM, Bean Y, Pejovic T, Kellar M, Le ND, Cook LS, Kelemen LE, Brooks-Wilson A, Lubinski J, Gronwald J, Cybulski C, Jakubowska A, Wentzensen N, Brinton LA, Lissowska J, Yang H, Nedergaard L, Lundvall L, Hogdall C, Song H, Campbell IG, Eccles D, Glasspool R, Siddiqui N, Carty K, Paul J, McNeish IA, Sieh W, McGuire V, Rothstein JH, Whittemore AS, McLaughlin JR, Risch HA, Phelan CM, Anton-Culver H, Ziogas A, Menon U, Ramus SJ, Gentry-Maharaj A, Harrington P, Pike MC, Modugno F, Rossing MA, Ness RB, Pharoah PD, Stram DO, Wu AH, Pearce CL. Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study. Gynecol Oncol 136(3):542-8, 2015. e-Pub 2015. PMID: 25528498.
105. Kuchenbaecker KB, Ramus SJ, Tyrer J, Lee A, Shen HC, Beesley J, Lawrenson K, McGuffog L, Healey S, Lee JM, Spindler TJ, Lin YG, Pejovic T, Bean Y, Li Q, Coetzee S, Hazelett D, Miron A, Southey M, Terry MB, Goldgar DE, Buys SS, Janavicius R, Dorfling CM, van Rensburg EJ, Neuhausen SL, Ding YC, Hansen TV, Jønson L, Gerdes AM, Ejlertsen B, Barrowdale D, Dennis J, Benitez J, Osorio A, Garcia MJ, Komenaka I, Weitzel JN, Ganschow P, Peterlongo P, Bernard L, Viel A, Bonanni B, Peissel B, Manoukian S, Radice P, Papi L, Ottini L, Fostira F, Konstantopoulou I, Garber J, Frost D, Perkins J, Platte R, Ellis S, EMBRACE, Godwin AK, Schmutzler RK, Meindl A, Engel C, Sutter C, Sinilnikova OM, Collaborators GS, Damiola F, Mazoyer S, Stoppa-Lyonnet D, Claes K, De Leeneer K, Kirk J, Rodriguez GC, Piedmonte M, O'Malley DM, de la Hoya M, Caldes T, Aittomäki K, Nevanlinna H, Collée JM, Rookus MA, Oosterwijk JC, Family Registry BC, Tihomirova L, Tung N, Hamann U, Isaccs C, Tischkowitz M, Imyanitov EN, Caligo MA, Campbell IG, Hogervorst FB, HEBON, Olah E, Diez O, Blanco I, Brunet J, Lazaro C, Pujana MA, Jakubowska A, Gronwald J, Lubinski J, Sukiennicki G, Barkardottir RB, Plante M, Simard J, Soucy P, Montagna M, Tognazzo S, Teixeira MR, Investigators K, Pankratz VS, Wang X, Lindor N, Szabo CI, Kauff N, Vijai J, Aghajanian CA, Pfeiler G, Berger A, Singer CF, Tea MK, Phelan CM, Greene MH, Mai PL, Rennert G, Mulligan AM, Tchatchou S, Andrulis IL, Glendon G, Toland AE, Jensen UB, Kruse TA, Thomassen M, Bojesen A, Zidan J, Friedman E, Laitman Y, Soller M, Liljegren A, Arver B, Einbeigi Z, Stenmark-Askmalm M, Olopade OI, Nussbaum RL, Rebbeck TR, Nathanson KL, Domchek SM, Lu KH, Karlan BY, Walsh C, Lester J, Cancer Investigators) ACS(, Study Group AOC, Hein A, Ekici AB, Beckmann MW, Fasching PA, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Lambrechts S, Dicks E, Doherty JA, Wicklund KG, Rossing MA, Rudolph A, Chang-Claude. Identification of six new susceptibility loci for invasive epithelial ovarian cancer. Nat Genet 47(2):164-71, 2015. e-Pub 2015. PMID: 25581431.
106. Liu X, Meng QH, Ye Y, Hildebrandt MA, Gu J, Wu X. Prognostic significance of pretreatment serum levels of albumin, LDH and total bilirubin in patients with non-metastatic breast cancer. Carcinogenesis 36(2):243-248, 2015. e-Pub 2015. PMID: 25524924.
107. Wen CP, Zhang F, Liang D, Wen C, Gu J, Skinner H, Chow WH, Ye Y, Pu X, Hildebrandt MA, Huang M, Chen CH, Hsiung CA, Tsai MK, Tsao CK, Lippman SM, Wu X. The ability of bilirubin in identifying smokers with higher risk of lung cancer: a large cohort study in conjunction with global metabolomic profiling. Clin Cancer Res 21(1):193-200, 2015. e-Pub 2015. PMID: 25336700.
108. Hildebrandt MA, Roth JA, Vaporciyan AA, Pu X, Ye Y, Correa AM, Kim JY, Swisher SG, Wu X. Genetic variation in the TNF/TRAF2/ASK1/p38 kinase signaling pathway as markers for postoperative pulmonary complications in lung cancer patients. Sci Rep 5:12068, 2015. e-Pub 2015. PMID: 26165383.
109. Lawrenson K, Li Q, Kar S, Seo JH, Tyrer J, Spindler TJ, Lee J, Chen Y, Karst A, Drapkin R, Aben KK, Anton-Culver H, Antonenkova N, Study Group AOC, Baker H, Bandera EV, Bean Y, Beckmann MW, Berchuck A, Bisogna M, Bjorge L, Bogdanova N, Brinton LA, Brooks-Wilson A, Bruinsma F, Butzow R, Campbell IG, Carty K, Chang-Claude J, Chenevix-Trench G, Chen A, Chen Z, Cook LS, Cramer DW, Cunningham JM, Cybulski C, Dansonka-Mieszkowska A, Dennis J, Dicks E, Doherty JA, Dörk T, du Bois A, Dürst M, Eccles D, Easton DT, Edwards RP, Eilber U, Ekici AB, Fasching PA, Fridley BL, Gao YT, Gentry-Maharaj A, Giles GG, Glasspool R, Goode EL, Goodman MT, Grownwald J, Harrington P, Harter P, Hasmad HN, Hein A, Heitz F, Hildebrandt MA, Hillemanns P, Hogdall E, Hogdall C, Hosono S, Iversen ES, Jakubowska A, James P, Jensen A, Ji BT, Karlan BY, Kruger Kjaer S, Kelemen LE, Kellar M, Kelley JL, Kiemeney LA, Krakstad C, Kupryjanczyk J, Lambrechts D, Lambrechts S, Le ND, Lee AW, Lele S, Leminen A, Lester J, Levine DA, Liang D, Lissowska J, Lu K, Lubinski J, Lundvall L, Massuger LF, Matsuo K, McGuire V, McLaughlin JR, Nevanlinna H, McNeish I, Menon U, Modugno F, Moysich KB, Narod SA, Nedergaard L, Ness RB, Azmi MA, Odunsi K, Olson SH, Orlow I, Orsulic S, Weber RP, Pearce CL, Pejovic T, Pelttari LM, Permuth-Wey J, Phelan CM, Pike MC, Poole EM, Ramus SJ, Risch HA, Rosen B, Rossing MA, Rothstein JH, Rudolph A, Runnebaum IB, Rzepecka IK, Salvesen HB, Schildkraut JM, Schwaab I, Sellers TA, Shu XO, Shvetsov YB, Siddiqui N, Sieh W, Song H, Southey MC, Sucheston L, Tangen IL, Teo SH, Terry KL, Thompson PJ, Timorek A, Tsai YY, Tworoger SS, van Altena AM, Van Nieuwenhuysen E, Vergote I, Vierkant RA, Wang-Gohrke S, Walsh C, Wentzensen N, Whittemore AS, Wicklund KG, Wilkens LR, Woo YL, Wu X, Wu AH, Yang H, Zheng W, Ziogas A, Monteiro A, Pharoah PD, Gayther SA, Freedman ML. Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer. Nat Commun 6:8234, 2015. e-Pub 2015. PMID: 26391404.
110. Jim HS, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Chornokur G, Chen Z, Chen AY, Permuth-Wey J, Aben KK, Anton-Culver H, Antonenkova N, Bruinsma F, Bandera EV, Bean YT, Beckmann MW, Bisogna M, Bjorge L, Bogdanova N, Brinton LA, Brooks-Wilson A, Bunker CH, Butzow R, Campbell IG, Carty K, Chang-Claude J, Cook LS, Cramer DW, Cunningham JM, Cybulski C, Dansonka-Mieszkowska A, du Bois A, Despierre E, Sieh W, Doherty JA, Dörk T, Dürst M, Easton DF, Eccles DM, Edwards RP, Ekici AB, Fasching PA, Fridley BL, Gao YT, Gentry-Maharaj A, Giles GG, Glasspool R, Goodman MT, Gronwald J, Harter P, Hasmad HN, Hein A, Heitz F, Hildebrandt MA, Hillemanns P, Hogdall CK, Hogdall E, Hosono S, Iversen ES, Jakubowska A, Jensen A, Ji BT, Karlan BY, Kellar M, Kiemeney LA, Krakstad C, Kjaer SK, Kupryjanczyk J, Vierkant RA, Lambrechts D, Lambrechts S, Le ND, Lee AW, Lele S, Leminen A, Lester J, Levine DA, Liang D, Lim BK, Lissowska J, Lu K, Lubinski J, Lundvall L, Massuger LF, Matsuo K, McGuire V, McLaughlin JR, McNeish I, Menon U, Milne RL, Modugno F, Thomsen L, Moysich KB, Ness RB, Nevanlinna H, Eilber U, Odunsi K, Olson SH, Orlow I, Orsulic S, Palmieri Weber R, Paul J, Pearce CL, Pejovic T, Pelttari LM, Pike MC, Poole EM, Schernhammer E, Risch HA, Rosen B, Rossing MA, Rothstein JH, Rudolph A, Runnebaum IB, Rzepecka IK, Salvesen HB, Schwaab I, Shu XO, Shvetsov YB, Siddiqui N, Song H, Southey MC, Spiewankiewicz B, Sucheston-Campbell L, Teo SH, Terry KL, Thompson PJ, Tangen IL, Tworoger SS, van Altena AM, Vergote I, Walsh CS, Wang-Gohrke S, Wentzensen N, Whittemore AS, Wicklund KG, Wilkens LR, Wu AH, Wu X, Woo YL, Yang H, Zheng W, Ziogas A, Amankwah E, Berchuck A, management group GCOBOTA, , Schildkraut JM, Kelemen LE, Ramus SJ, Monteiro AN, Goode EL, Narod SA, Gayther SA, Pharoah PD, Sellers TA, Phelan CM. Common genetic variation in circadian rhythm genes and risk of epithelial ovarian cancer (EOC). J Genet Genome Res 2(2), 2015. e-Pub 2015. PMID: 26807442.
111. Chornokur G, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Amankwah EK, Qu X, Tsai YY, Jim HS, Chen Z, Chen AY, Permuth-Wey J, KKh A, Anton-Culver H, Antonenkova N, Bruinsma F, Bandera EV, Bean YT, Beckmann MW, Bisogna M, Bjorge L, Bogdanova N, Brinton LA, Brooks-Wilson A, Bunker CH, Butzow R, Campbell IG, Carty K, Chang-Claude J, Cook LS, Cramer DW, Cunningham JM, Cybulski C, Dansonka-Mieszkowska A, du Bois A, Despierre E, Dicks E, Doherty JA, Dörk T, Dürst M, Easton DF, Eccles DM, Edwards RP, Ekici AB, Fasching PA, Fridley BL, Gao YT, Gentry-Maharaj A, Giles GG, Glasspool R, Goodman MT, Gronwald J, Harrington P, Harter P, Hein A, Heitz F, Hildebrandt MA, Hillemanns P, Hogdall CK, Hogdall E, Hosono S, Jakubowska A, Jensen A, Ji BT, Karlan BY, Kelemen LE, Kellar M, Kiemeney LA, Krakstad C, Kjaer SK, Kupryjanczyk J, Lambrechts D, Lambrechts S, Le ND, Lee AW, Lele S, Leminen A, Lester J, Levine DA, Liang D, Lim BK, Lissowska J, Lu K, Lubinski J, Lundvall L, Massuger LF, Matsuo K, McGuire V, McLaughlin JR, McNeish I, Menon U, Milne RL, Modugno F, Moysich KB, Ness RB, Nevanlinna H, Eilber U, Odunsi K, Olson SH, Orlow I, Orsulic S, Weber RP, Paul J, Pearce CL, Pejovic T, Pelttari LM, Pike MC, Poole EM, Risch HA, Rosen B, Rossing MA, Rothstein JH, Rudolph A, Runnebaum IB, Rzepecka IK, Salvesen HB, Schernhammer E, Schwaab I, Shu XO, Shvetsov YB, Siddiqui N, Sieh W, Song H, Southey MC, Spiewankiewicz B, Sucheston L, Teo SH, Terry KL, Thompson PJ, Thomsen L, Tangen IL, Tworoger SS, van Altena AM, Vierkant RA, Vergote I, Walsh CS, Wang-Gohrke S, Wentzensen N, Whittemore AS, Wicklund KG, Wilkens LR, Wu AH, Wu X, Woo YL, Yang H, Zheng W, Ziogas A, Hasmad HN, Berchuck A, management group GCOBOTA, Iversen ES, Schildkraut JM, Ramus SJ, Goode EL, Monteiro AN, Gayther SA, Narod SA, Pharoah PD, Sellers TA, Phelan CM. Common genetic variation in cellular transport genes and epithelial ovarian cancer (EOC) risk. PLoS One 10(6):e0128106, 2015. e-Pub 2015. PMID: 26091520.
112. Pu X, Wang L, Chang JY, Hildebrandt MA, Ye Y, Lu C, Skinner HD, Niu N, Jenkins GD, Komaki R, Minna JD, Roth JA, Weinshilboum RM, Wu X. Inflammation-related genetic variants predict toxicity following definitive radiotherapy for lung cancer. Clin Pharmacol Ther 96(5):609-15, 2014. e-Pub 2014. PMID: 25054431.
113. Kelemen LE, Terry KL, Goodman MT, Webb PM, Bandera EV, McGuire V, Rossing MA, Wang Q, Dicks E, Tyrer JP, Song H, Kupryjanczyk J, Dansonka-Mieszkowska A, Plisiecka-Halasa J, Timorek A, Menon U, Gentry-Maharaj A, Gayther SA, Ramus SJ, Narod SA, Risch HA, McLaughlin JR, Siddiqui N, Glasspool R, Paul J, Carty K, Gronwald J, Lubinski J, Jakubowska A, Cybulski C, Kiemeney LA, Massuger LF, van Altena AM, Aben KK, Olson SH, Orlow I, Cramer DW, Levine DA, Bisogna M, Giles GG, Southey MC, Bruinsma F, Kjaer SK, Høgdall E, Jensen A, Høgdall CK, Lundvall L, Engelholm SA, Heitz F, du Bois A, Harter P, Schwaab I, Butzow R, Nevanlinna H, Pelttari LM, Leminen A, Thompson PJ, Lurie G, Wilkens LR, Lambrechts D, Van Nieuwenhuysen E, Lambrechts S, Vergote I, Beesley J, Group/ACS Investigators AS, Fasching PA, Beckmann MW, Hein A, Ekici AB, Doherty JA, Wu AH, Pearce CL, Pike MC, Stram D, Chang-Claude J, Rudolph A, Dörk T, Dürst M, Hillemanns P, Runnebaum IB, Bogdanova N, Antonenkova N, Odunsi K, Edwards RP, Kelley JL, Modugno F, Ness RB, Karlan BY, Walsh C, Lester J, Orsulic S, Fridley BL, Vierkant RA, Cunningham JM, Wu X, Lu K, Liang D, Hildebrandt MA, Weber RP, Iversen ES, Tworoger SS, Poole EM, Salvesen HB, Krakstad C, Bjorge L, Tangen IL, Pejovic T, Bean Y, Kellar M, Wentzensen N, Brinton LA, Lissowska J, Garcia-Closas M, Campbell IG, Eccles D, Whittemore AS, Sieh W, Rothstein JH, Anton-Culver H, Ziogas A, Phelan CM, Moysich KB, Goode EL, Schildkraut JM, Berchuck A, Pharoah PD, Sellers TA, Brooks-Wilson A, Cook LS, Le ND. Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk. Mol Nutr Food Res 58(10):2023-35, 2014. e-Pub 2014. PMID: 25066213.
114. Melkonian SC, Daniel CR, Hildebrandt MA, Tannir NM, Ye Y, Chow WH, Wood CG, Wu X. Joint association of genome-wide association study-identified susceptibility loci and dietary patterns in risk of renal cell carcinoma among non-Hispanic whites. Am J Epidemiol 180(5):499-507, 2014. e-Pub 2014. PMID: 25053674.
115. Pu X, Hildebrandt MA, Lu C, Roth JA, Stewart DJ, Zhao Y, Heist RS, Ye Y, Chang DW, Su L, Minna JD, Lippman SM, Spitz MR, Christiani DC, Wu X. Inflammation-related genetic variations and survival in patients with advanced non-small cell lung cancer receiving first-line chemotherapy. Clin Pharmacol Ther 96(3):360-9, 2014. e-Pub 2014. PMID: 24755914.
116. Earp MA, Kelemen LE, Magliocco AM, Swenerton KD, Chenevix-Trench G, Study AC, Study Group AOC, Lu Y, Hein A, Ekici AB, Beckmann MW, Fasching PA, Lambrechts D, Despierre E, Vergote I, Lambrechts S, Doherty JA, Rossing MA, Chang-Claude J, Rudolph A, Friel G, Moysich KB, Odunsi K, Sucheston-Campbell L, Lurie G, Goodman MT, Carney ME, Thompson PJ, Runnebaum IB, Dürst M, Hillemanns P, Dörk T, Antonenkova N, Bogdanova N, Leminen A, Nevanlinna H, Pelttari LM, Butzow R, Bunker CH, Modugno F, Edwards RP, Ness RB, du Bois A, Heitz F, Schwaab I, Harter P, Karlan BY, Walsh C, Lester J, Jensen A, Kjær SK, Høgdall CK, Høgdall E, Lundvall L, Sellers TA, Fridley BL, Goode EL, Cunningham JM, Vierkant RA, Giles GG, Baglietto L, Severi G, Southey MC, Liang D, Wu X, Lu K, Hildebrandt MA, Levine DA, Bisogna M, Schildkraut JM, Iversen ES, Weber RP, Berchuck A, Cramer DW, Terry KL, Poole EM, Tworoger SS, Bandera EV, Chandran U, Orlow I, Olson SH, Wik E, Salvesen HB, Bjorge L, Halle MK, van Altena AM, Aben KK, Kiemeney LA, Massuger LF, Pejovic T, Bean YT, Cybulski C, Gronwald J, Lubinski J, Wentzensen N, Brinton LA, Lissowska J, Garcia-Closas M, Dicks E, Dennis J, Easton DF, Song H, Tyrer JP, Pharoah PD, Eccles D, Campbell IG, Whittemore AS, McGuire V, Sieh W, Rothstein JH, Flanagan JM, Paul J, Brown R, Phelan CM, Risch HA, McLaughlin JR, Narod SA, Ziogas A, Anton-Culver H, Gentry-Maharaj A, Menon U, Gayther SA, Ramus SJ, Wu AH, Pearce CL, Pike MC, Dansonka-Mieszkowska A, Rzepecka IK, Szafron LM, Kupryjanczyk J, Cook LS, Le ND, Brooks-Wilson A, Association Consortium OC. Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. Hum Genet 133(5):481-97, 2014. e-Pub 2014. PMID: 24190013.
117. Charbonneau B, Block MS, Bamlet WR, Vierkant RA, Kalli KR, Fogarty Z, Rider DN, Sellers TA, Tworoger SS, Poole E, Risch HA, Salvesen HB, Kiemeney LA, Baglietto L, Giles GG, Severi G, Trabert B, Wentzensen N, Chenevix-Trench G, group FA, Whittemore AS, Sieh W, Chang-Claude J, Bandera EV, Orlow I, Terry K, Goodman MT, Thompson PJ, Cook LS, Rossing MA, Ness RB, Narod SA, Kupryjanczyk J, Lu K, Butzow R, Dörk T, Pejovic T, Campbell I, Le ND, Bunker CH, Bogdanova N, Runnebaum IB, Eccles D, Paul J, Wu AH, Gayther SA, Hogdall E, Heitz F, Kaye SB, Karlan BY, Anton-Culver H, Gronwald J, Hogdall CK, Lambrechts D, Fasching PA, Menon U, Schildkraut J, Pearce CL, Levine DA, Kjaer SK, Cramer D, Flanagan JM, Phelan CM, Brown R, Massuger LF, Song H, Doherty JA, Krakstad C, Liang D, Odunsi K, Berchuck A, Jensen A, Lubinski J, Nevanlinna H, Bean YT, Lurie G, Ziogas A, Walsh C, Despierre E, Brinton L, Hein A, Rudolph A, Dansonka-Mieszkowska A, Olson SH, Harter P, Tyrer J, Vitonis AF, Brooks-Wilson A, Aben KK, Pike MC, Ramus SJ, Wik E, Cybulski C, Lin J, Sucheston L, Edwards R, McGuire V, Lester J, du Bois A, Lundvall L, Wang-Gohrke S, Szafron LM, Lambrechts S, Yang H, Beckmann MW, Pelttari LM, Van Altena AM, van den Berg D, Halle MK, Gentry-Maharaj A, Schwaab I, Chandran U, Menkiszak J, Ekici AB, Wilkens LR, Leminen A, Modugno F, Friel G, Rothstein JH, Vergote I, Garcia-Closas M, Hildebrandt MA, Sobiczewski P, Kelemen LE, Pharoah PD, Moysich K, Knutson KL, Cunningham JM, Fridley BL, Goode EL. Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10. Cancer Res 74(3):852-61, 2014. e-Pub 2014. PMID: 24272484.
118. Wei H, Ke HL, Lin J, Shete S, Wood CG, Hildebrandt MA. MicroRNA target site polymorphisms in the VHL-HIF1α pathway predict renal cell carcinoma risk. Mol Carcinog 53(1):1-7, 2014. e-Pub 2014. PMID: 22517515.
119. Meng QH, Xu E, Hildebrandt MA, Liang D, Lu K, Ye Y, Wagar EA, Wu X. Genetic variants in the fibroblast growth factor pathway as potential markers of ovarian cancer risk, therapeutic response, and clinical outcome. Clin Chem 60(1):222-32, 2014. e-Pub 2014. PMID: 24146310.
120. Wang Y, Gu J, Roth JA, Hildebrandt MA, Lippman SM, Ye Y, Minna JD, Wu X. Pathway-based serum microRNA profiling and survival in patients with advanced non-small cell lung cancer. Cancer Res 73(15):4801-9, 2013. e-Pub 2013. PMID: 23774211.
121. Wu X, Wang L, Ye Y, Aakre JA, Pu X, Chang GC, Yang PC, Roth JA, Marks RS, Lippman SM, Chang JY, Lu C, Deschamps C, Su WC, Wang WC, Huang MS, Chang DW, Li Y, Pankratz VS, Minna JD, Hong WK, Hildebrandt MA, Hsiung CA, Yang P. Genome-wide association study of genetic predictors of overall survival for non-small cell lung cancer in never smokers. Cancer Res 73(13):4028-4038, 2013. e-Pub 2013. PMID: 23704207.
122. Schumacher FR, Wang Z, Skotheim RI, Koster R, Chung CC, Hildebrandt MA, Kratz CP, Bakken AC, Bishop DT, Cook MB, Erickson RL, Fosså SD, Greene MH, Jacobs KB, Kanetsky PA, Kolonel LN, Loud JT, Korde LA, Le Marchand L, Lewinger JP, Lothe RA, Pike MC, Rahman N, Rubertone MV, Schwartz SM, Siegmund KD, Skinner EC, Turnbull C, Van Den Berg DJ, Wu X, Yeager M, Nathanson KL, Chanock SJ, Cortessis VK, McGlynn KA. Testicular germ cell tumor susceptibility associated with the UCK2 locus on chromosome 1q23. Hum Mol Genet 22(13):2748-53, 2013. e-Pub 2013. PMID: 23462292.
123. Chung CC, Kanetsky PA, Wang Z, Hildebrandt MA, Koster R, Skotheim RI, Kratz CP, Turnbull C, Cortessis VK, Bakken AC, Bishop DT, Cook MB, Erickson RL, Fosså SD, Jacobs KB, Korde LA, Kraggerud SM, Lothe RA, Loud JT, Rahman N, Skinner EC, Thomas DC, Wu X, Yeager M, Schumacher FR, Greene MH, Schwartz SM, McGlynn KA, Chanock SJ, Nathanson KL. Meta-analysis identifies four new loci associated with testicular germ cell tumor. Nat Genet 45(6):680-5, 2013. e-Pub 2013. PMID: 23666239.
124. Ke HL, Chen M, Ye Y, Hildebrandt MA, Wu WJ, Wei H, Huang M, Chang DW, Dinney CP, Wu X. Genetic variations in micro-RNA biogenesis genes and clinical outcomes in non-muscle-invasive bladder cancer. Carcinogenesis 34(5):1006-11, 2013. e-Pub 2013. PMID: 23322153.
125. Pu X, Roth JA, Hildebrandt MA, Ye Y, Wei H, Minna JD, Lippman SM, Wu X. MicroRNA-related genetic variants associated with clinical outcomes in early stage non-small cell lung cancer patients. Cancer Res 73(6):1867-75, 2013. e-Pub 2013. PMID: 23378343.
126. Wu X, Ajani JA, Gu J, Chang DW, Tan W, Hildebrandt MA, Huang M, Wang KK, Hawk E. MicroRNA expression signatures during malignant progression from Barrett's esophagus to esophageal adenocarcinoma. Cancer Prev Res 6(3):196-205, 2013. e-Pub 2013. PMID: 23466817.
127. Shen H, Fridley BL, Song H, Lawrenson K, Cunningham JM, Ramus SJ, Cicek MS, Tyrer J, Stram D, Larson MC, Köbel M, Consortium P, Ziogas A, Zheng W, Yang HP, Wu AH, Wozniak EL, Woo YL, Winterhoff B, Wik E, Whittemore AS, Wentzensen N, Weber RP, Vitonis AF, Vincent D, Vierkant RA, Vergote I, Van Den Berg D, Van Altena AM, Tworoger SS, Thompson PJ, Tessier DC, Terry KL, Teo SH, Templeman C, Stram DO, Southey MC, Sieh W, Siddiqui N, Shvetsov YB, Shu XO, Shridhar V, Wang-Gohrke S, Severi G, Schwaab I, Salvesen HB, Rzepecka IK, Runnebaum IB, Rossing MA, Rodriguez-Rodriguez L, Risch HA, Renner SP, Poole EM, Pike MC, Phelan CM, Pelttari LM, Pejovic T, Paul J, Orlow I, Omar SZ, Olson SH, Odunsi K, Nickels S, Nevanlinna H, Ness RB, Narod SA, Nakanishi T, Moysich KB, Monteiro AN, Moes-Sosnowska J, Modugno F, Menon U, McLaughlin JR, McGuire V, Matsuo K, Adenan NA, Massuger LF, Lurie G, Lundvall L, Lubinski J, Lissowska J, Levine DA, Leminen A, Lee AW, Le ND, Lambrechts S, Lambrechts D, Kupryjanczyk J, Krakstad C, Konecny GE, Kjaer SK, Kiemeney LA, Kelemen LE, Keeney GL, Karlan BY, Karevan R, Kalli KR, Kajiyama H, Ji BT, Jensen A, Jakubowska A, Iversen E, Hosono S, Høgdall CK, Høgdall E, Hoatlin M, Hillemanns P, Heitz F, Hein R, Harter P, Halle MK, Hall P, Gronwald J, Gore M, Goodman MT, Giles GG, Gentry-Maharaj A, Garcia-Closas M, Flanagan JM, Fasching PA, Ekici AB, Edwards R, Eccles D, Easton DF, Dürst M, du Bois A, Dörk T, Doherty JA, Despierre E, Dansonka-Mieszkowska A, Cybulski C, Cramer DW, Cook LS, Chen X, Charbonneau B, Chang-Claude J, Campbell I, Butzow R, Bunker CH, Brueggmann D, Brown R, Brooks-Wilson A, Brinton LA, Bogdanova N, Block MS, Benjamin E, Beesley J, Beckmann MW, Bandera EV, Baglietto L, Bacot F, Armasu SM, Antonenkova N, Anton-Culver H, Aben KK, Liang D, Wu X, Lu K, Hildebrandt MA, Study AC, Schildkraut JM, Sellers TA, Huntsman D, Berchuck A, Chenevix-Trench G, Gayther SA, Pharoah PD, Laird PW, G. Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat Commun 4:1628, 2013. e-Pub 2013. PMID: 23535649.
128. Pu X, Ye Y, Spitz MR, Wang L, Gu J, Lippman SM, Hildebrandt MA, Hong WK, Minna JD, Roth JA, Yang P, Wu X. Predictors of survival in never-smokers with non-small cell lung cancer: a large-scale, two-phase genetic study. Clin Cancer Res 18(21):5983-91, 2012. e-Pub 2012. PMID: 22977190.
129. Kim JY, Hildebrandt MA, Pu X, Ye Y, Correa AM, Vaporciyan AA, Wu X, Roth JA. Variations in the vascular endothelial growth factor pathway predict pulmonary complications. Ann Thorac Surg 94(4):1079-85, 2012. e-Pub 2012. PMID: 22795057.
130. Hildebrandt MA, Lippman SM, Etzel CJ, Kim E, Lee JJ, Khuri FR, Spitz MR, Lotan R, Hong WK, Wu X. Genetic variants in the PI3K/PTEN/AKT/MTOR pathway predict head and neck cancer patient second primary tumor/recurrence risk and response to retinoid chemoprevention. Clin Cancer Res 18(13):3705-13, 2012. e-Pub 2012. PMID: 22577058.
131. Lin M, Gu J, Eng C, Ellis LM, Hildebrandt MA, Lin J, Huang M, Calin GA, Wang D, Dubois RN, Hawk ET, Wu X. Genetic polymorphisms in microRNA-related genes as predictors of clinical outcomes in colorectal adenocarcinoma patients. Clin Cancer Res 18(14):3982-91, 2012. e-Pub 2012. PMID: 22661538.
132. Hildebrandt MA, Tan W, Tamboli P, Huang M, Ye Y, Lin J, Lee JS, Wood CG, Wu X. Kinome expression profiling identifies IKBKE as a predictor of overall survival in clear cell renal cell carcinoma patients. Carcinogenesis 33(4):799-803, 2012. e-Pub 2012. PMID: 22266464.
133. Xing J, Dinney CP, Shete S, Huang M, Hildebrandt MA, Chen Z, Gu J. Comprehensive pathway-based interrogation of genetic variations in the nucleotide excision DNA repair pathway and risk of bladder cancer. Cancer 118(1):205-15, 2012. e-Pub 2012. PMID: 21692063.
134. Wu X, Scelo G, Purdue MP, Rothman N, Johansson M, Ye Y, Wang Z, Zelenika D, Moore LE, Wood CG, Prokhortchouk E, Gaborieau V, Jacobs KB, Chow WH, Toro JR, Zaridze D, Lin J, Lubinski J, Trubicka J, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Mates D, Jinga V, Bencko V, Slamova A, Holcatova I, Navratilova M, Janout V, Boffetta P, Colt JS, Davis FG, Schwartz KL, Banks RE, Selby PJ, Harnden P, Berg CD, Hsing AW, Grubb RL, Boeing H, Vineis P, Clavel-Chapelon F, Palli D, Tumino R, Krogh V, Panico S, Duell EJ, Quirós JR, Sanchez MJ, Navarro C, Ardanaz E, Dorronsoro M, Khaw KT, Allen NE, Bueno-de-Mesquita HB, Peeters PH, Trichopoulos D, Linseisen J, Ljungberg B, Overvad K, Tjønneland A, Romieu I, Riboli E, Stevens VL, Thun MJ, Diver WR, Gapstur SM, Pharoah PD, Easton DF, Albanes D, Virtamo J, Vatten L, Hveem K, Fletcher T, Koppova K, Cussenot O, Cancel-Tassin G, Benhamou S, Hildebrandt MA, Pu X, Foglio M, Lechner D, Hutchinson A, Yeager M, Fraumeni JF, Lathrop M, Skryabin KG, McKay JD, Gu J, Brennan P, Chanock SJ. A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23. Hum Mol Genet 21(2):456-62, 2012. e-Pub 2012. PMID: 22010048.
135. Pilarski R, Patel DA, Weitzel J, McVeigh T, Dorairaj JJ, Heneghan HM, Miller N, Weidhaas JB, Kerin MJ, McKenna M, Wu X, Hildebrandt M, Zelterman D, Sand S, Shulman LP. The KRAS-variant is associated with risk of developing double primary breast and ovarian cancer. PLoS One 7(5):e37891, 2012. e-Pub 2012. PMID: 22662244.
136. Yin J, Lu C, Gu J, Lippman SM, Hildebrandt MA, Lin J, Stewart D, Spitz MR, Wu X. Common genetic variants in cell cycle pathway are associated with survival in stage III-IV non-small-cell lung cancer. Carcinogenesis 32(12):1867-71, 2011. e-Pub 2011. PMID: 21965272.
137. Tan W, Hildebrandt MA, Pu X, Huang M, Lin J, Matin SF, Tamboli P, Wood CG, Wu X. Role of inflammatory-related gene expression in clear cell renal cell carcinoma development and clinical outcomes. J Urol 186(5):2071-7, 2011. e-Pub 2011. PMID: 21944129.
138. Lin M, Stewart DJ, Spitz MR, Hildebrandt MA, Lu C, Lin J, Gu J, Huang M, Lippman SM, Wu X. Genetic variations in the transforming growth factor beta pathway as predictors of survival in advanced non-small cell lung cancer. Carcinogenesis 32(7):1050-6, 2011. e-Pub 2011. PMID: 21515830.
139. Wu X, Ye Y, Rosell R, Amos CI, Stewart DJ, Hildebrandt MA, Roth JA, Minna JD, Gu J, Lin J, Buch SC, Nukui T, Ramirez Serrano JL, Taron M, Cassidy A, Lu C, Chang JY, Lippman SM, Hong WK, Spitz MR, Romkes M, Yang P. Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy. J Natl Cancer Inst 103(10):817-25, 2011. e-Pub 2011. PMID: 21483023.
140. Gu J, Ye Y, Spitz MR, Lin J, Kiemeney LA, Xing J, Hildebrandt MA, Hong WK, Amos CI, Wu X. A genetic variant near the PMAIP1/Noxa gene is associated with increased bleomycin sensitivity. Hum Mol Genet 20(4):820-6, 2011. e-Pub 2011. PMID: 21106707.
141. Lee JJ, Wu X, Hildebrandt MA, Yang H, Khuri FR, Kim E, Gu J, Ye Y, Lotan R, Spitz MR, Hong WK. Global assessment of genetic variation influencing response to retinoid chemoprevention in head and neck cancer patients. Cancer Prev Res 4(2):185-93, 2011. e-Pub 2011. PMID: 21292633.
142. Pu X, Hildebrandt MA, Lu C, Lin J, Stewart DJ, Ye Y, Gu J, Spitz MR, Wu X. PI3K/PTEN/AKT/mTOR pathway genetic variation predicts toxicity and distant progression in lung cancer patients receiving platinum-based chemotherapy. Lung Cancer 71(1):82-8, 2011. e-Pub 2011. PMID: 20447721.
143. Yin J, Lu K, Lin J, Wu L, Hildebrandt MA, Chang DW, Meyer L, Wu X, Liang D. Genetic variants in TGF-ß pathway are associated with ovarian cancer risk. PLoS One 6(9):e25559, 2011. e-Pub 2011. PMID: 21984931.
144. Rothman N, Garcia-Closas M, Chatterjee N, Malats N, Wu X, Figueroa JD, Real FX, Van Den Berg D, Matullo G, Baris D, Thun M, Kiemeney LA, Vineis P, De Vivo I, Albanes D, Purdue MP, Rafnar T, (co-second author) HM, Kiltie AE, Cussenot O, Golka K, Kumar R, Taylor JA, Mayordomo JI, Jacobs KB, Kogevinas M, Hutchinson A, Wang Z, Fu YP, Prokunina-Olsson L, Burdett L, Yeager M, Wheeler W, Tardón A, Serra C, Carrato A, García-Closas R, Lloreta J, Johnson A, Schwenn M, Karagas MR, Schned A, Andriole G, Grubb R, Black A, Jacobs EJ, Diver WR, Gapstur SM, Weinstein SJ, Virtamo J, Cortessis VK, Gago-Dominguez M, Pike MC, Stern MC, Yuan JM, Hunter DJ, McGrath M, Dinney CP, Czerniak B, Chen M, Yang H, Vermeulen SH, Aben KK, Witjes JA, Makkinje RR, Sulem P, Besenbacher S, Stefansson K, Riboli E, Brennan P, Panico S, Navarro C, Allen NE, Bueno-de-Mesquita HB, Trichopoulos D, Caporaso N, Landi MT, Canzian F, Ljungberg B, Tjonneland A, Clavel-Chapelon F, Bishop DT, Teo MT, Knowles MA, Guarrera S, Polidoro S, Ricceri F, Sacerdote C, Allione A, Cancel-Tassin G, Selinski S, Hengstler JG, Dietrich H, Fletcher T, Rudnai P, Gurzau E, Koppova K, Bolick SC, Godfrey A, Xu Z, Sanz-Velez JI, D García-Prats M, Sanchez M, Valdivia G, Porru S, Benhamou S, Hoover RN, Fraumeni JF, Silverman DT, Chanock SJ. A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet 42(11):978-84, 2010. e-Pub 2010. PMID: 20972438.
145. Chen M, Hildebrandt MA, Clague J, Kamat AM, Picornell A, Chang J, Zhang X, Izzo J, Yang H, Lin J, Gu J, Chanock S, Kogevinas M, Rothman N, Silverman DT, Garcia-Closas M, Grossman HB, Dinney CP, Malats N, Wu X. Genetic variations in the Sonic hedgehog pathway affect clinical outcomes in non-muscle invasive bladder cancer. Cancer Prev Res 3(10):1235-45, 2010. e-Pub 2010. PMID: 20858759.
146. Hildebrandt MA, Gu J, Lin J, Ye Y, Tan W, Tamboli P, Wood CG, Wu X. Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma. Oncogene 29(42):5724-8, 2010. e-Pub 2010. PMID: 20676129.
147. Chen M, Gu J, Delclos GL, Killary AM, Fan Z, Hildebrandt MA, Chamberlain RM, Grossman HB, Dinney CP, Wu X. Genetic variations of the PI3K-AKT-mTOR pathway and clinical outcome in muscle invasive and metastatic bladder cancer patients. Carcinogenesis 31(8):1387-91, 2010. e-Pub 2010. PMID: 20530239.
148. Clague J, Lippman SM, Yang H, Hildebrandt MA, Ye Y, Lee JJ, Wu X. Genetic variation in MicroRNA genes and risk of oral premalignant lesions. Mol Carcinog 49(2):183-9, 2010. e-Pub 2010. PMID: 19851984.
149. Hildebrandt MA, Komaki R, Liao Z, Gu J, Chang JY, Ye Y, Lu C, Stewart DJ, Minna JD, Roth JA, Lippman SM, Cox JD, Hong WK, Spitz MR, Wu X. Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer. PLoS One 5(8):e12402, 2010. e-Pub 2010. PMID: 20811626.
150. Hildebrandt MA, Yang H, Hung MC, Izzo JG, Huang M, Lin J, Ajani JA, Wu X. Genetic variations in the PI3K/PTEN/AKT/mTOR pathway are associated with clinical outcomes in esophageal cancer patients treated with chemoradiotherapy. J Clin Oncol 27(6):857-71, 2009. e-Pub 2009. PMID: 19164214.
151. Chen M, Cassidy A, Gu J, Delclos GL, Zhen F, Yang H, Hildebrandt MA, Lin J, Ye Y, Chamberlain RM, Dinney CP, Wu X. Genetic variations in PI3K-AKT-mTOR pathway and bladder cancer risk. Carcinogenesis 30(12):2047-52, 2009. e-Pub 2009. PMID: 19875696.
152. Li L, Fridley B, Kalari K, Jenkins G, Batzler A, Safgren S, Hildebrandt M, Ames M, Schaid D, Wang L. Gemcitabine and cytosine arabinoside cytotoxicity: association with lymphoblastoid cell expression. Cancer Res 68(17):7050-8, 2008. e-Pub 2008. PMID: 18757419.
153. Yu Z, Wang L, Hildebrandt MA, Schaid DJ. Testing whether genetic variation explains correlation of quantitative measures of gene expression, and application to genetic network analysis. Stat Med 27(19):3847-67, 2008. e-Pub 2008. PMID: 18444230.
154. Ji Y, Olson J, Zhang J, Hildebrandt M, Wang L, Ingle J, Fredericksen Z, Sellers T, Miller W, Dixon JM, Brauch H, Eichelbaum M, Justenhoven C, Hamann U, Ko Y, Brüning T, Chang-Claude J, Wang-Gohrke S, Schaid D, Weinshilboum R. Breast cancer risk reduction and membrane-bound catechol O-methyltransferase genetic polymorphisms. Cancer Res 68(14):5997-6005, 2008. e-Pub 2008. PMID: 18632656.
155. Wang L, Kumar S, Fridley BL, Kalari KR, Moon I, Pelleymounter LL, Hildebrandt MA, Batzler A, Eckloff BW, Wieben ED, Greipp PR. Proteasome beta subunit pharmacogenomics: gene resequencing and functional genomics. Clin Cancer Res 14(11):3503-13, 2008. e-Pub 2008. PMID: 18519783.
156. Moyer AM, Salavaggione OE, Wu TY, Moon I, Eckloff BW, Hildebrandt MA, Schaid DJ, Wieben ED, Weinshilboum RM. Glutathione s-transferase p1: gene sequence variation and functional genomic studies. Cancer Res 68(12):4791-801, 2008. e-Pub 2008. PMID: 18559526.
157. Moyer AM, Salavaggione OE, Hebbring SJ, Moon I, Hildebrandt MA, Eckloff BW, Schaid DJ, Wieben ED, Weinshilboum RM. Glutathione S-transferase T1 and M1: gene sequence variation and functional genomics. Clin Cancer Res 13(23):7207-16, 2007. e-Pub 2007. PMID: 18056202.
158. Hildebrandt MA, Carrington DP, Thomae BA, Eckloff BW, Schaid DJ, Yee VC, Weinshilboum RM, Wieben ED. Genetic diversity and function in the human cytosolic sulfotransferases. Pharmacogenomics J 7(2):133-43, 2007. e-Pub 2007. PMID: 16801938.
159. Schaid DJ, Batzler AJ, Jenkins GD, Hildebrandt MA. Exact tests of Hardy-Weinberg equilibrium and homogeneity of disequilibrium across strata. Am J Hum Genet 79(6):1071-80, 2006. e-Pub 2006. PMID: 17186465.
160. Hildebrandt MA, Salavaggione OE, Martin YN, Flynn HC, Jalal S, Wieben ED, Weinshilboum RM. Human SULT1A3 pharmacogenetics: gene duplication and functional genomic studies. Biochem Biophys Res Commun 321(4):870-8, 2004. e-Pub 2004. PMID: 15358107.
161. Thomae BA, Rifki OF, Theobald MA, Eckloff BW, Wieben ED, Weinshilboum RM. Human catecholamine sulfotransferase (SULT1A3) pharmacogenetics: functional genetic polymorphism. J Neurochem 87(4):809-19, 2003. e-Pub 2003. PMID: 14622112.
162. Rauschendorfer SV, Brandt A, Amini B, Livingston J, Roth ME, Kleinerman ES, Hildebrandt MAT. Genetic Markers of Early Skeletal Muscle Loss in Adolescent and Young Adult Cancer Patients Treated with Anthracyclines.
163. Valcarcel B, Riva E, Peña C, Glasenapp AV, Leautaud V, Malpica L, Hildebrandt MA. Burden of multiple myeloma in the Americas region and utility of existing registries: A population-based analysis.
164. Rauschendorfer SV, Brandt A, Amini B, Livingston J, Roth ME, Kleinerman ES, Hildebrandt MAT. Genetic Markers of Early Skeletal Muscle Loss in Adolescent and Young Adult Cancer Patients Treated with Anthracyclines.
165. Swaminathan M, Abbas H, Roth M, Hildebrandt MA, Fingrut W, Daver N, Kadia T, DiNardo C, Borthakur G, Jabbour E, Pemmaraju N, Alvarado Y, Ohanian M, Jain N, Short N, Bose P, Takahashi K, Hwang H, Huang X, Edelkamp P, Kebriaei P, Popat U, Shpall E, Garcia-Manero G, Kantarjian H, Ravandi F. Treatment in clinical trials mitigate socioeconomic and racial disparities in outcomes of patients with acute myeloid leukemia.
166. Macauda A, Clay-Gilmour A, Morelli F, Hielscher T, Försti A, Hemminki K, Butrym A, Brown EE, Weinhold N, Mazur G, Unal P, Machiela MJ, Tyczyńska A, Chanock SJ, Guler M, Hildebrandt MAT, Serin I, Norman AD, Briem K, Rybicka-Ramos M, Camp NJ, Manasanch E, Rymko M, Rajkumar S, Buda G, Hofmann JN, Watek M, Berndt SI, Vangsted A, Bhatti P, Grzasko N, Jurczyszyn A, Jamroziak K, Subocz E, Giles GG, Zawirska D, Vogel UB, Ziv E, Kruszewski M, del Giudice ML, Frost N, Dudziński M, Kumar SK, Goldschmidt H, Cozen W, Gemignani F, Slager SL, Perez JS, Campa D, Vachon C, Canzian F. A pleiotropy scan on multiple myeloma survival.
167. Subramanian N, Pleitez HG, Hildebrandt MA, Pasvolsky O, Kalariya N, Patel KK, Ferreri CJ. Clinical Outcomes of Multiple Myeloma Patients Receiving Treatment Following Disease Progression After BCMA-Targeted CAR T-cell Therapy.
168. Dillard CM, Gurumurthi A, Lee HC, Thomas SK, Weber DM, Orlowski RZ, Qazilbash MH, Patel KK, Hildebrandt MA. Analysis of Social Drivers of Health Status, Race, and Ethnicity with Survival in Myeloma Patients. Clin Lymphoma Myeloma.
169. Koutroumpakis E, Triantafyllou E, Livingston J, Song J, Viguet C, Hughes A, Rauschendorfer S, Jeyabal P, Honey TA, Chandra J, Daw NC, Hildebrandt M, Banchs J, Gilchrist S, Roth M, Deswal A, Kleinerman E. Early Anthracycline-Related Cardiotoxicity in Adolescent and Young Adult Patients of Sarcoma: A Prospective Echocardiographic Study.
170. Cheng D, Maegawa S, Guo L, Singh A, Yang Y, Sridharan S, Sharma A, Siddaway R, Lai Y, Kennis B, Dobson T, Swaminathan J, Shaik D, Gordon N, Daw N, Najjar A, Hildebrandt MAT, Tarapore R, Prabhu V, Allen JE, Xie Y, Hawkins C, Xu L, Gorlick R, Zaky W, Gopalakrishnan V. Integrated multi-omics analyses identify synergistic interactions with ONC201 against DIPG.
171. Hayek S, Miller KA, Roth ME, Hildebrandt MA, Freyer DR, Milam J. Social Roles, Emotional Distress, and Successful Aging Indicators in Adult Childhood Cancer Survivors – Findings from Project Forward. Sci Reports.
172. Gowda K, Gupta M, Aguilar A, Cruz C, Warner A, Rodriguez ER, Ahmed S, Cuglievan B, Milam J, Freyer DR, Miller KA, Aune G, Eshelman-Kent D, Albritton K, Koutroumpakis E, Roth ME, Hildebrandt MAT. Survival after Diagnosis of Cardiovascular Disease in Survivors of Adolescent and Young Adult Lymphoma.
173. Dillard CM, Lee H, Kalariya N, Subramanian N, Pasvolsky O, Ferreri C, Gaballa M, Thomas SK, Weber DM, Becnel M, Kaufman G, Qazilbash M, Orlowski RZ, Hildebrandt MAT, Patel KK. Association of Genetic Ancestry with Outcomes and Toxicity of Idecabtagene Vicleucel in Patients with Relapsed/Refractory Multiple Myeloma. Blood Cancer J.
174. Sánchez-Maldonado JM, Macauda A, Cabrera-Serrano AJ, Thomsen H, Horst RT, Güler M, Netea MG, Hemminki K, López-Nevot MÁ, Campa D, Hildebrandt MAT, Clay-Gilmour A, Slager S, Vachon C, Försti A, Canzian F, Sainz J. ULK4 and CDKN2A polymorphisms influence the risk of developing Monoclonal Gammopathy of Undetermined Significance.

Invited Articles

1. Hildebrandt MA, Ajani JA, Hofstetter W, Swisher S, Wu X. The role of PI3K/PTEN/AKT/mTOR Genetic Variation and Clinical Outcomes following Chemoradiotherapy for Esophageal Cancer. Am J Hemtol Oncol, 2009. e-Pub 2009.

Review Articles

1. Lopez Moreno SF, Lenz SA, Casso-Chapa B, Paniagua-Bojorges A, Kim JH, Palaskas NL, Nead KT, Samanthapudi VSK, Mejia G, Hoang O, Lee J, Lin SH, Herrmann J, Wang G, Yusuf SW, Iliescu CA, Beinart NI, Manisty C, Ushio-Fukai M, Fukai T, Ameri P, Nurieva RI, Hildebrandt MAT, Schadler K, Koutroumpakis E, Kotla S, Le NT, Abe JI. SHP2: A Redox-Sensitive Regulator Linking Immune Checkpoint Inhibitor Therapy to Cancer Treatment and Vascular Risk. Antioxidants (Basel) 14(12), 2025. e-Pub 2025. PMID: 41462587.
2. Berkman AM, Hildebrandt MAT, Landstrom AP. The genetic underpinnings of anthracycline-induced cardiomyopathy predisposition. Clin Genet 100(2):132-143, 2021. e-Pub 2021. PMID: 33871046.
3. Williams S, Ayers AA, Hildebrandt MT, McNeill LH, Flowers CR. Strategies for Overcoming Disparities for Patients With Hematologic Malignancies and for Improving Enrollment on Clinical Trials. Oncology (Williston Park) 34(6):216-223, 2020. e-Pub 2020. PMID: 32609869.
4. Scelo G, Hofmann JN, Banks RE, Bigot P, Bhatt RS, Cancel-Tassin G, Chew SK, Creighton CJ, Cussenot O, Davis IJ, Escudier B, Frayling TM, Häggström C, Hildebrandt MA, Holcatova I, Johansson M, Linehan WM, McDermott DF, Nathanson KL, Ogawa S, Perlman EJ, Purdue MP, Stattin P, Swanton C, Vasudev NS, Wu X, Znaor A, Brennan P, Chanock SJ. International cancer seminars: a focus on kidney cancer. Ann Oncol 27(8):1382-5, 2016. e-Pub 2016. PMID: 27130845.
5. Wu X, Hildebrandt MA, Chang DW. Genome-wide association studies of bladder cancer risk: a field synopsis of progress and potential applications. Cancer Metastasis Rev 28(3-4):269-80, 2009. e-Pub 2009. PMID: 20016998.
6. Hildebrandt MA, Gu J, Wu X. Pharmacogenomics of platinum-based chemotherapy in NSCLC. Expert Opin Drug Metab Toxicol 5(7):745-55, 2009. e-Pub 2009. PMID: 19442035.
7. Hildebrandt M, Adjei A, Weinshilboum R, Johnson JA, Berlin DS, Klein TE, Altman RB. Very important pharmacogene summary: sulfotransferase 1A1. Pharmacogenet Genomics 19(6):404-6, 2009. e-Pub 2009. PMID: 19451861.
8. Gordon N, Gopalakrishnan V, Najjar A, Zaky W, Hildebrandt MA, Anjier A, Gibson A, Rav E, Nash A, Huse J, Lazar A, Austin M, Sandberg D, Bhattacharjee MB, Daw NC, Gorlick R. Overcoming Barriers to Developing and Scaling a Pediatric Biospecimen Core: Lessons from MD Anderson Cancer Center.

Abstracts

1. Cruz CA, Rodriguez ER, Thawani M, Mazer M, Hayhurst M, Swanson M, Romero A, Livingston J, Aune G, Eshelman-Kent D, Albritton K, Cuglievan B, Ahmed S, Roth ME, Hildebrandt MA. Differences in time to treatment and impact on overall survival in adolescents and young adults with Hodgkin lymphoma. Health Disparities in Hematological Malignancies, New York, NY, 2025. e-Pub 2025.
2. Gupta M, Brandt A, Clay-Gilmour A, Xiao Q, Stavinoha P, Choi E, Livingston J, Milam J, Freyer D, Miller KA, Merriman K, Peterson S, Roth M, Hildebrandt MA. Genetic Chronotype, Sleep, and Health in AYA Cancer Survivors: the MD Anderson AYA Cancer Survivorship Study (AYACSS). Health Disparities in Hematologic Malignancies, New York, NY, 2025. e-Pub 2025.
3. Swaminathan M, Bazinet A, Sasaki K, Fox DA, Hill W, Bataller A, Chien K, Montalban-Bravo G, Hammond D, Hildebrandt M, Bouligny I, Jen WY, Kadia T, Takahashi K, DiNardo C, Jabbour E, Daver N, Garcia-Manero G. Area deprivation index does not influence survival in patients with lower-risk myelodysplastic syndromes at a major cancer center. American Society of Hematology Annual Meeting, Orlando, FL, 2025. e-Pub 2025.
4. Swaminathan M, Bazinet A, Sasaki K, Fox DA, Hill W, Bataller A, Chien K, Montalban-Bravo G, Hammond D, Hildebrandt M, Bouligny I, Jen WY, Kadia T, Takahashi K, DiNardo C, Jabbour E, Daver N, Garcia-Manero G. Area deprivation index independently predicts outcomes in IPSS-R higher-risk myelodysplastic syndromes at a major cancer center. American Society of Hematology Annual Meeting, Orlando, FL, 2025. e-Pub 2025.
5. Thomas SK, Manasanch EE, Jagannath S, Korde N, Lee HC, Berrios D, Patel KK, Iyer S, Mailankody S, Amini B, Lin P, Lutter-Berka Z, Weber DM, Kaufman GP, Feng L, Hildebrandt MA, Wang L, Neelapu SS, Orlowski RZ, Landgren O. Final results of a multi-center phase 2 trial of isatuximab-lenalidomide in patients with high risk smoldering multiple myeloma (HRSMM). American Society of Hematology Annual Meeting, Orlando, FL, 2025. e-Pub 2025.
6. Ferreri CJ, Gaballa M, Santiago M, Castro MD, Abid MB, Hildebrandt MA, Funk L, Crumpton B, Varga C, Atrash S, Patel KK. Cost-conscious CAR T delivery: Outpatient (OP) cilta-cel administration reduces health care resource utilization (HCRU) and the associated post-infusion cost. American Society of Hematology Annual Meeting, Orlando, FL, 2025. e-Pub 2025.
7. Warner A, Brandt A, Xiao Q, Wang J, Aune G, Eshelman-Kent D, Albritton K, Ahmed S, Koutroumpakis E, Roth ME, Hildebrandt M. Epigenetic Age Acceleration and Cardiac Dysfunction in Survivors of Adolescent and Young Adult Cancer. AACR Conference on The Science of Cancer Health Disparities, Baltimore, MD, 2025. e-Pub 2025.
8. Clay-Gilmour A, Guler M, Turner JJ, Cholack G, Hildebrandt MAT, Kalach NE, Masek E, Cozen W, Brown, Elizabeth E, Koff JL, Macuada A, Sucheston-Campbell L, Birmann B, Epstein MM, Berndt S, Shah P, Earle A, Pahnke S, Park HL, Norman A, Boddicker N, Teras L, Wang S, Hjaligrim H, McKay J, Diepstra A, Cerhan JR, Smedby K. InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO 5th Edition classification (2024): update. International Conference on Malignant Lymphoma (IMCL) Annual Meeting, Lugano, Switzerland, 2025. e-Pub 2025.
9. Dillard CM, Singhal R, Pasvolsky O, Nze C, Feng L, Hunzeker Z, Ye C, Thomas S, Becnel M, Gaballa M, Weber D, Richards T, Diaz F, Ahmed S, Hawkins M, Johnson N, Ow K, Adkins S, Lewis J, Kroll M, Orlowski RZ, Hildebrandt MA, Patel KK. Treatment history not race or duffy-null status predicts outcomes with teclistamab in Relapsed/Refractory multiple myeloma. American Society of Hematology Annual Meeting, Orlando, FL, 2025. e-Pub 2025.
10. Ferreri CJ, Gaballa M, Santiago M, Castro MD, Abid MB, Hildebrandt MA, Funk L, Crumpton B, Varga C, Atrash S, Patel KK. Cost-conscious CAR T delivery: Outpatient (OP) cilta-cel administration reduces health care resource utilization (HCRU) and the associated post-infusion cost. American Society of Hematology Annual Meeting, Orlando, FL, 2025. e-Pub 2025.
11. Rauschendorfer SV, Koutroumpakis E, Amini B, Song J, Hildebrandt M, Deswal A, Livingston J, Roth M, Kleinerman ES. Mediastinal adipose tissue: a potential biomarker and predictor of cardiotoxicity in AYAs with cancer. American Society of Pediatric Hematology/Oncology Annual Meeting, Louisville, KY, 2025. e-Pub 2025.
12. Valcarcel BS, Rodriguez MA, Hildebrandt MAT, Ahmed S, Flowers CR, Malpica LE. Mortality outcomes compared to the general population among long-term Hodgkin lymphoma survivors: A population-based analysis. American Society of Hematology Annual Meeting, Orlando, FL, 2025. e-Pub 2025.
13. Ballerini M, Larson M, Foran J, Howren MB, Hildebrandt M, Pamela, Allen, Riska S, Maurer M, Slager S, Feldman A, Jaye D, Thomas, Habermann, Cohen J, Kahl B, Martin P, Lossos IS, Friedberg J, Link B, Mou E, Nze C, Thompson C, Williams A, Yost K, Flowers C, Cerhan J. Survival differences in metropolitan versus nonmetropolitan/rural counties in the US: An analysis according to rural-urban continuum codes (RUCC) in the lymphoma epidemiology of outcomes (LEO) study cohort. American Society of Hematology Annual Meeting, Orlando, FL, 2025. e-Pub 2025.
14. Sokolova T, Cahn EJ, Tsang M, Strouse CS, Hildebrandt MAT, Rosenthal AC, Feldman AL, Jaye DL, Martin P, Cohen JB, Kahl BS, Lossos IS, Friedberg JW, Nastoupil LJ, Link BK, Habermann TM, Flowers CR, Maurer MJ, Casulo C, Thompson CA, Williams AM, Cerhan JR. Vulnerable Elders Survey (VES-13) and Longitudinal Analysis of Quality of Life in Indolent Non-Hodgkin Lymphoma: A Multi-Institutional Prospective Cohort Study. American Society of Hematology Annual Meeting, San Diego, CA, 2024. e-Pub 2024.
15. Dillard CM, Gurumurthi A, Lee HC, Thomas SK, Weber DM, Orlowski RZ, Qazilbash MH, Patel KK, Hildebrandt MAT. Association of Social Determinants of Health Status (SDOH) and Ethnicity with Survival in Multiple Myeloma Patients. American Society of Hematology Annual Meeting, San Diego, CA, 2024. e-Pub 2024.
16. Thawani M, Mazer M, Hayhurst M, Romero A, Swanson M, Roth M, Hildebrandt M. Disparities in Cardiovascular Dysfunction among Hispanic and Black Survivors of AYA Cancer. Advancing the Science of Cancer in Latinos, San Antonio, TX, 2024. e-Pub 2024.
17. Brown E, Dillard C, Hildebrandt MAT, Patel K. Differences in Time to CAR T Therapy based on Race/Ethnicity and ADI. Medical Student Scholars for Health Equity in Myeloma at National Medical Association Annual Convention, New York, NY, 2024. e-Pub 2024.
18. Gowda K, Gupta M, Aguilar A, Cruz C, Rodriguez ER, Ahmed S, Cuglievan B, Koutroumpakis E, Roth ME, Hildebrandt MAT. Mortality after Diagnosis of Cardiovascular Disease in Survivors of Adolescent and Young Adult Lymphoma. American Society of Hematology Annual Meeting, San Diego, CA, 2024. e-Pub 2024.
19. Dillard CM, Hildebrandt MAT, Lee H, Kalariya N, Subramanian N, Pasvolsky O, Ferreri C, Gaballa M, Thomas SK, Weber DM, Becnel M, Manasanch EE, Kaufman G, Chen J, Hawkins M, Abreu M, Qazilbash M, Orlowski RZ, Patel KK. Impact of Genetic Ancestry on Outcomes and Toxicity of Idecabtagene vicleucel (Ide-cel) in Patients with Relapsed/Refractory Multiple Myeloma (RRMM). International Myeloma Society Annual Meeting, Rio de Janeiro, Brazil, 2024. e-Pub 2024.
20. Manasanch E, Lee H, Orlowski R, Becnel M, Kaufman GP, Patel K, Iyer S, Jagannath S, Lutter-Berka Z, Berrios D, Carpenter S, Feng L, Amini B, Weber DM, Hildebrandt MAT, Neelapu SS, Thomas SK. Interim Results of a Phase 2 Trial of Isatuximab-Lenalidomide for Patients with High-Risk Smoldering Multiple Myeloma. International Myeloma Society Annual Meeting, Rio de Janeiro, Brazil, 2024. e-Pub 2024.
21. Gouni S, Lionel A, Feng L, Gaulin C, Reddy T, Gonugunta A, Chu V, Hopper T, Ayers A, Jackson I, Al Zaki A, Hildebrandt MAT, Nastoupil L, Chihara D, Nze C, Ramdial J, Shpall EJ, Westin J, Flowers C, Strati P, Neelapu S, Lynn R, Ahmed S. Impact of Pre-Existing Mental Health Disorders (MHD) on CAR T-Cell Therapy Outcomes in Patients with Large B-Cell Lymphoma. American Society of Hematology Annual Meeting, San Diego, CA, 2024. e-Pub 2024.
22. Tsang M, Nobel BN, Bommier C, Casulo C, Thompson C, Rosenthal AC, Chihara D, Mou E, Durani U, Williams AM, Hildebrandt M, Yost K, Larson MC, Gysbers B, Slager SL, Feldman AL, Maurer MJ, Jaye DL, Tilburt J, Villasboas JCC, Major A, Phphali PA, Hilal T, Wang Y, Call TG, Koehler A, Munoz JL, Thanarajasingam G, Hampel PJ, Parikh SA, Nastoupil LJ, Witzig TE, Nowakowski GS, Ansell SM, Cohen JB, Habermann TM, Strouse C, Lossos LS, Kahl BS, Martin P, Flowers CR, Cerhan JR. Frontline Management Strategy and Quality of Life in Follicular Lymphoma: A Multi-Institutional Prospective Cohort Study. American Society for Hematology Annual Meeting, San Diego, CA, 2023. e-Pub 2023.
23. Bernstein CJ, Ahmed S, Livingston JA, Koutroumpakis E, Roth ME, Banchs J, Hildebrandt MAT. Effect of Cardiotoxic Treatment on Cardiac Aging in AYA Cancer Patients. 5th Global Adolescent and Young Adult Cancer Congress, Long Beach, CA, 2023. e-Pub 2023.
24. Pasvolsky O, Hildebrandt MAT, Subramanian N, Ferreri C, Lee H, Manasanch E, Thomas S, Weber D, Gaballa M, Dillard C, Becnel M, Hosing C, Lin P, Amini B, Qazilbash M, Orlowski R, Patel KK. Safety and Efficacy Outcomes for Patients with High-Risk Multiple Myeloma Receiving Idecabtagene Vicleucel: The MD Anderson Experience. American Society for Hematology Annual Meeting, San Diego, CA, 2023. e-Pub 2023.
25. Jafry M, George G, Tonn T, Rodriguez E, Xiao Q, Roth M, Hildebrandt M. Effect of Social Determinants of Health and Race/Ethnicity on Health-Related Quality of Life and Survival Among AYA Cancer Survivors. 5th Global Adolescent and Young Adult Cancer Congress, Long Beach, CA, 2023. e-Pub 2023.
26. Strati P, Brandt A, Henderson J, Westin JR, Nastoupil LJ, Al Zaki A, Jallouk A, Adkins S, Shpall EJ, Kebriaei P, Ramdial J, Saini N, Ahmed S, Flowers CR, Neelapu SS, Hildebrandt MAT. Germline Determinants of Toxicity and Efficacy in Patients with Large B-cell Lymphoma Treated with Anti-CD19 Autologous CAR T-cell Therapy. American Society of Hematology Annual Meeting, San Diego, CA, 2023. e-Pub 2023.
27. Lee MJ, Koff JL, Leautaud V, Hildebrandt MAT, Morin RD, Flowers CR. Understanding Racial Differences in the Presentation, Outcome, and Driving Mutations of Diffuse Large B-cell Lymphoma (DLBCL). Health Disparities in Hematologic Malignancies: From Genes to Outreach Meeting, New York, NY, 2023. e-Pub 2023.
28. Tonn T, Rodriguez E, Jafry M, Huff C, Ahmed S, Livingston JA, Aune G, Albritton K, Roth M, Hildebrandt M. Assessing Cardiovascular Disparities among Survivors of Adolescent and Young Adult (AYA) lymphoma by race/ethnicity and genetic ancestry. 5th Global Adolescent and Young Adult Cancer Congress, Long Beach, CA, 2023. e-Pub 2023.
29. Hildebrandt MAT, Bernstein C, Ahmed S, Livingston JA, Koutroumpakis E, Roth ME, Banchs J. Accelerated cardiac aging in adolescent and young adult cancer survivors previously treated with cardiotoxic therapy. American Association for Cancer Research Annual Meeting, Orlando, FL, 2023. e-Pub 2023.
30. Conry MT, Camp N, Vachon C, Hildebrandt M, Brown E, Lipkin SM, Garber J, Slager S, Stokes S, Norman A, Izhar A, Dandiker S, Maclachlan K, Offit K, Usmani S, Joseph V. Pathogenic germline mutations in a large cohort of Multiple Myeloma. American Association for Cancer Research Annual Meeting, Orlando, FL, 2023. e-Pub 2023.
31. Manasanch EE, Norde N, Lee HC, Patel K, Becnel M, Berrios D, Thomas SK, Iyer S, Mailankody S, Amini B, Lin P, Berkova Z, Weber DM, Feng L, Neelapu SS, Jagannath S, Hildebrandt MAT, Orlowski R, Langren O. ISAMAR: multicenter phase II trial of isatuximab (ISA) with/without lenalidomide (LEN) in high risk smoldering multiple myeloma (HRSMM). American Society for Clinical Oncology Annual Meeting, Chicago, IL, 2023. e-Pub 2023.
32. Bommier C, Tsang M, Nobel BM, Thompson C, Casulo C, Hildebrandt M, Rosenthal AC, Mou E, Durani U, Williams AM, Yost K, Larson MC, Gysbers B, Maurer MJ, Feldman AL, Jaye DL, Chihara D, Lossos LS, Strouse C, Kahl BS, Habermann TM, Flowers CR, Dueck AC, Cerhan JR, Cohen JB. Lymphoma-Related Quality of Life (QOL) is Not Impacted by Initial Treatment Choice in Patients with Marginal Zone Lymphoma (MZL): Results from the Prospective Lymphoma Epidemiology of Outcomes Study (LEO) Cohort. American Society of Hematology Annual Meeting, San Diego, CA, 2023. e-Pub 2023.
33. Rodriguez E, Tonn T, Jafry M, Xiao Q, Ahmed S, Cuglievan B, Livingston JA, Flowers CR, Aune GJ, Albritton KH, Roth ME, Hildebrandt MAT. Social Determinants of Health Burden among Adolescent and Young Adult Cancer Patients and Impact on Overall Survival. American Society of Clinical Oncology Annual Meeting, Chicago IL, 2023. e-Pub 2023.
34. Sandblom L, Hildebrandt M. Genetic mediators of cardiac dysfunction among AYA cancer survivors: investigation of risk loci from childhood cancer survivor populations. 4th Annual reImagine Health Research Symposium, "Health and Disease over the Lifespan", Virtual, 2022. e-Pub 2022.
35. Swartz MC, Siembida E, George G, Salsman J, Reeve B, Livingston AJ, Hildebrandt M, Peterson S, Andersen C, Roth M. Integrating Patient-Reported Outcomes Assessment into the Clinical Care Pathway for Adolescents and Young Adults with Cancer. Society for Behavioral Medicine Annual Meeting, Phoenix, AZ, 2022. e-Pub 2022.
36. George G, Andersen CR, Tang X, Livingston JA, Roth ME, Hildebrandt MAT. Health-related quality of life at diagnosis in survivors of adolescent and young adult cancer. American Association for Cancer Research Annual Meeting, New Orleans, LA, 2022. e-Pub 2022.
37. George I, Souder B, Berkman A, Campbell MJ, Barker P, Roth M, Hildebrandt M, Oeffinger K, Landstrom A, McCrary A. Obesity predisposes pediatric cancer patients exposed to anthracyclines to subclinical cardiac dysfunction detectable by strain echocardiography. American Heart Association Scientific Sessions, Boston, MA, 2022. e-Pub 2022.
38. Kalariya N, Ferreri C, Dillard C, Hawkins M, Manasanch E, Lee H, Weber D, Thomas S, Steiner R, Hosing C, Qazilbash M, Popat U, Orlowski R, Hildebrandt M, Patel K. Clinical Characteristics And Response Outcomes in Older Multiple Myeloma Patients Who Received idecabtagene vicleucel: A Single Center Study. Society for Hematology Oncology Annual Meeting, Houston, TX, 2022. e-Pub 2022.
39. Ferreri CJ, Hildebrandt MAT, Hashmi H, Shune L, McGuirk J, Sborov D, Wagner C, Kocoglu MH, AtrashS, Voorhees P, Khouri J, Dima D, Afrough A, Sannareddy A, Simmons G, Davis J, Kalariya N, Peres LC, Alsina M, Locke FL, Sidana S, Hansen DK, Patel KK, Castaneda Puglianini O. Idecabtagene Vicleucel (Ide-cel) Chimeric Antigen Receptor (CAR) T-cell Therapy in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Who Have Received A Prior BCMA-Targeted Therapy: Real World, Multi-Institutional Experience. American Society for Hematology Annual Meeting, New Orleans, LA, 2022. e-Pub 2022.
40. Rodriguez E, Tonn T, Jafry M, Buglievan B, Ahmed S, Livingston JA, Roth M, Hildebrandt M. Investigating the Impact of Neighborhood Deprivation Level on Cardiovascular Burden in Adolescent and Young Adult Lymphoma Survivors. American Medical Association Research Challenge, Virtual, 2022. e-Pub 2022.
41. Conry MT, Camp N, Vachon C, Hildebrandt M, Brown E, Lipkin SM, Garber J, Slager S, Stokes S, Norman A, Izhar A, Dandiker S, Offit K, Usmani S, Joseph V. Pathogenic germline mutations in a large cohort of Multiple Myeloma. 19th International Myeloma Society Annual Meeting, Los Angeles, CA, 2022. e-Pub 2022.
42. Scheet P, Yu Y, Chang K, Hildebrandt M, Permuth J, Li D, Huff C. Whole exome sequencing case-control study implicates truncating variants in ATM as major risk factors in pancreatic cancer. American Association for Cancer Research Annual Meeting, Virtual, 2020. e-Pub 2020.
43. Pluta J, Pyle L, Bishop T, Benitez J, Cortessis V, Ferlin A, Gietema J, Greene M, Grotmol T, Gupta R, Hamilton R, Hildebrandt M, Kiemeney L, Lessel D, Rafnar T, Richiardi L, Skotheim R, Turnbull C, Wiklund F, Zheng T, Rajpert-De Meyts E, Schwartz S, McGlynn K, Kanetsky P, Nathanson K. Identification of 22 novel loci associated with susceptibility to testicular germ cell tumors. American Association for Cancer Research Annual Meeting, Virtual, 2020. e-Pub 2020.
44. Lee MJ, Koff JL, Hildebrandt MAT, Switchenko JM, Jhaney CI, Harkins RA, Patel SP, Dave SP, Dave SS, Flowers CR. Mutational landscape of diffuse large B cell lymphoma in patients with genome-defined African ancestry. American Association for Cancer Research Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, Virtual, 2020. e-Pub 2020.
45. Chien A, Callender R, Salamon N, Vinuela F, Ye Y, Hildebrandt M. Patient- and Aneurysm-specific Predictors of Intracranial Aneurysm Growth in a Longitudinally-followed Population. International Stroke Conference, Honolulu, Hawaii, 2019. e-Pub 2019.
46. Clay-Gilmour AI, Hildebrandt M, Asmann Y, Brown EE, Hofmann JN, Spinelli J, Giles G, Bhatti P, Cozen W, Robinson DP, O'Brien, Rajkumar SV, Tian S, Berndt SI, Chanock SJ, Machiela M, Norman AD, Sinnwell JP, Wu X, Waller RG, Milne RL, Slager SL, Kumar SK, Camp NJ, Ziv J, Vachon CM. Association between a Polygenic Risk Score for Multiple Myeloma Risk and Overall Survival. American Society for Hematology Annual Meeting, Orlando, FL, 2019. e-Pub 2019.
47. Belachew AA, Tang X, Sandblom LK, Acevedo-Soto LA, Orlowski RZ, Manasanch EE, Hildebrandt MAT. A Multi-Ethnic Comparison of Multiple Myeloma Clinical Characteristics in Hispanics. American Association for Cancer Research Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, San Francisco, CA, 2019. e-Pub 2019.
48. Pyle LC, Pluta J, Nead K, Mitra N, Bishop DT, Benitez J, Cortessis V, Ferlin A, Gietema J, Greene M, Grotmol T, Gupta R, Hamilton R, Hildebrandt MAT, Kiemeney L, Lessel D, Rafnar T, Richiardi L, Skotheim R, Turnbull C, Wiklund F, Zheng T, Rajpert-De Meyts E, Schwartz SM, McGlynn KA, Kanetsky PA, Nathanson KM, of TECAC OB. Identification of 14 novel genetic loci for testicular germ cell tumor susceptibility. American Association for Cancer Research Annual Meeting, Atlanta, GA, 2019. e-Pub 2019.
49. Medapalli D, Tang X, Banchs J, Livingston JA, Roth M, Hildebrandt MAT. Quality of Life as a Predicator of Long-Term Cardiovascular Health in AYA Cancer Survivors. MD Anderson Cancer Survivorship Research Symposium, Houston, TX, 2019. e-Pub 2019.
50. Manasanch EE, Jagannath S, Lee HC, Patel K, Graham C, Kaufman G, Thomas SK, Iyer S, Mailankody S, Korde N, Amini B, Lin P, Berkova Z, Weber DM, Feng L, Lendvai N, Hildebrandt M, Neelapu SS, Orlowski RZ, Landgren O. A multicenter phase II single arm trial of Isatuximab in patients with high risk smoldering multiple myeloma. American Society for Hematology Annual Meeting, Orlando, FL, 2019. e-Pub 2019.
51. Reyes ME, Callender CA, Ma J, Grove ML, Morrison AC, Hildebrandt MAT. GPX4 gene expression is dose-responsive to doxorubicin exposure in iPSC-cardiomyocytes and correlated with mitochondrial function. American Heart Association Basic Cardiovascular Sciences Scientific Sessions, Boston, MA, 2019. e-Pub 2019.
52. Clay-Gilmour AI, Hildebrandt MAT, Camp NJ, Ziv E, Brown WW, Hofmann JN, Spinelli JJ, Giles GG, Bhatti P, Cozen W, Wu X, Robinson DP, Norman AD, Sinnwell JP, Kumar SK, Rajkumar VS, Slager SL, Vachon CM. Associations between a polygenic risk score and risk of multiple myeloma and its precursor. American Association for Cancer Research Annual Meeting, Atlanta, GA, 2019. e-Pub 2019.
53. Chien A, Callender R, Salamon N, Vinuela F, Ye Y, Hildebrandt M. A Predictive Model for Intracranial Aneurysm Growth Trajectory. International Stroke Conference, Honolulu, Hawaii, 2019. e-Pub 2019.
54. Eterovic AK, Ezzedine N, Song P, Tang L, Mohammad M, Daw NC, Gill J, Khatua S, Hildebrandt M, Zaky W. A robust cell-free DNA (cfDNA) assay to detect mutations in plasma samples of pediatric high grade glioma patients despite genomic DNA contamination. Society of Neuro-oncology Pediatric Neuro-Oncology Basic and Translational Research Conference, San Francisco, CA, 2019. e-Pub 2019.
55. Reyes MA, Callender R, Ma J, Grove ML, Morrison AC, Hildebrandt MAT. Doxorubicin-induced cardiotoxicity in iPSC-cardiomyocytes: Altered mitochondrial gene expression and function. American Association for Cancer Research Annual Meeting, Chicago, IL, 2018. e-Pub 2018.
56. Hildebrandt MAT, Callender RA, Belachew AA, Claussen C, Lee HC, Patel K, Richards TA, Thomas S, Weber DM, Orlowski RZ, Manasanch EE. Quality of Life and Cancer Worry in a Follow-up Cohort of Patients with Asymptomatic Monoclonal Gammopathies. American Society for Clinical Oncology Annual Meeting, Chicago, IL, 2018. e-Pub 2018.
57. Reyes MA, Callender R, Ma J, Grove ML, Morrison AC, Hildebrandt MAT. Doxorubicin-induced cardiotoxicity in iPSC-cardiomyocytes: Altered mitochondrial gene expression and function. MD Anderson Cancer Survivorship Research Symposium, Houston, TX, 2018. e-Pub 2018.
58. Reyes ME, Ma J, Grove ML, Ater JA, Morrison AC, Hildebrandt MAT. RNAseq hiPSC-cardiomyocytes reveals altered expression of DNA damage and cell cycle genes in response to doxorubicin. MD Anderson Cancer Survivorship Research Symposium, Houston, TX, 2017. e-Pub 2017.
59. Chien A, Hildebrandt M, Callendar R, Ye Y. Coronary artery disease and diabetes may be positively associated with annual growth rate of brain aneurysms. International Stroke Conference, Houston, TX, 2017. e-Pub 2017.
60. Reyes ME, Ma J, Grove-Gaona M, Ater JL, Morrison AC, Hildebrandt MA. RNAseq hiPSC-cardiomyocytes reveals altered expression of DNA damage and cell cycle genes in response to doxorubicin. 15th International Conference on Long-Term Complications of Treatment of Children and Adolescents for Cancer, Atlanta, GA, 2017. e-Pub 2017.
61. Reyes ME, Ma J, Grove-Gaona M, Ater JL, Morrison AC, Hildebrandt MA. RNAseq hiPSC-cardiomyocytes reveals altered expression of DNA damage and cell cycle genes in response to doxorubicin. American Association for Cancer Research Annual Meeting, Washington, D.C, 2017. e-Pub 2017.
62. Ater JA, Thompson K, Hildebrandt MA. Relationships Among Hypertension (HTN) Susceptibility Loci, Hypertension, and Late Anthracycline-Related Cardiotoxicity in Childhood Cancer Survivors (CCS). MD Anderson Cancer Survivorship Research Symposium, Houston, TX, 2017. e-Pub 2017.
63. Thompson KA, Hildebrandt M, Yarbrough A, Badeaux C, Ater JA. Cardiac outcomes with pregnancy after cardiotoxic therapy for childhood cancer. MD Anderson Cancer Survivorship Research Symposium, Houston, TX, 2016. e-Pub 2016.
64. Ater JL, Thompson KA, Hildebrandt MA. Relationship among hypertension susceptibility loci, hypertension, and late anthracycline-related cardiotoxicity in long-term childhood cancer survivors. 48th Congress of the International Society of Paediatric Oncology, Dublin, Ireland, 2016. e-Pub 2016.
65. Pierzynski JA, Hildebrandt MA, Ye Y, Roth JA, Wu X. Baseline quality of life and genetic determinants and the impact on five-year lung cancer survival. American Association for Cancer Research Annual Meeting, Philadelphia, PA, 2015. e-Pub 2015.
66. Shu X, Hildebrandt MA, Gu J, Tannir NM, Matin S, Karam JA, Wu X. MicroRNA expression links obesity and recurrence in renal cell carcinoma. American Association for Cancer Research Annual Meeting, Philadelphia, PA, 2015. e-Pub 2015.
67. Thompson KA, Hildebrandt MA, Ater J. Cardiac outcomes with pregnancy after cardiotoxic cancer therapy in childhood. International Conference on Long-Term Complications of Treatment of Children and Adolescents for Cancer, Arlington, VA, 2015. e-Pub 2015.
68. Santibanez M, Rodriguez MA, Hildebrandt MA, Chang DW, Wu X. Mitochondrial DNA copy number and risk of second primary tumors in long-term breast cancer survivors. American Association for Cancer Research Annual Meeting, Philadelphia, PA, 2015. e-Pub 2015.
69. Hildebrandt MA, Wu X, Pu X, Ye Y, Morrison A, Ater J. Hypertension susceptibility loci are predictors of late anthracycline-related cardiotoxicity in long-term childhood cancer survivors. MD Anderson Cancer Survivorship Research Symposium, Houston, TX, 2015. e-Pub 2015.
70. Yu Y, Hu F, Chen JS, Sivakumar S, Hu H, Deshpande AD, Liu Y, Fowler R, Shankaracharya, Moore B, Ye Y, Hildebrandt M, Zhao H, Scheet P, Yandell M, Wu X, Huff CD. Whole-exome case-control association and somatic-germline interaction analyses of five major cancer types. Translating Cancer Epidemiology, Salt Lake City, UT, 2015. e-Pub 2015.
71. Zhang F, Meng QH, Ye Y, Hildebrandt MA, Huang M, Wu X. Pre-treatment clinical laboratory tests indicative of metabolic status are associated with survival in patients with non-small cell lung cancer. American Association for Cancer Research Annual Meeting, San Diego, CA, 2014. e-Pub 2014.
72. Hildebrandt MA, Ye Y, Zhou Y, Orlowski R, Wu X. Common, germline genetic variants within the Wnt/beta-catenin stem cell pathway as determinants of multiple myeloma risk. American Association for Cancer Research Annual Meeting, San Diego, CA, 2014. e-Pub 2014.
73. Pierzynski JA, Hildebrandt MA, Ye Y, Rodriguez A, Wu X. Genetic and social determinants of quality of life in lung cancer patients. American Association for Cancer Research Annual Meeting, San Diego, CA, 2014. e-Pub 2014.
74. Sanchez-Espiridion B, Liang D, Ajani JA, Liang S, Ye Y, Hildebrandt MA, Gu J, Wu X. Global metabolic profiling identifies novel serum markers for esophageal adenocarcinoma. American Association for Cancer Research Annual Meeting, San Diego, CA, 2014. e-Pub 2014.
75. Hildebrandt MA, Wu X, Pu X, Ye Y, Morrison A, Ater J. Hypertension susceptibility loci are predictors of late anthracycline-related cardiotoxicity in long-term childhood cancer survivors. European Symposium on Late Complications after Childhood Cancer, Edinburgh, Scotland, 2014. e-Pub 2014.
76. Melkonian SC, Daniel-MacDougall C, Hildebrandt MA, Tannir N, Ye Y, W-H C, Wood C, Wu X. Established genetic variants and dietary patterns jointly impact risk of renal cell carcinoma. American Association for Cancer Research Annual Meeting, San Diego, CA, 2014. e-Pub 2014.
77. Xu E, Lu KH, Hildebrandt MA, Huang M, Wu X, Liang D. Genetic variants in Notch signaling pathway and ovarian cancer. American Association for Cancer Research Annual Meeting, Washington, D.C, 2013. e-Pub 2013.
78. Pu X, Hildebrandt MA, Ye Y, Wang L, Weinshilboum RM, Wu X. Inflammation-related genetic variants predict radiation-induced toxicity following definitive radiotherapy for non-small cell lung cancer. American Association for Cancer Research Annual Meeting, Washington, D.C, 2013. e-Pub 2013.
79. Lian J, Lin J, Hildebrandt MA, Pu X, Chang J, Wu X. Genetic polymorphisms in DNA repair genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer. American Association for Cancer Research Annual Meeting, Washington, D.C, 2013. e-Pub 2013.
80. Pierzynski JA, Hildebrandt MA, Wu X, Lu KH, Liang D. Genetic variants in the Wnt/β-catenin signaling pathway as indicators of ovarian cancer risk and survival. American Association for Cancer Research Annual Meeting, Washington, D.C, 2013. e-Pub 2013.
81. Pu X, Hildebrandt MA, Kim JY, Ye Y, Vaporciyan AA, Correa AM, Swisher SG, Roth JA, Wu X. Genetic variations in the JAK-STAT pathway are associated with postoperative pulmonary complications after lobectomy in lung cancer patients. American Association for Cancer Research International Conference on Frontiers in Cancer Prevention Research, Anaheim, CA, 2012. e-Pub 2012.
82. Pu X, Ye Y, Spitz MR, Wang L, Gu J, Lippman SM, Hildebrandt MA, Hong WK, Minna JD, Roth JA, Yang P, Wu X. Predictors of survival in never-smokers with non-small cell lung cancer: A large-scale, two-phase genetic study. American Association for Cancer Research Annual Meeting, Chicago, IL, 2012. e-Pub 2012.
83. Hildebrandt MA, Lin M, Eng C, Kopetz S, He Y, Lin J, Sun W, Hawk E, Wu X. Common, germline genetic variants in the Wnt/beta-catenin signaling pathway and colorectal cancer susceptibility. American Association for Cancer Research International Conference on Frontiers in Cancer Prevention Research, Anaheim, CA, 2012. e-Pub 2012.
84. Zhang F, Eng C, Lin M, Hildebrandt MA, He Y, Lin J, Huang M, Gu J, Wu X. Genetic variations in aging related genes/pathways and colorectal cancer risk. American Association for Cancer Research International Conference on Frontiers in Cancer Prevention Research, Anaheim, CA, 2012. e-Pub 2012.
85. Hildebrandt MA, Pu X, Lippman SM, Wu X. Mitochondrial DNA copy number is inversely associated with overall survival in non-small cell lung cancer. American Association for Cancer Research Annual Meeting, Chicago, IL, 2012. e-Pub 2012.
86. Chung CC, Zhaoming W, Kanetsky CT, Turnbull C, McGlynn K, Greene MH, Hildebrandt MAT, Skotheim RI, Kratz C, Cook M, Schumacher F, Koster R, Yeager M, Jacobs KB, Schwartz S, Bishop DT, Cortessis V, Rahman N, Wu X, Chanockl SJ, Nathanson KL. Meta-analysis identifies four new loci for testicular germ cell tumor. American Society for Human Genetics Annual Meeting, San Francisco, CA, 2012. e-Pub 2012.
87. Wei H, Hildebrandt MA, Gu J, Ye Y, Huang M, Dinney CP, Wu X. A combined bioinformatics and GWAS approach indentifies a functional 3'-UTR insertion/deletion in YES1 associated with bladder cancer risk. American Association for Cancer Research Annual Meeting, Chicago, IL, 2012. e-Pub 2012.
88. Hildebrandt MA, Roth JA, Vaporciyan AA, Pu X, Ye Y, Correa AM, Kim JY, Swisher SG, Wu X. Genetic variation in the p38 signaling pathway as markers for postoperative pulmonary complications in lung cancer patients. American Association for Cancer Research Annual Meeting, Orlando, FL, 2011. e-Pub 2011.
89. Zhang X, Hildebrandt MA, Horikawa Y, Pu X, Wood CG, Gu J. The expression of RN7SK paralogs in tumors of renal cell carcinoma is associated with patient survival. American Association for Cancer Research Annual Meeting, Orlando, FL, 2011. e-Pub 2011.
90. Pu X, Spitz MR, Amos CI, Ye Y, Hildebrandt MA, Chang DW, Lu C, Stewart S, Roth JA, Lippman SM, Christiani D, Wu X. Genetic predictors of clinical outcomes for patients with non-small cell lung cancer. American Association for Cancer Research Annual Meeting, Orlando, FL, 2011. e-Pub 2011.
91. Hildebrandt MA, Gu J, Lin J, Ye Y, Tan W, Tamboli P, Wood CG, Wu X. Hsa-miR-9 expression patterns are associated with metastatic recurrence in patients with clear cell renal cell carcinoma through hypermethylation of the gene in tumor tissue. American Association for Cancer Research Annual Meeting, Washington, D.C, 2010. e-Pub 2010.
92. Tan W, Gu J, Hildebrandt MA, Huang M, Wistuba II, Roth JA, Spitz MR, Wu X. Aberrant MiRNA methylation in tumors from surgically resected lung cancer patients and association with survival. American Association for Cancer Research Annual Meeting, Washington, D.C, 2010. e-Pub 2010.
93. Yin J, Gu J, Lu C, Chang J, Hildebrandt MA, Spitz MR, Stewart D, Wu X. Genetic variations in the cell-cycle pathway and survival of patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy. American Association for Cancer Research Annual Meeting, Washington, D.C, 2010. e-Pub 2010.
94. Tan W, Hildebrandt MA, Pu X, Huang M, Tamboli P, Wood CG, Wu X. Role of inflammatory-related gene expression in clear cell renal cell carcinoma. American Association for Cancer Research International Conference on Frontiers in Cancer Prevention Research, Philadelphia, PA, 2010. e-Pub 2010.
95. Lin M, Hildebrandt M, Stewart D, Lippman SM, Lu C, Spitz MR, Wu X. Lung cancer chemotherapy: genetic variations in the transforming growth factor beta pathway as predictors of survival. American Association for Cancer Research Annual Meeting, Washington, D.C, 2010. e-Pub 2010.
96. Gu J, Ye Y, Spitz MR, Lin J, Kiemeney LA, Xing J, Hildebrandt MA, Hong WK, Amos CI, Wu X. A genetic variant near the PMAIP1/Noxa gene is associated with increased bleomycin sensitivity and cancer risk. American Association for Cancer Research Annual Meeting, Washington, D.C, 2010. e-Pub 2010.
97. Clague J, Chang J, Hildebrandt MA, Yang H, Lin J, Lu C, Stewart DJ, Wu X. Genetic variation in Sonic hedgehog pathway genes as predictors of survival in patients with non-small cell lung cancer. American Association for Cancer Research Annual Meeting, Denver, CO, 2009. e-Pub 2009.
98. Pu X, Lu C, Stewart DJ, Gu J, Hildebrandt MA, Lin J, Lippman SM, Wu X. MicroRNA-related polymorphisms are associated with clinical outcomes in early stage non-small cell lung cancer patients. American Association for Cancer Research International Conference on Frontiers in Cancer Prevention Research, Houston, TX, 2009. e-Pub 2009.
99. Hildebrandt MA, Lippman SM, Kim E, Lee JJ, Khuri FR, Spitz MR, Lotan R, Hong WK, Wu X. Pharmacogenetics of retinoid chemoprevention in head and neck cancer patients: modulation of response by common genetic variation in the mTOR signaling pathway. American Association for Cancer Research International Conference on Frontiers in Cancer Prevention Research, Houston, TX, 2009. e-Pub 2009.
100. Chen M, Kamat A, Hildebrandt MA, Zhang X, Grossman, HB, Dinney CP, Wu X. Genetic variations in the Sonic hedgehog pathway and clinical outcomes in bladder cancer. American Association for Cancer Research International Conference on Frontiers in Cancer Prevention Research, Houston, TX, 2009. e-Pub 2009.
101. Pu X, Lippman SM, Hildebrandt MA, Chang JY, Lu C, Stewart DJ, Wu X. Genetic variations in genes encoding microRNA processing genes are associated with overall survival in non-small cell lung cancer patients. American Association for Cancer Research Annual Meeting, Denver, CO, 2009. e-Pub 2009.
102. Hildebrandt MA, Komaki R, Chang JY, Liao Z, Stewart DJ, Ye Y, Gu J, Spitz MR, Wu X. Genetic variants in inflammation pathway genes are associated with the development of radiation-induced toxicity following treatment for non-small cell lung cancer. American Association for Cancer Research Annual Meeting, Denver, CO, 2009. e-Pub 2009.
103. Ji Y, Olson J, Zhang J, Hildebrandt MA, Wang L, Ingle J, Fredericksen Z, Sellers T, Miller W, Dixon M, Brauch H, Eichelbaum M, Justenhove C, Hamann U, Ko Y, Buning T, Chang-Claude J, Wang-Gohrke S, Schaid D, Weinshilboum R. Membrane-bound (MB) catechol O-methyltransferase (COMT) genetic polymorphisms: catecholestrogen conjugation and breast cancer risk reduction. American Society of Clinical Pharmacology and Experimental Therapeutics Annual Meeting, Orlando, FL, 2008. e-Pub 2008.
104. Moyer A, Sun Z, Jenkins G, Batzler A, Hildebrandt MA, Schaid D, Yang P, Weinshilboum R. Glutathione pathway pharmacogenomics and response to platinum-based chemotherapy of lung cancer. American Society of Clinical Pharmacology and Experimental Therapeutics Annual Meeting, Orlando, FL, 2008. e-Pub 2008.
105. Hildebrandt MA, Tamboli P, Huang M, Ye Y, J-S L, Wu X. Kinase gene expression profiles are associated with clinical outcomes in clear cell renal cell carcinoma patients. American Association for Cancer Research International Conference on Frontiers in Cancer Prevention Research, Washington, DC, 2008. e-Pub 2008.
106. Chen M, Cassidy A, Gu J, Yang H, Hildebrandt MA, Lin J, Ye Y, Dinney CP, Wu X. Genetic variation in PI3K-AKT-mTOR pathway and urinary bladder cancer risk. American Association for Cancer Research International Conference on Frontiers in Cancer Prevention Research, Washington, DC, 2008. e-Pub 2008.
107. Hildebrandt MA, Yang H, M-C H, Izzo J, Huang M, Ajani J, Wu X. Genetic variation in AKT1 and AKT2 is associated with clinical outcomes following chemotherapy of esophageal cancer. American Association for Cancer Research Annual Meeting, San Diego, CA, 2008. e-Pub 2008.
108. Clague J, Lin J, Chang J, Hildebrandt MA, Izzo J, Yang H, Kamat A, Wu X. Genetic variations in Sonic pathway genes as predictors of bladder cancer risk. American Association for Cancer Research International Conference on Frontiers in Cancer Prevention Research, Washington, DC, 2008. e-Pub 2008.
109. Li L, Fridley B, Kalari K, Jenkins G, Batzler A, Hildebrandt MA, Schaid D, Weinshilboum R, Wang L. A genome-wide approach to identify pharmacogenomic candidate genes that contribute to variation in cytosine arabinoside (Ara-C) cytotoxicity. American Society of Human Genetics Annual Meeting, Anaheim, CA, 2007. e-Pub 2007.
110. Hildebrandt MA, Yang H, M-C H, Izzo J, Huang M, Ajani J, Wu X. Genetic variation in AKT1 and AKT2 is associated with clinical outcomes following chemotherapy of esophageal cancer. 60th Annual Symposium on Cancer Research - Personalized Risk Assessment and Management, Houston, TX, 2007. e-Pub 2007.
111. Moyer A, Salavaggione O, Hebbring S, Moon I, Hildebrandt MA, Eckloff B, Schaid D, Wieben E, Weinshilboum R. Glutathione S-Transferase T1 and M1 pharmacogenomics. American Society of Clinical Pharmacology and Experimental Therapeutics Annual Meeting, San Diego, CA, 2007. e-Pub 2007.
112. Wang, L, Li L, Fridley B, Kalari K, Batzler A, Jenkins G, Hildebrandt MA, Schaid D. Pharmacogenomics of cytidine analogues: application of a cell-based model system. Cold Spring Harbor Laboratory/Sanger Centre Joint Pharmacogenetics Meeting, Sanger Centre, Hinxton, UK, 2007. e-Pub 2007.
113. Schaid D, Hildebrandt MA, Weinshilboum R. Scanning for ‘Hot Spot’ SNPs having a large number of trans-effects on quantitative gene expressions. 8th International Meeting on Human Genome Variation and Complex Genome Analysis, Hong Kong, 2006. e-Pub 2006.
114. Hildebrandt MA, Carrington D, Thomae B, Eckloff B, Schaid D, Yee V, Weinshilboum R, Wieben E. Sulfotransferase pharmacogenomics: gene family sequence variation and functional genomics. 46th Annual Short Course in Experimental and Mammalian Genetics, The Jackson Laboratory, Bar Harbor, ME, 2005. e-Pub 2005.
115. Hildebrandt MA, Salavaggione O, Martin, Y, Flynn H, Jalal S, Wieben E Weinshilboum R. Human SULT1A3 pharmacogenetics: gene duplication and functional genomic studies. Engebretson Symposium on Drug Discovery and Development, Minneapolis, MN, 2005. e-Pub 2005.
116. Hildebrandt MA, Carrington D, Thomae B, Eckloff B, Schaid D, Yee V, Weinshilboum R, Wieben E. Genetic diversity and function in the human cytosolic sulfotransferases. NIGMS Pharmacogenomics Resarch Network (PGRN) II Scientific Meeting, St. Louis, MO, 2005. e-Pub 2005.
117. Hildebrandt MA, Salavaggione O, Martin, Y, Flynn H, Jalal S, Wieben E Weinshilboum R. Human SULT1A3 pharmacogenetics: gene duplication and functional genomic studies. American Society of Clinical Pharmacology and Experimental Therapeutics Annual Meeting, 2005. e-Pub 2005.
118. Thomae B, Rifki O, Theobald MA, Eckloff B, Wieben E, Weinshilboum R. Human catecholamine sulfotransferase (SULT1A3) pharmacogenetics: common functional genetic polymorphism in African-American subjects. American Society of Clinical Pharmacology and Experimental Therapeutics Annual Meeting, 2003. e-Pub 2003.